datetime,headline,summary,related,lang,source
2020-12-10 02:41:34-05:00,"Transient Protein Expression Market with Top Players like Thermo Fisher Scientific, Promega Corporation, Merck KGaA Takara Bio, Qiagen Bio-Rad Laboratories, STEMCELL Technologies, Bioline, New England Biolabs, TOYOBO.inc, Genscript Biotech Corporation","In popularizing transient expression, advances in genetic science have played a crucial role. In the field of zoology, studying animal cells has become a focus, generating new growth prospects across the global market for transient protein expression. Throughout the field",QGEN,en,OpenPR
2020-12-09 06:26:39-05:00,Warburg Research Stick to Their Hold Rating for Qiagen NV,Warburg Research Stick to Their Hold Rating for Qiagen NV,QGEN,en,Investing.com
2020-12-08 08:07:00-05:00,Qiagen: Corona-Tests sorgen für Prognoseerhöhung,Corona-Testkits treiben nach wie vor die Geschäfte bei Qiagen an und sorgen für Zuversicht im Management. Umsatz und Gewinn sollen sich 2020 noch besser entwickeln als ohnehin schon gedacht – das treibt die Qiagen-Aktie an.,QGEN,de,Finanztreff
2020-12-07 11:24:26-05:00,Qiagen launches coronavirus T-cell test for long-term immunity research,Qiagen has launched a new COVID-19 blood test designed for researchers trying to uncover the intricacies of the body’s immune response to the novel coronavirus.,QGEN,en,FierceBiotech
2020-12-07 02:00:00-05:00,"QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response - Stocks News Feed","• T-cell response has the potential to give a clearer picture of immunity and course of illness • T-cell response to SARS-CoV-2 may decline less rapidly than antibodies • Potentially vital tool for research into immune response and vaccination efficacy HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)–$QGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today… Read More »QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response",QGEN,en,Stocks News Feed
2020-12-04 21:45:36-05:00,"Cancer Tumor Profiling Market is Expected to reach $82,447 million by 2023 With Top Key Players Like Qiagen N.V.,Roche Molecular Systems Inc. (Roche),Abbott Molecular (Abbott Laboratories)","Cancer/tumor profiling uses several molecular biology techniques, such as microarray, polymerase chain reaction (PCR), and in situ hybridization (ISH), to provide specific information about genetic and molecular makeup of tumor. It can detect the presence or absence of distinct disease-associated",QGEN,en,OpenPR
2020-12-04 14:31:49-05:00,"Global Electrophoresis Reagents Market Share Size, Statistics, Demand, Revenue, Top Companies And Forecast 2026||Top Players-Lonza, QIAGEN, Merck KGaA, Takara Bio Inc., Thermo Fisher Scientific, SEBIA, Randox Laboratories Ltd., ELITechGroup, Expedeon Ltd","Global Electrophoresis Reagents Market is estimated to rise from its initial estimated value of USD 0.94 billion in 2018 to an estimated value of USD 1.44 billion by 2026, registering a CAGR of 5.5% in the forecast period of 2019-2026.",QGEN,en,OpenPR
2020-12-04 06:59:30-05:00,"Enteroviruses Testing Kit Market - Sartorius AG, Abbexa Ltd, Cepheid Inc., Aviva Systems Biology Corporation, Cusabio Technology LLC, ELITech Group SAS, Creative Diagnostics, Quidel Corporation, DiaSorin, bioMérieux, Primerdesign Ltd, and QIAGEN.",An informative study on the Enteroviruses Testing Kit Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and,QGEN,en,OpenPR
2020-12-03 06:44:59-05:00,"Global immunodiagnostics market 2020 Is Thriving Globally With F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC",Databridgemarketresearch.com Present “Global immunodiagnostics market– Industry Trends and Forecast to 2027” new report to its research database. The report spread No of pages: 350 No of Figures: 60 No of Tables: 220 in it. Global immunodiagnostics market latest research report,QGEN,en,OpenPR
2020-12-02 11:06:35-05:00,"Global Next Generation Cancer Diagnostics Market Growth Factors and Applications by 2027 with Top Key Players: Telerad Tech, F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Hologic Inc., Illumina, Inc., QIAGEN, BioGenex, Siemens Healthcare GmbH",The Next Generation Cancer Diagnostics report published by Data Bridge Market research is the representation of data and analysis of the market. It gives detailed analysis of the current market scenario and a market forecast till 2027. The,"QGEN,GE",en,OpenPR
2020-12-02 03:27:28-05:00,"Companion Diagnostics Market Impact Of covid19 - Abbott Laboratories, Agilent Technologies Inc., Danaher Corporation, Qiagen N.V., F. Hoffmann-La Roche AG, bioMerieux S.A., Illumina, Inc., GE Healthcare, Myriad Genetics Inc., and Siemens Healthineers.",An informative study on the Companion Diagnostics Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries,QGEN,en,OpenPR
2020-12-01 10:07:11-05:00,"Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Share and SWOT Analysis: QIAGEN, Beckman, Johnson & Johnson","Market Growth Insight has presented updated research report on ‘Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market’, offering insightful information like market share, market size, and growth rate during the forecast period 2020 - 2026 that",QGEN,en,OpenPR
2020-11-27 10:07:46-05:00,"Global Coronavirus Test Kits Market Recent Study including Growth Factors 2027 - Top Companies QIAGEN, F.Hoffmann-La Roche Ltd, Seegene Inc, SolGent Co. Ltd",DBMR has added a new report titled Global Coronavirus Test Kits Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. The Global Coronavirus Test Kits Market,QGEN,en,OpenPR
2020-11-26 04:48:30-05:00,"Non-Invasive Cancer Diagnostics Market - Roche Diagnostics, Hologic Inc., Qiagen, Gen-Probe Inc., Digene Corporation, Abbott Molecular, IVDiagnostics, Laboratory Corporation of America Holdings, OncoCyte Corporation, Arquer Diagnostics Ltd. and Affymetrix",An informative study on the Non-Invasive Cancer Diagnostics Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and,QGEN,en,OpenPR
2020-11-26 04:37:59-05:00,"Immune Repertoire Sequencing Market - Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Techn",An informative study on the Immune Repertoire Sequencing Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and,QGEN,en,OpenPR
2020-11-25 00:45:13-05:00,Independent Research Stick to Their Sell Rating for Qiagen NV,Independent Research Stick to Their Sell Rating for Qiagen NV,QGEN,en,Investing.com
2020-11-24 08:21:19-05:00,"Germany's DAX Index Announces Biggest Overhaul Since Inception, Expanding From 30 To 40 Companies","Germany's DAX Index Announces Biggest Overhaul Since Inception, Expanding From 30 To 40 Companies Tyler Durden Tue, 11/24/2020 - 08:21 Imagine if the Dow Jones just announced it would expand by a third, growing from 30 member stocks to 40. Well, that's what happened overnight in Germany, when the operator of Germany's DAX index announced its most sweeping overhaul since its inception, adding 10 new companies and new quality controls after the implosion of Wirecard rocked investor confidence in the gauge. According to Bloomberg , the changes will trigger ""billions of euros of passive flows for the new members"" which are likely to come from the largest stocks in Germany’s MDAX gauge, which include Airbus SE, Siemens Healthineers AG, Sartorius AG and Zalando SE. Qontigo, which operates the DAX index, said in a statement that it will boost the number of DAX members to 40 from 30 in the third quarter of next year, while reducing MDAX membership to 50 from 60 companies. “In general, the larger volume, the slightly higher diversification and the slightly increased share of dynamically growing companies is positive for the DAX and should slightly improve the leading German index,” said Ulrich Urbahn, head of multi-asset strategy and research at Berenberg Bank.",QGEN,en,Zero Hedge
2020-11-24 08:03:39-05:00,"RNA Analysis/Transcriptomics Market worth USD 8.7 Billion by 2025 - Leading Companies are Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Illumina Inc, QIAGEN N.V, F. Hoffmann-La Roche Ltd, Danaher Corporation","According to the new market research report ""RNA Analysis/Transcriptomics Market by Product (Reagents, Instruments, Software), By Technology (Microarrays, NGS, Sanger), By Application (Clinical Diagnostics, Drug Discovery), By End User (CROs, Hospitals), COVID-19 Impact - Global Forecast to 2025"", published by",QGEN,en,OpenPR
2020-11-24 07:04:28-05:00,Qiagen: Strategische Probleme | www.4investors.de,Die Pandemie sorgt für einen Nachfrageschub bei Qiagen. Es werden vermehrt Corona-Testlösungen benötigt. Daher steigt auch die Prognose bei Qiagen wieder,QGEN,de,4investors
2020-11-24 04:01:28-05:00,"Biomarker Market to See Huge Growth by 2025 | QIAGEN N.V., PerkinElmer, Merck Millipore","Latest Research Study on Global Biomarker Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Global Biomarker Market research report shows the latest market insights with upcoming trends and breakdown of the products",QGEN,en,OpenPR
2020-11-24 02:56:24-05:00,"Hepatitis C Virus (HCV) Testing Market Updates is Coming In Days — Here’s What to Look Out For | Players Roche Diagnostics, Abbott, Siemens, Qiagen, bioMrieux, Bio-Rad Laboratories,, Meridian Bioscience, Vista Diagnostics, Biogate Laboratories, Siemen","Stratagem Market Insights has recently added a Hepatitis C Virus (HCV) Testing Market Research Report that reveals diverse information allowing keen market participants to understand the measures of the market. The report provides an overview of competitive landscape analysis, major",QGEN,en,OpenPR
2020-11-24 01:33:42-05:00,"Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Will Make The Biggest Moves During 2020-2027 | F. Hoffmann-La Roche, Alere, Abbott, Beckman Coulter, Bio-Rad, Qiagen, ViennaLab, Wama Diagnostica, Autobio Diagnostics, Hema Diagnostics",Stratagem Market Insights has recently added a Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Research Report that reveals diverse information allowing keen market participants to understand the measures of the market. The report provides an overview of competitive landscape,QGEN,en,OpenPR
2020-11-23 06:37:24-05:00,"In Vitro Diagnostics Market worth USD 96.0 billion by 2025 - Leading Companies Roche Diagnostics Limited, Siemens Healthineers, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Ortho-Clinical Diagnostics, and Qiagen","According to the new market research report ""In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025"", published by MarketsandMarkets™, analyzes",QGEN,en,OpenPR
2020-11-20 11:14:10-05:00,News briefing: ADC gets a speedy FDA review for their DLBCL therapy; Qiagen teams with the world's new favorite biotech,"The transatlantic biotech ADC Therapeutics is getting a speedy review for its anti-body drug conjugate loncastuximab tesirine (Lonca), developed for relapsed or refractory diffuse large B-cell lymphoma. ADC $ADCT said Friday morning that the FDA put their drug on the fast lane, providing a priority review for the drug with",QGEN,en,Endpoints News
2020-11-19 23:54:23-05:00,"mRNA Sequencing Market Rapidly Increasing In Size Globally (2020-2025) and Market Analysis by Top Key Vendors (GE, Roche, Thermo Fisher, Illumina, QIAGEN, Agilent, Bio-Rad Lab, Fluidigm)","Global mRNA Sequencing Market Synopsis: The report covers a forecast and an analysis of the mRNA Sequencing Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020",QGEN,en,OpenPR
2020-11-19 09:37:00-05:00,QIAGEN- und BioNTech-Aktien legen zu: QIAGEN und BioNTech forschen gemeinsam,"Das gewebebasierte Diagnostikum soll zur Identifizierung von Patienten mit Plattenepithelkarzinomen in der Kopf-Hals-Region eingesetzt werden, die auf Infektionen mit dem humanen Papillomavirus (HPV) zurückzuführen sind, wie QIAGEN mitteilte. Den Test, der auf die Präsenz von HPV-Genotypen…",QGEN,de,Finanzen CH
2020-11-19 06:00:00-05:00,QIAGEN und BioNTech forschen gemeinsam - BioNTech-Aktie vorbörslich höher,"Das gewebebasierte Diagnostikum soll zur Identifizierung von Patienten mit Plattenepithelkarzinomen in der Kopf-Hals-Region eingesetzt werden, die auf Infektionen mit dem humanen Papillomavirus (HPV) zurückzuführen sind, wie QIAGEN mitteilte. Den Test, der auf die Präsenz von HPV-Genotypen…",QGEN,de,Finanzen CH
2020-11-19 01:59:02-05:00,"Global Next Generation Cancer Diagnostics Market Future Demand, Market Analysis & Outlook to 2027|| Telerad Tech, F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Hologic Inc., Illumina, Inc., QIAGEN, BioGenex","Data Bridge Market research presents the top quality and comprehensive Next Generation Cancer Diagnostics research report which provides clear insights into market dynamics and prospects the whole market including global production, revenue forecast, value and volume. This Next Generation",QGEN,en,OpenPR
2020-11-18 08:52:39-05:00,"PHARMACOGENETIC TESTING MARKET SIZE & SHARE ANALYSIS BY F. HOFFMANN-LA ROCHE LTD, QIAGEN, LUMINEX CORPORATION, EUROFINS SCIENTIFIC","Pharmacogenetic Testing Market By Type (Single Gene Tests, Array-Based Tests, Whole Genome Sequencing & NGS, Whole Exome Sequencing), Sample (Blood, Saliva), Therapeutic Area (Oncology, Neurology, Cardiology, Genomics, Immunology & Hypersensitivity, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies, Direct-To-Customer",QGEN,en,OpenPR
2020-11-18 06:56:13-05:00,"Recent Updates on NGS-Based RNA-Sequencing Market 2020-2027, Global Players are Oxford Nanopore Technologies., PerkinElmer, Psomagen, QIAGEN, Takara Bio",Global NGS-Based RNA-Sequencing Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales promotion efforts. The market report is a professional yet exhaustive study on the current state for the,QGEN,en,OpenPR
2020-11-17 07:10:11-05:00,"Consumer Genomics Market : COVID-19 Impact Analysis with Size, Share, Industry Outlook and Future Scope, Leading Players are Gene by Gene, Veritas Genetics, Myriad Genetics, Toolbox Genomics, QIAGEN, Eurofins Scientific","Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the Consumer Genomics Market research report. Further, manufacturer can adjust production according to the conditions of demand which are analyzed here. The report aids",QGEN,en,OpenPR
2020-11-16 22:20:00-05:00,This Is What Hedge Funds Bought And Sold In Q3: Complete 13F Summary,"This Is What Hedge Funds Bought And Sold In Q3: Complete 13F Summary Tyler Durden Mon, 11/16/2020 - 22:20 While we live in a time when the holdings of the top 20 Robinhood ""investors"" have far more information value for markets and other traders than a glimpse into what hedge funds are doing, not in the least because retail investors are outperforming both the S&P500 and hedge funds 10-to-1… ... unfortunately there is still no regulatory requirement for even superstar retail investors to disclose their holdings, which is why we have to be satisfied with the quarterly 13-F publication spectacle, which just concluded today, and which revealed that even as tech stocks suffered two correction shakeouts since early September, hedge funds mostly stuck with the ""safety"" of tech stocks during the third quarter heading into the election, even as some hedge funds trimmed Amazon.com as the dominant e-commerce platform thrived amid a pandemic-fueled surge in online shopping, while others sold Netflix Courtesy of Bloomberg, below is a snapshot of what some of the most prominent tech stock additions as disclosed by today's barrage of 13F filings: Coatue Management doubled its holdings of Tesla in the three months ended Sept. 30, making the electric-vehicle maker its second-biggest publicly disclosed holding.","QCOM,QRVO,QGEN,PYPL",en,Zero Hedge
2020-11-16 16:05:00-05:00,QIAGEN führt NeuMoDx-Multiplex-Test zur Vervollständigung des SARS-CoV-2-Testportfolios in Europa und weiteren Märkten ein,"QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung des NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Tests bekannt gegeben, mi",QGEN,de,Business Wire
2020-11-12 13:11:50-05:00,Qiagen Rises on Launch of Covid Antigen Test,Qiagen shares were higher after the medical-diagnostics company launched an antigen test to detect coronavirus infections within two to 15 minutes.,QGEN,en,The Street
2020-11-12 12:32:10-05:00,"Metagenomics Market Top-Companies, Future-Growth, Regional Analysis, Business-Opportunities 2027 | Agilent Technologies, Enterome SA, Roche, Illumina, Qiagen, Swift Biosciences","Despite being in the infant stage, the field of metagenomics has already generated large amount of data, which aids in the comparison of healthy microbiomes to disease states. Additionally, metagenomic sequencing products and bioinformatics tools have facilitated the analysis of",QGEN,en,OpenPR
2020-11-12 09:12:00-05:00,QIAGEN führt mobilen digitalen Corona-Test ein - QIAGEN-Aktie tiefer,"Mit diesem soll ein Nachweis von SARS-CoV-2-Antigenen bei Menschen mit aktiven Infektionen innerhalb von 2 bis 15 Minuten möglich sein, teilte das Biotech -Unternehmen mit. Der QIAreach SARS-CoV-2-Antigentest, entwickelt im Rahmen der Partnerschaft mit dem australischen Anbieter für digitale…",QGEN,de,Finanzen CH
2020-11-11 16:05:00-05:00,QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour,QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour,QGEN,en,Business Wire
2020-11-11 16:05:00-05:00,QIAGEN führt mobilen digitalen SARS-CoV-2-Antigentest mit hoher Genauigkeit und einer Analysekapazität von mehr als 30 Proben pro Stunde ein,"QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat in den USA mit der Vermarktung eines mobilen digitalen Tests für Labore begonnen, mit dem ein N",QGEN,de,Business Wire
2020-11-11 02:52:40-05:00,QIAGEN kauft bis Mitte Dezember rund 2 Millionen Aktien zurück,"Das Biotech-Unternehmen aus dem niederländischen Venlo setzt nach einer Mitteilung vom Mittwoch ab sofort ein ursprünglich im Mai vergangenen Jahres angekündigtes Rückkaufprogramm um. Auf Basis des Schlusskurses vom Dienstag reicht das Geld, um rund 2 Millionen",QGEN,de,Finanzen CH
2020-11-10 12:14:02-05:00,"Global Protein Purification and Isolation Market 2020:Industry Demand, Future prospects and Applications||Healthy Growth Analysis By GENERAL ELECTRIC COMPANY, Thermo Fisher Scientific Inc., QIAGEN, BIO-RAD LABORATORIRES INC., Agilent, Promega Corporation,","Global Protein Purification and Isolation Market According to Data Bridge Market Research new Market report, “By Technology (Ultrafiltration, Precipitation, Preparative Chromatography Techniques {Affinity Chromatography [Immobilized Metal Ion Affinity Chromatography, Immunoaffinity Chromatography, Bead Based Chromatography], Ion Exchange Chromatography, Reverse Phase Chromatography,",QGEN,en,OpenPR
2020-11-10 11:09:00-05:00,"Corona-Test-Hersteller am Anschlag: ""Wir sind in einer Tsunami-Welle""",Die Hersteller von Corona-Tests arbeiten am Anschlag. Kai te Kaat vom Diagnostikhersteller Qiagen vergleicht die Situation im Podcast mit einer Tsunami-Welle.,QGEN,de,Stern
2020-11-10 11:09:00-05:00,"""Die Stunde Null"": Corona-Test-Hersteller am Anschlag: ""Wir sind in einer Tsunami-Welle""","Die Hersteller von Corona-Tests arbeiten am Anschlag. Kai te Kaat vom Diagnostikhersteller Qiagen vergleicht die Situation mit einer Tsunami-Welle. Im Podcast erzählt er, warum Labore und Testhersteller neue Strategien entwickeln müssten.",QGEN,de,Stern
2020-11-10 05:15:02-05:00,"New Study Report on Global DNA/RNA Extraction Kits Market by Forecast to 2026 | Roche Life Science, Thermo Fisher Scientific, Qiagen, Merck Millipore","This report titled as “Global DNA/RNA Extraction Kits Market”, gives a brief about the comprehensive research and an outline of its growth in the market globally. It states about the significant market drivers, trends, limitations and opportunities to give a",QGEN,en,OpenPR
2020-11-09 07:35:38-05:00,"S&P Futures, Global Stocks Soar To All Time High, Russell Limit Up On Covid Vaccine News","S&P Futures, Global Stocks Soar To All Time High, Russell Limit Up On Covid Vaccine News Tyler Durden Mon, 11/09/2020 - 07:35 Biden in, COVID out. Global stocks and S&P futures exploded higher, hitting all time highs, following this morning's news that a Pfizer covid vaccine is more than 90% effective, which came at a time when stocks were already euphoric in the overnight session following the weekend's political news that Biden was in. ""This is about the best the news could possibly be for the world and for the United States and for public health,"" said William Gruber, Pfizer senior vice president for vaccine clinical research and development. It was better than even the best result he had hoped for, he said. The news, which conveniently came just days after Biden was declared president elect by the media, sent Emini S&P futures up as much as 4%, last seen up 124 points to 3,634 or up 3.8%… ... and hitting new all time highs... ... pushing European stocks up 3.9%, led by travel, banks, energy and auto sectors... ... and Dow futures up 5%, or more than 1,400 points, to 29,650... ... the ETF of Russell 2000 ETF small-caps, the RTY, just hit the 7% limit up.",QGEN,en,Zero Hedge
2020-11-06 14:06:45-05:00,"Biochips Market 2020 SWOT Analysis By Major Eminent Vendors: Fluidigm Corporation, Horiba Ltd, Qiagen N.V, Thermo Fisher Scientific, Randox Laboratories","Global Biochips market report provides a detailed analysis of the market Competitive Situation and Trends, Agreements, Partnerships, and Collaborations, Product Launches, and Enhancements, Stakeholders and outlook by 2024 To help clients improve their market position, this biochip market forecast report",QGEN,en,OpenPR
2020-11-06 10:56:48-05:00,"Research Antibodies And Reagents Market : Seeking Excellent Growth |Industry Trends, Covid-19 Impact Analysis 2026 | Top Companies- Thermo Fisher Scientific, Inc., QIAGEN , Abcam plc, Abbott","The Research Antibodies And Reagents Market business report endows with wide-ranging statistical analysis of the market’s continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. The major topics such as market definition, market segmentation, competitive analysis and research methodology",QGEN,en,OpenPR
2020-11-06 05:43:32-05:00,"COVID-19 Detection Kits Market - Co-Diagnostics, Inc F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Abbott Laboratories, BGI, Cepheid Inc, BioFire Diagnostics, GenMark Diagnostics, Qiagen","The COVID-19 Detection Kits research report covers the current scenario and the growth prospects of the global COVID-19 Detection Kits industry forecast 2020 - 2027. The report enlists several important factors, starting from the basics principal to advanced market intelligence",QGEN,en,OpenPR
2020-11-05 08:10:01-05:00,"Global Carrier Screening Market 2020:Size, Development and Overview by 2027||Companies Included- Abbott, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Illumina, Inc., QIAGEN",A credible Carrier Screening market report is an important source for the best market and business solutions for the healthcare industry in this rapidly altering market place. The report has been formed by taking into thought numerous aspects of marketing,QGEN,en,OpenPR
2020-11-05 06:59:33-05:00,"Global Diagnostic Tests Market 2020 May See A Big Move||Key Players-ABBOTT, Danaher, BD, Thermo Fisher Scientific Inc., ACON Laboratories Inc., Hemosure, Inc., MicroGen Diagnostics, QIAGEN, Grifols, S.A, BODITECH MED INC","Global Diagnostic Tests Market - Industry Trends and Forecast to 2027 Global Diagnostic Tests Market is expected to take a steep surge in the business, according to an analysis by Data Bridge Market Research. Increase in prevalence of chronic disease, rising",QGEN,en,OpenPR
2020-11-03 09:44:20-05:00,"Vector-Based RNAi Market SWOT Analysis by Key Players- Thermo Fisher Scientific, Qiagen, Merck & Co","Global Vector-Based RNAi Market Report 2020 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers,",QGEN,en,OpenPR
2020-11-03 01:56:21-05:00,"Transplant Diagnostics Market Account To US$ 1,542.89 Mn By 2027 By Top Players Like Thermo Fisher Scientific, Abbott, Illumina, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, bioMérieux SA, QIAGEN, Hologic, Luminex Corporation and Omixon and others",A report by The Insight Partner's on the Transplant Diagnostics Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the,QGEN,en,OpenPR
2020-11-03 01:35:46-05:00,"Molecular Diagnostics Market Overview, Outlook, Recent Trend By 2026 | Abbott Laboratories, Johnson & Johnson, Qiagen N.V., Novartis AG","This Molecular Diagnostics Market research report is a great store to acquire current as well as upcoming technical and financial details of the industry for the precise forecast period. This market report also provides information about the brand awareness, market",QGEN,en,OpenPR
2020-11-03 00:41:07-05:00,"Oxidative Stress Analysis Market 2020 Industry Segmentation, CAGR Status, Leading Trends and Forecast To 2026 | Enzo Life Sciences, QIAGEN, BioVision, Cell Biolabs, Array BioPharma","This Oxidative Stress Analysis Market research report is a great store to acquire current as well as upcoming technical and financial details of the industry for the precise forecast period. This market report also provides information about the brand awareness,",QGEN,en,OpenPR
2020-10-30 03:25:54-05:00,"Lab Automation in Clinical Diagnostics Market With Top Players like Tecan Group, PerkinElmer, Danaher, Agilent Technologies, Thermo Fisher, Hamilton Robotics, Abbott Diagnostics, Eppendorf, QIAGEN, Roche Diagnostics","Lab Automation in Clinical Diagnostics is a milestone in a field of medical science. Lab automation refers to a multi- disciplinary approach used in laboratory to increase the productivity, increase the efficiency and reduce overall time of procedure. Automation provides",QGEN,en,OpenPR
2020-10-28 07:24:15-05:00,"Plasma Separation Tube Market Technological Advancement, Worldwide Industry Growth and Top Manufacturers: Immucor, Medtronic, QIAGEN N.V., Sarstedt AG & Co.",Global Plasma Separation Tube Market Analysis to 2025 is a specialized and in-depth study of the Plasma Separation Tube industry with a focus on the global market trend. The research report on Plasma Separation Tube Market provides comprehensive analysis on,QGEN,en,OpenPR
2020-10-28 06:26:00-05:00,QIAGEN-Aktie auf Kaufzetteln: QIAGEN erhöht Ausblick für 2020,Das im MDAX und TecDAX notierte Unternehmen hob den Ausblick für das Gesamtjahr an. So rechnet QIAGEN für 2020 nun mit einem Umsatzwachstum auf Basis konstanter Wechselkurse von etwa 20 Prozent.,QGEN,de,Finanzen CH
2020-10-28 05:08:00-05:00,Wichtige Kursbewegungen: Qiagen liefert erhoffte Prognoseanhebung - Aktie steigt,Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:,QGEN,de,BORSE ONLINE
2020-10-27 15:58:55-05:00,FXNEWS24 |Qiagen (QGEN) Tops Q3 Earnings and Income Estimates | UK Forex Reviews,"Qiagen (QGEN) Tops Q3 Earnings and Income Estimates | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News",QGEN,en,FXNews24
2020-10-27 12:26:00-05:00,Starkes Umsatzwachstum: Hohe Nachfrage nach Corona-Tests: Qiagen hebt Jahresprognose,"Der Hildener Biotechkonzern kündigt mehr Umsatz und mehr Gewinn je Aktie an, Covid-19-Tests zeigen sich als Wachstumstreiber. Die Aktie legt zu.",QGEN,de,Handelsblatt
2020-10-27 12:21:10-05:00,Ex-Chef von Qiagen wurde ungewöhnlich gut bezahlt,Jahrelang zahlte das Biotech-Unternehmen Qiagen Millionen ans Topmanagement und nutzte Steuersparmodelle. Zugleich gab es Geld vom Staat.,QGEN,de,Süddeutsche Zeitung
2020-10-27 12:07:43-05:00,QIAGEN erhöht Ausblick für 2020 - QIAGEN-Aktie nachbörslich auf Kaufzetteln,Das im MDAX und TecDAX notierte Unternehmen hob den Ausblick für das Gesamtjahr an. So rechnet QIAGEN für 2020 nun mit einem Umsatzwachstum auf Basis konstanter Wechselkurse von etwa 20 Prozent.,QGEN,de,Finanzen CH
2020-10-27 07:23:49-05:00,"Liquid Biopsy Market (COVID-19 Impact Analysis) 2020 Outlook Industry Analysis, Size, Share, Growth, Trends And Forecast, Leading Players are Eurofins Scientific, QIAGEN, Myriad Genetics, Genomic Health, RainDance Technologies","This Liquid Biopsy Market research report makes available state-of-the-art information about the entire market along with the holistic view of the market. This global market research report displays a complete overview of the market, including myriad of aspects such as",QGEN,en,OpenPR
2020-10-27 06:21:19-05:00,"Oncology Molecular Diagnostics Market Top Key Players-Danaher Corporation, Gen Probe(Hologic), Qiagen N.V., Roche Diagnostics, Siemens Healthcare Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027","Summary of the Oncology Molecular Diagnostics Market Report Due to the various economic, technological, research & development and geographical aspects, the Oncology Molecular Diagnostics Market would gain a healthy CAGR and market size from 2020 to 2027. The growth",QGEN,en,OpenPR
2020-10-27 04:28:25-05:00,"Coronavirus (Covid-19) Test Kits Market to 2027 Report on Industry Insights, Market Overview, Top Company Players and Comprehensive Analysis| QIAGEN, Hoffmann-La Roche Ltd, Seegene, SolGent Co. Ltd, Curetis, KURBO INDUSTRIES LTD, Mologic","An up-to-date intelligence study by Global Coronavirus Test Kits Market provides the present scenario of the market and offers a comparative assessment of the market. The report provides historical data, significance, statistical data, size & share, market price & demand,",QGEN,en,OpenPR
2020-10-27 04:01:37-05:00,"CANCER BIOMARKERS Market Top Key Players- Merck KGaA, PerkinElmer, Inc., Qiagen N.V., Siemens AG Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027","Summary of the CANCER BIOMARKERS Market Report Increasing demand, rising product acceptance and improving research and development are some of the key factors boosting the growth of the CANCER BIOMARKERS Market. The market is growing at a significant growth rate at",QGEN,en,OpenPR
2020-10-27 03:40:41-05:00,"Biomarkers Market– Leaders, Size, Production and Growth Forecast, Key Players -Qiagen N.V., Perkinelmer, Inc., Me ,ck Millipore",Summary of the Report The Biomarkers Market has been growing at a good pace and is expected to reach to a notable market size by 2027 growing at a momentous compound annual growth rate (CAGR). The growth being attributed to the,QGEN,en,OpenPR
2020-10-23 10:55:53-05:00,Sovereign Wealth Funds Forestall Real-Estate Investments As COVID-19 Pandemic Bites,"Sovereign Wealth Funds Forestall Real-Estate Investments As COVID-19 Pandemic Bites Tyler Durden Fri, 10/23/2020 - 11:55 President Trump elicited jeers from New York City's remaining residents Thursday night when he called their city a ""ghost town"" during a lengthy riff on the myriad problems created by COVID-19-inspired lockdowns. But a mountain of data shows that Manhattan rents and property prices have tumbled to their most affordable levels in years. But even more so than residential real estate, commercial real estate has taken a huge hit in the months since the outbreak, as office head counts dwindled and once thriving commercial areas in places like London became veritable ghost towns, so much so that the British government briefly encouraged finance types to return to their offices in Canary Wharf as the shops that depended on their foot traffic struggled. But on the high end of the CRE market, sovereign wealth funds, which have been an active buyer of real estate in cities around the world, but especially in places like New York City and London, likely won't be making a return any time soon.",QGEN,en,Zero Hedge
2020-10-23 08:42:40-05:00,"Global Lateral Flow Assay Market 2020:Coronavirus Impact Analysis,Size, Growth, Industry Trends,Analysis 2027||Key Players-Siemens Healthcare GmbH, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, PerkinElmer Inc., Ab",Data Bridge Market Research Present “Global Lateral Flow Assay Market – Industry Trends and Forecast to 2027” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of,QGEN,en,OpenPR
2020-10-23 03:11:41-05:00,"Metagenomics Market Share Size, Statistics, Demand, Revenue, Top Companies and Forecast 2027 By Agilent Technologies, Enterome, Illumina, PerkinElmer, Qiagen, Abbott, Siemens","Metagenomics is a relatively new field, which comprises the analysis of collective genomes of the members of the microbial community along with studying the interaction of microbes. In addition, metagenomic technologies enable the study of microbial communities as entire units",QGEN,en,OpenPR
2020-10-22 08:40:36-05:00,"Global Protein Purification and Isolation Market 2020:Covid-19 Impact Analysis|Global Business Outlook |Key Players-Thermo Fisher Scientific Inc., QIAGEN, BIO-RAD LABORATORIRES INC., Agilent, Promega Corporation","Protein purification and isolation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 11.21 billion by 2027, growing at a CAGR of 8.35%",QGEN,en,OpenPR
2020-10-22 05:34:59-05:00,"Protein Assays Market Top-Companies, Future-Growth, Regional Analysis, Business-Opportunities 2027 | By Key Players Thermo Fischer Scientific, Qiagen, Merck KGaA, PerkinElmer, GE Healthcare, Takara Bio","protein assays market is expected to register a substantial growth in the near future owing thigh demand in numerous applications of various stages of pre-clinical, clinical trial, and later stage of drug development. Moreover, high investment across various private &",QGEN,en,OpenPR
2020-10-22 03:55:23-05:00,"Human Identification Market 2020-2027: Top Companies, Countries, Applications, Challenges & Opportunities-Thermo Fisher Scientific, QIAGEN, Promega, Agilent Technologies, New England Biolabs","A consciously conceived and designed Business Intelligence Report titled Global Human Identification Market Size, Share, Growth, Industry Trends and Forecast to 2027 by Data Bridge Market Research unveils a succinct analysis of the market size, growth, demand, trends, regional spectrum,",QGEN,en,OpenPR
2020-10-21 06:25:16-05:00,"Biochips Market Expected to Reach $ 21,419 Million by 2025| Industry Analysis By bioMérieux, Bio-Rad Laboratories, PerkinElmer, QIAGEN, Thermo Fisher Scientific, Dynamic Biosensors","Biochips have garnered a substantial share in the recent years, due to large number of applications across the life science field, increase in prevalence of cancer, and high preference for biochip products. Development of advanced biochips with improved features has",QGEN,en,OpenPR
2020-10-20 13:34:47-05:00,"qPCR and dPCR Market Is Thriving Worldwide: Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; QIAGEN; Takara Bio Inc.; Agilent Technologies, Inc.; bioMérieux SA","Global qPCR and dPCR Market is expected to rise from its initial estimated value of USD 3.64 billion in 2018 to a projected value of USD 7.14 billion by 2026, registering a CAGR of 8.78% in the forecast period of 2019-2026.",QGEN,en,OpenPR
2020-10-20 10:13:40-05:00,"Veterinary Diagnostics Market 2020-2027 Share, Growth, Trends, And Covid-19: Potential Impact Analysis || Leading Players – IDEXX, Abaxis, QIAGEN, Thermo Fisher Scientific, Heska Corporation, Pfizer",Global veterinary diagnostics market is registering a substantial CAGR of 8.76% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed,QGEN,en,OpenPR
2020-10-20 08:05:17-05:00,"DNA Next Generation Sequencing Market Undertake Strapping Growth in 2020 With Illumina, Inc., Thermo Fisher, Qiagen N.V., Beijing Genomics Institute, PerkinElmer, Inc., F.Hoffman-La Roche Ltd., Agilent Technologies, Eurofins Scientific",This research report will give you deep insights about the DNA next generation sequencing Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports,QGEN,en,OpenPR
2020-10-20 06:08:49-05:00,"Global Tropical Disease Testing Products Market 2020:Size, Share, Precise Outlook,Industry Statistics by 2020-2027||Key Players-Abbott, Bio-Rad Laboratories Inc., BD, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Sofinas.a & Others","The Tropical Disease Testing Products Market is poised to grow strong during the forecast period 2020 to 2027. Some of the prominent trends that the market is witnessing include improved profitability as a result of aim, introduction of maintenance-as-a-service model",QGEN,en,OpenPR
2020-10-19 10:31:55-05:00,"DBMR Updates : Absorbable and Non Absorbable Sutures Market Forecast And Analysis As Corona Virus Outbreak Disturbs Investment Plans, Leading Players are Siemens Healthcare, SeegeneInc, FastSense Diagnostics, Curetis, QIAGEN","Absorbable and Non Absorbable Sutures Market report has been formulated by keeping in mind all the vital aspects of the market research that simply brings market landscape into focus. CAGR value fluctuation percentage for market, during the forecast period of",QGEN,en,OpenPR
2020-10-19 07:07:35-05:00,"Protein Expression Market 2020 Industry Will Fastest Grow in Future by Key Companies Analysis- Accelagen Inc, Becton, Dickinson and Co,. LGC Ltd, Merck KGaA, New England Biolabs Inc, Promega Corp, QIAGEN NV| Forecast to 2024",The Protein Expression Market 2020 industry Research Report will provide a valuable insight with an emphasis on global market. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the,QGEN,en,OpenPR
2020-10-19 05:40:55-05:00,"RNA Sequencing Market Global Trends, Segmentation and Opportunities Forecast To 2027 | Affymetrix, Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, QIAGEN, Sigma-Aldrich","Advancements of in sequencing technology, increase in acceptance of NGS technology, and growth in number of partnerships & collaborations drive the growth of the global RNA sequencing market. However, dearth of skilled professionals and problems associated with storage of sequencing",QGEN,en,OpenPR
2020-10-16 05:19:41-05:00,"Global Oxidative Stress Analysis Market 2020 Future Estimations with Top Key Players - Abcam, Cell Biolabs, Qiagen NV, Enzo Biochem, Biovision","The most recent market research study titled Global Oxidative Stress Analysis Market 2020 by Company, Regions, Type and Application, Forecast to 2025 offers a concise study on the market to illustrate valuable insights related to significant market trends. The report spotlights",QGEN,en,OpenPR
2020-10-15 14:53:33-05:00,"Laboratory Centrifuge Market Business Growth, Sales Review, Forecasting to 2026: Thermo Fisher Scientific Inc., Sartorius AG, GTCR, LLC. Eppendorf AG, QIAGEN, Cole-Parmer Instrument Company, LLC",Laboratory Centrifuge Market analysis report also offers list of the chief competitors and provides the strategic insights and analysis of the key factors influencing the industry. All statistical and numerical data is interpreted with the use of established and advanced tools,QGEN,en,OpenPR
2020-10-14 08:43:05-05:00,"Immuno Oncology Assays Market Year: 2020-2027 Forecasts and its Details Analysis by Sartorius AG, Qiagen, PerkinElmer Inc., Merck KGaA, Illumina, Inc.",A report by The Insight Partner's on the Immuno Oncology Assays Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in,QGEN,en,OpenPR
2020-10-14 05:16:53-05:00,"Global Nucleic Acid Isolation and Purification Market Shows Strong Growth with Leading Players are Illumina, Inc., Thermo Fisher Scientific Inc, Agilent Technologies, Inc, QIAGEN, Protean, Hamilton Company",Data Bridge Market Research has recently added a concise research on the Global Nucleic Acid Isolation and Purification Market to depict valuable insights related to significant market trends driving the industry. Global Nucleic Acid Isolation and Purification Market report comprises of,QGEN,en,OpenPR
2020-10-13 09:25:38-05:00,QIAGEN setzt dank Corona-Tests mehr um als erwartet - QIAGEN-Aktie sinkt,"So stiegen die Erlöse im dritten Quartal sowohl nominal als auch wechselkursbereinigt im Vergleich zum Vorjahr um 26 Prozent auf 481,3 Millionen US-Dollar (407 Mio Euro), wie QIAGEN anhand vorläufiger Zahlen am Dienstag in Venlo mitteilte. Damit wuchs der Umsatz stärker als erwartet. So hatte QIAGEN Mitte Juli…",QGEN,de,Finanzen AT
2020-10-13 08:29:40-05:00,QIAGEN steigert Umsatz und Gewinn im dritten Quartal - QIAGEN-Aktie im Minus,Das Diagnostikunternehmen QIAGEN profitierte dabei weiterhin vor allem von einer hohen Nachfrage nach Corona-Tests. Wie das im MDAX und TecDAX notierte Unternehmen auf Basis vorläufiger Zahlen…,QGEN,de,Finanzen CH
2020-10-12 09:35:08-05:00,"Clinical Laboratory Tests Market (COVID-19 Impact Analysis), 2020 Top Impacting Factors That Could Escalate Markets Growth | Abbott, Genoptix, Healthscope, Labco, QIAGEN, Quest Diagnostics, Siemens Healthcare","The CLINICAL LABORATORY TESTS Market report makes available a thoughtful overview of product specification, technology, product type and production analysis taking into account major factors such as revenue, cost, and gross margin. The report is sure to offer brilliant solution",QGEN,en,OpenPR
2020-10-12 07:14:43-05:00,"Veterinary Diagnostics Market (COVID-19 Impact Analysis), 2020 Size, Global Industry Growth, Statistics, Trends, Revenue Analysis 2027 | QIAGEN, Thermo Fisher Scientific, Zoetis, Pfizer, Virbac","The VETERINARY DIAGNOSTICS Market report makes available a thoughtful overview of product specification, technology, product type and production analysis taking into account major factors such as revenue, cost, and gross margin. The report is sure to offer brilliant solution to",QGEN,en,OpenPR
2020-10-12 06:51:42-05:00,"Global Bioinformatics Market Growth, Trends, Latest Tech Innovation, Global Technology by DNAnexus, Inc., Qiagen, Thermo Fisher Scientific, Inc., Agilent Technologies, DassaultSystemes","“Global Bioinformatics Market- Industry Trends and Forecast to 2026” Worldwide Industry Size, Offer and trends analysis during Period. Bioinformatics Market report is a thoughtful analysis of the market presenting the propelled situation in the market and additionally plots that guide",QGEN,en,OpenPR
2020-10-09 06:11:13-05:00,"Global Genomics Market Outlook, Growth Analysis, Business Opportunities and Forecasts 2019 - 2026 | With Key Players Analysis On General Electric, Danaher, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Qiagen",The market analysis and insights covered in the universal Global Genomics Market report presents key statistics on the market status of global and regional manufacturers and is an essential source of guidance which provides right direction to the companies and,QGEN,en,OpenPR
2020-10-08 19:15:00-05:00,"Genetic Testing Market to reach $ 4.86 bn by 2024, Abbott Laboratories, Agilent Technologies Inc., and Thermo Fisher Scientific Inc., emerge as Key Contributors to growth | Technavio","Technavio has been monitoring the genetic testing market and it is poised to grow by $ 4.86 bn during 2020-2024, progressing at a CAGR of over 12% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005738/en/ Technavio has announced its latest market research report titled Global Genetic Testing Market 2020-2024 (Graphic: Business Wire) Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.",QGEN,en,Benzinga
2020-10-08 11:49:21-05:00,"Liquid Biopsy Market (COVID - 19 Updates) Complete Survey 2020 Insights, Demand, Analysis, Type, Size and Share, Leading Players are Immucor, Thermo Fisher Scientific, QIAGEN, Myriad Genetics, Natera, Genomic Health","This Liquid Biopsy Market research report is a detailed synopsis on the study of industry and its impact on the market environment. By systematically understanding and keeping into thought customer requirement, one step or combination of many steps has been",QGEN,en,OpenPR
2020-10-08 11:08:00-05:00,"SNP, AMS und QIAGEN - Wie lassen sich diese drei Aktien handeln?",Alle drei Aktien der heutigen DAX-Mittagssendung werden mittelfristig in intakten Aufwärtstrends gehandelt. Wie kann ein Trader jetzt weiter agieren?,QGEN,de,GodmodeTrader
2020-10-08 10:01:57-05:00,"Neurological Biomarker Market Growth, Trends And Forecasts (2020-2027) by Thermo Fisher Scientific Inc.; Abbott;Myriad RBM; Bio-Rad Laboratories, Inc.; Qiagen; Banyan Biomarkers, Inc.; Immunarray Pvt. Ltd.; Quest Diagnostics Incorporated; PerkinElmer, Inc","The neurological biomarker market is expected to reach US$ 5,501.8 million by 2027 from US$ 14,454.7 million in 2019. The market is estimated to grow at a CAGR of 13.0% from 2020 to 2027. The key players profiled in the Neurological",QGEN,en,OpenPR
2020-10-08 07:24:55-05:00,"Autoimmune Disease Diagnostics Market Targeted to Grow at a Healthy CAGR by 2026 | Major Key Players: EUROIMMUN, QIAGEN, Quest Diagnostics, Roche Diagnostics, Tecan","Autoimmune Disease Diagnostics Market research Report is an inestimable supply of insightful data for business strategists. This Autoimmune Disease Diagnostics Market study provides extensive data which enlarge the understanding, scope and application of this report. A specified study of competitive landscape",QGEN,en,OpenPR
2020-10-08 06:52:19-05:00,"The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) argenx SE – ADR (NASDAQ: ARGX ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cassava Sciences Inc (NASDAQ: SAVA ) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) InVitae Corp (NYSE: NVTA ) Insulet Corporation (NASDAQ: PODD ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kura Oncology Inc (NASDAQ: KURA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Natera Inc (NASDAQ: NTRA ) Novocure Ltd (NASDAQ: NVCR ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (preannounced positive Q3 revenues) Oncorus Inc (NASDAQ: ONCR ) (debuted on Friday) Prelude Therapeutics Inc (NASDAQ: PRLD ) Pulmonx Corp (NASDAQ: LUNG ) Qiagen NV (NYSE: QGEN ) Repligen Corporation (NASDAQ: RGEN ) Stoke Therapeutics Inc (NASDAQ: STOK ) (announced decision to dose STK-001 in children and adolescents in its Phase 1/2a study for Dravet syndrome) Surface Oncology Inc (NASDAQ: SURF ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Twist Bioscience Corp (NASDAQ: TWST ) Ultragenyx …",QGEN,en,Benzinga
2020-10-07 08:35:57-05:00,"In-Vitro Diagnostics Market In-Depth Market Research Report 2020 to 2027 | F. Hoffmann-la Roche Ltd., Danaher, Abbott, Siemens AG, Sysmex Corporation, Thermo Fisher Scientific, BD, Biomérieux SA, Bio-Rad Laboratories and Qiagen","A new research document with title Global In-Vitro Diagnostics Market Report covering detailed analysis, Competitive landscape, forecast and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific,",QGEN,en,OpenPR
2020-10-07 08:05:37-05:00,"Biological Data Visualization Market to explore the gigantic trend in the upcoming period 2020-2028| Key Players - 3M, Media Cybernetics, Agilent Technologies, Molecular Devices, Genedata AG, QIAGEN, Carl Zeiss AG, Oxford Instruments, Genialis, Danaher, P","A new-fangled market study report, titled Biological Data Visualization Market 2020-2028 has been featured on Report Consultant. The Report is engrossed in approaching occurrences in the global healthcare industry that tends to exhibit both positive and negative impacts on the",QGEN,en,OpenPR
2020-10-07 07:37:02-05:00,Vorwürfe gegen Qiagen wegen Steuervermeidung,"Eine Nichtregierungsorganisation wirft dem Biotechnologieunternehmen Qiagen vor, umfangreich Steuerzahlungen vermieden zu haben, indem Tochterfirmen in Niedrigsteuerländern wie Luxemburg untereinander Geschäfte gemacht haben. Ergebnisse entsprechender Recherchen werden in einem Bericht der niederlän",QGEN,de,T-Online
2020-10-07 06:30:09-05:00,"The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CareDx Inc (NASDAQ: CDNA ) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Inspire Medical Systems Inc (NYSE: INSP ) InVitae Corp (NYSE: NVTA ) Kura Oncology Inc (NASDAQ: KURA ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Novocure Ltd (NASDAQ: NVCR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Inc (NASDAQ: PRLD ) ProPhase Labs Inc (NASDAQ: PRPH ) Qiagen NV (NYSE: QGEN ) Repligen Corporation (NASDAQ: RGEN ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 6) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) (reacted to negative results for a mid-stage study of lenabasum in cystic fibrosis patients) Dyne Therapeutics Inc (NASDAQ: DYN ) Outset Medical Inc (NASDAQ: OM ) Teligent Inc (NASDAQ: TLGT ) Stocks In Focus Integra LifeSciences' Preliminary Q3 Revenues Exceed Estimate Medtech company Integra Lifesciences Holdings Corp (NASDAQ: IART ) preannounced third-quarter results, expecting revenues of $368 million to $370 million, down about 2.7%, but exceeding the company's guidance provided at …",QGEN,en,Benzinga
2020-10-07 05:03:00-05:00,Corona-Test-Hersteller: Qiagen drückt offenbar im großen Stil seine Steuerlast,Öffentliche Förderung kassieren und gleichzeitig Steuern vermeiden: Der deutsche Corona-Test-Hersteller Qiagen hat Berichten zufolge mit fragwürdigen Methoden seine Einnahmen maximiert.,QGEN,de,manager magazin
2020-10-07 03:46:27-05:00,Genomics Personalized Health Market: Technological Progress and Innovations Are Estimated to Bolster Market Growth,"The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market. Some of the key players in the industry are Thermo Fisher Scientific, Inc., QIAGEN,",QGEN,en,OpenPR
2020-10-07 02:23:25-05:00,Qiagen drückt offenbar im großen Stil seine Steuerlast - DER SPIEGEL - Wirtschaft,Öffentliche Förderung kassieren und gleichzeitig Steuern vermeiden: Der deutsche Corona-Test-Hersteller Qiagen hat Berichten zufolge mit fragwürdigen Methoden seine Einnahmen maximiert.,QGEN,de,Der Spiegel
2020-10-06 10:38:07-05:00,"Global Immunodiagnostics Market Report Covers Growing Strategies Used By Top Key Players || Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC",Data Bridge Market Research has recently added a concise research on the Global immunodiagnostics market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market,QGEN,en,OpenPR
2020-10-06 09:28:14-05:00,Qiagen to launch new kit complementing its COVID-19 diagnostic portfolio (NYSE:QGEN),Qiagen (QGEN +2.3%) said it plans to introduce a new kit that will remove testing bottlenecks for SARS-CoV-2 and other RNA viruses. The QIAprep&amp kit com,QGEN,en,Seeking Alpha
2020-10-06 07:24:11-05:00,"The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) argenx SE – ADR (NASDAQ: ARGX ) (presented positive new data from a Phase 3 trial evaluating efgartigimod in patients with generalized myasthenia gravis) Ascendis Pharma A/S (NASDAQ: ASND ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) C4 Therapeutics, Inc. (NASDAQ: CCCC ) (went public Friday) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) Cytokinetics, Inc. (NASDAQ: CYTK ) (reacted to presentations at the Heart Failure Society of America virtual meeting) Eidos Therapeutics Inc (NASDAQ: EIDX ) - announced a deal to be bought by BridgeBio Pharma Inc (NASDAQ: BBIO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) Myokardia Inc (NASDAQ: MYOK ) - announced a deal to be bought by Bristol-Myers Squibb Co (NYSE: BMY ) for $13.","PYPD,QGEN",en,Benzinga
2020-10-06 06:26:18-05:00,"Laboratory Centrifuge Market Share, Size, Demand, Growth Rate, Outlook and Top Leaders - Thermo Fisher Scientific Inc., Sartorius AG, GTCR, LLC. Eppendorf AG, QIAGEN, Cole-Parmer Instrument Company, LLC",Global laboratory centrifuge market is set to witness steady CAGR of 3.9% in the forecasted period of 2019-2026. This rise in the market can be credited to the rising use of increasing predominance occurrence of illnesses Growth in research exercises.,QGEN,en,OpenPR
2020-10-06 00:59:05-05:00,"Global Transcriptomics Market Deep Study By Top Players, Segmentation & Geological Regions : 2020-2025","This report studies the Transcriptomics Market size by top key players, regions, end industries, history data and forecast data 2020-2025. Top Key Players operating in this report are QIAGEN (Exiqon), Thermo Fisher Scientific, Illumina, Agilent Technologies, GE Healthcare Dharmacon, Bio-Rad",QGEN,en,OpenPR
2020-10-02 12:01:42-05:00,Large-Scale Tax Avoidance By Coronavirus Test Manufacturer Qiagen,"New research reveals large-scale tax avoidance by coronavirus test manufacturer Qiagen Q2 2020 hedge fund letters, conferences and more Qiagen Has Been Dodging Millions Of Euros In Tax Amsterdam, 29 September 2020 – New research by the Centre for Research on Multinational Corporations (SOMO) shows that the German coronavirus test producer Qiagen has been able […] The post Large-Scale Tax Avoidance By Coronavirus Test Manufacturer Qiagen appeared first on ValueWalk .",QGEN,en,ValueWalk
2020-10-02 08:10:12-05:00,“Dutch” coronavirus test maker Qiagen accused of tax avoidance,"Coronavirus test producer Qiagen evaded millions of euros in taxes since 2010 through tax avoidance constructions in Ireland, Luxembourg and Malta, according to research by foundation SOMO. ""To add insult to injury"", the biotech giant, which on paper is based in Venlo in Limburg, is currently also receiving public financing on a large scale, SOMO said.",QGEN,en,NL Times
2020-09-30 02:44:30-05:00,"Liquid Biopsy Market to Grow at a CAGR of 9.9% Through 2027 - Lead by Biocept, Inivata, MDxHealth, Qiagen, LungLife AI and Exosome Diagnostics","Liquid Biopsy Market was valued at US$ 3,861.49 million in 2019 and is projected to reach US$ 8,123.85 million by 2027; it is expected to grow with a CAGR of 9.9% during 2020 - 2027. The report provides trends prevailing",QGEN,en,OpenPR
2020-09-29 03:19:39-05:00,"Global Function Driven Metagenomics Market Projected To Show Strong Growth By 2026 | |Danaher; Merck KGaA; Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Novogene Corporation","The numerous recent developments, products launches, research, joint ventures, mergers and acquisitions in the Function Driven Metagenomics market which is changing the face healthcare industry.We at Data Bridge Market Research understand what is important in the Function Driven",QGEN,en,OpenPR
2020-09-29 01:35:34-05:00,"Gene Editing Market Size, Regional Insights and Industry Dynamics By 2023 | By Top Leading Vendors Intellia Therapeutics, Qiagen, GE Healthcare Lonza, Cellectis, Dharmacon, AstraZeneca, Agilent Technologies.","The Business Research Company offers ""Gene Editing Global Market Report 2020-30: COVID-19 Growth And Change"" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it",QGEN,en,OpenPR
2020-09-28 11:04:50-05:00,"Novel Cell Sorting and Separation Market 2020-2025: Assessment and Growth Opportunities by Leading Players - QIAGEN, NanoCellect Biomedical, Innovative Biochips, RareCyte, Cytonome",Global Novel Cell Sorting and Separation Market Synopsis: The exclusive research report on the Global Novel Cell Sorting and Separation Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the,QGEN,en,OpenPR
2020-09-28 08:40:12-05:00,"Single-Cell Genome Sequencing (SCGS) Market Rising Demand and its Analysis by 10x Genomics, Fluidigm, Novogene, QIAGEN",A report by The Insight Partner's on the global Single-Cell Genome Sequencing (SCGS) market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive,QGEN,en,OpenPR
2020-09-28 05:53:38-05:00,Kaufempfehlung von Kepler treibt QIAGEN-Aktie auf weiteres Hoch,"Die QIAGEN -Aktien ließen mit dem Tageshoch von 45,44 Euro via XETRA erstmals seit 2000 die Marke von 45 Euro hinter sich. Grund war eine Kaufempfehlung von Kepler Cheuvreux. Zuletzt betrug der Anstieg noch 1 Prozent auf 44,90 Euro. Das von 39 auf 51 Euro erhöhte Kursziel räumt den Aktien weitere…",QGEN,de,Finanzen AT
2020-09-28 04:34:14-05:00,"Metagenomics Market By The Increasing Demands of Various Therapies With COVID-19 Impact Analysis By Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen",A report by The Insight Partner's on the global Metagenomics Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the,QGEN,en,OpenPR
2020-09-22 07:30:38-05:00,"Auffällige Insidertransaktionen bei Qiagen, Grenke und Flatex","Bei Qiagen hat eine Führungskraft die gute Performance der vergangenen Monate zum Aktienverkauf genutzt, während bei der abgestürzten Grenke-Aktie massiv gekauft wurde. Von Jörg Bernhard",QGEN,de,BORSE ONLINE
2020-09-21 06:39:00-05:00,"United States Liquid Biopsy Market Research Report 2020-2025 Featuring Leading Players - CellMax Life, Exosome Diagnostics, QIAGEN, Roche Molecular Diagnostics, and Thermo Fisher Scientific. - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Liquid Biopsy Market Research Report by Product, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19"" report has been added to ResearchAndMarkets.com's offering. The United States Liquid Biopsy Market is projected to grow with a significant CAGR Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consum",QGEN,en,Business Wire
2020-09-18 05:46:00-05:00,Qiagen – vom Verkäufer zum Käufer,Nach der geplatzten Übernahme durch Thermo Fisher geht Qiagen selbst auf Einkaufstour und kauft für 248 Millionen US-Dollar in bar die restlichen 80 Prozent von US-Diagnostikspezialisten NeuMoDx.,QGEN,de,Finanztreff
2020-09-18 03:53:40-05:00,QIAGEN übernimmt NeuMoDx Molecular - Aktie gibt ab,"Wie das im MDAX und TexDAX gelistete Unternehmen mitteilte, wurden die verbliebenen 80,1 Prozent der Anteile an NeuMoDx Molecular, einem Entwickler von Diagnostikinstrumenten, für 248 Millionen US-Dollar in bar erworben. Mit der Übernahme will das Unternehmen…",QGEN,de,Finanzen CH
2020-09-18 03:24:10-05:00,GRAHAM to fit-out QIAGEN’s world-leading precision medicine campus - FMJ,"GRAHAM has won a contract with global molecular diagnostics company, QIAGEN, to complete the £9.9 million interior fit-out of its new Manchester headquarters. The privately-owned fit-out contractor will help to create 92,000 sq ft of high specification, flexible office, laboratory, and clinical space at the recently constructed Citylabs 2.0 building, which is located in Manchester’s …",QGEN,en,Facilities Management Journal
2020-09-18 00:29:10-05:00,Biotech-Hoffnung: Qiagen übernimmt US-Diagnostikfirma - manager magazin - Unternehmen,Nach dem Einstieg übernimmt die deutsche Biotech-Perle nun auch die restlichen 80 Prozent an NeuMoDx Molecular.,QGEN,de,manager magazin
2020-09-18 00:09:40-05:00,QIAGEN übernimmt NeuMoDx Molecular,"Wie das im MDAX und TexDAX gelistete Unternehmen mitteilte, wurden die verbliebenen 80,1 Prozent der Anteile an NeuMoDx Molecular, einem Entwickler von Diagnostikinstrumenten, für 248 Millionen US-Dollar in bar erworben. Mit der Übernahme will das Unternehmen…",QGEN,de,Finanzen CH
2020-09-17 15:13:16-05:00,QIAGEN buys remaining 80.1% interest in NeuMoDx (NYSE:QGEN),QIAGEN (NYSE:QGEN) has acquired the remaining 80.1% of NeuMoDx Molecular for $248M in cash. The acquisition strengthens QIAGEN’s portfolio of automated mol,QGEN,en,Seeking Alpha
2020-09-17 15:05:00-05:00,"QIAGEN übernimmt NeuMoDx Molecular, Inc. und vervollständigt sein Portfolio an PCR-basierten Automatisierungssystemen für die Diagnostik","QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute den Erwerb der verbliebenen 80,1 % der Anteile an NeuMoDx Molecular, Inc., einem Ent",QGEN,de,Business Wire
2020-09-17 06:00:00-05:00,Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership,"MINNEAPOLIS, Sept. 17, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new…",QGEN,en,PR Newswire
2020-09-17 05:00:00-05:00,Qatar Investment Authority and Credit Suisse Asset Management Enter into Strategic Partnership in the Direct Lending Market,"DOHA, Qatar and NEW YORK, Sept. 17, 2020 /PRNewswire/ -- Credit Suisse and the Qatar Investment Authority (QIA) are pleased to announce that QIA will partner with Credit Suisse Asset Management to form a multibillion dollar direct private credit platform that will provide financing…",QGEN,en,PR Newswire
2020-09-17 02:02:00-05:00,Graham wins Qiagen fit-out,Graham has been selected by diagnostics company Qiagen to complete the £9.9m interior fit-out of its new Manchester headquarters.,QGEN,en,Construction Index
2020-09-15 01:53:07-05:00,"QIAGEN to relocate to 92,000 sq ft office space at CityLabs 2.0","The space includes life sciences laboratories and 40,000 sq ft of support office space",QGEN,en,Business Live
2020-09-10 19:00:00-05:00,dpa-AFX: Deutsche Bank belässt Qiagen auf 'Buy' - Ziel 60 Euro,FRANKFURT (dpa-AFX Analyser) - Die Deutsche Bank hat die Einstufung für Qiagenauf 'Buy' mit einem Kursziel von 60 Euro belassen. Der vor der …,QGEN,de,Finanztreff
2020-09-10 11:32:37-05:00,"QPCR And DPCR Market Size, Trends And Worldwide Outlook To 2025","This market research report identifies Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., F. Hoffmann-La Roche, and Abbott Laboratories as the major vendors operating in the global qPCR and dPCR market. This report also provides a detailed analysis of the market by technology type (qPCR and dPCR), by product type (Instruments, Reagents & Consumables, and Software […] The post QPCR And DPCR Market Size, Trends And Worldwide Outlook To 2025 appeared first on South Africa Today .",QGEN,en,South Africa Today
2020-09-09 09:23:22-05:00,Qiagen Shares Rise on Plan to Launch Covid Antibody Test,Qiagen shares were higher after the company said that in the fourth quarter it would launch a test to detect antibodies against Covid-19.,QGEN,en,The Street
2020-09-09 03:26:20-05:00,Testergebnis in 15 Minuten: Qiagen kündigt Corona-Schnelltest für das vierte Quartal an - manager magazin - Unternehmen,Nach dem Schweizer Pharmakonzern Roche will auch die deutsche Biotech-Perle Qiagen einen Coronavirus-Schnelltest auf den Markt bringen. Der Test soll allerdings erst nach dem Produkt von Roche verfügbar sein.,QGEN,de,manager magazin
2020-09-09 03:26:20-05:00,"Qiagen: Coronavirus-Schnelltest soll im vierten Quartal auf den Markt kommen, Aktie legt zu",Nach dem Schweizer Pharmakonzern Roche will auch die deutsche Biotech-Perle Qiagen einen Coronavirus-Schnelltest auf den Markt bringen. Der Test soll allerdings erst nach dem Produkt von Roche verfügbar sein.,QGEN,de,manager magazin
2020-09-09 02:19:00-05:00,QIAGEN führt tragbaren Corona-Schnelltest ein - Aktie stark,"Dieser soll der mittels eines kleinen digitalen Testsystems SARS-CoV-2-Antigene bei Menschen mit aktiven Infektionen innerhalb von 15 Minuten nachweisen und durchschnittlich rund 30 Abstriche pro Stunde verarbeiten können. Der Antigentest, der spätestens im vierten Quartal 2020 eingeführt werden soll, sei für den Einsatz in…",QGEN,de,Finanzen AT
2020-09-09 02:18:00-05:00,QIAGEN führt tragbaren Corona-Schnelltest ein - QIAGEN-Aktie legt zu,"Dieser soll der mittels eines kleinen digitalen Testsystems SARS-CoV-2-Antigene bei Menschen mit aktiven Infektionen innerhalb von 15 Minuten nachweisen und durchschnittlich rund 30 Abstriche pro Stunde verarbeiten können. Der Antigentest, der spätestens im vierten Quartal 2020 eingeführt werden soll, sei für den Einsatz in…",QGEN,de,Finanzen CH
2020-09-09 01:58:00-05:00,QIAGEN führt tragbaren Corona-Schnelltest ein - Aktie vorbörslich stark,"Dieser soll der mittels eines kleinen digitalen Testsystems SARS-CoV-2-Antigene bei Menschen mit aktiven Infektionen innerhalb von 15 Minuten nachweisen und durchschnittlich rund 30 Abstriche pro Stunde verarbeiten können. Der Antigentest, der spätestens im vierten Quartal 2020 eingeführt werden soll, sei für den Einsatz in…",QGEN,de,Finanzen AT
2020-09-09 01:38:04-05:00,Wichtige Kursbewegungen: Aussicht auf Corona-Schnelltest beflügelt Qiagen,Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:,QGEN,de,BORSE ONLINE
2020-09-08 20:13:45-05:00,Qiagen: Ergebnis nach drei Minuten – Firma bringt Corona-Blitztest auf den Markt - WELT,"Wer sich auf das Coronavirus testen lässt, wartet meist zwei bis drei Tage auf das Resultat. Das Unternehmen Qiagen hat ein System entwickelt, das Infektionen deutlich schneller aufspüren soll. Es könnte schon bald an Flughäfen und in Stadien eingesetzt werden.",QGEN,de,WELT
2020-09-08 17:27:25-05:00,Qiagen says its new COVID-19 test delivers results in 15 minutes,"Test is designed for use in high-traffic facilities like airports and stadiums, diagnostic company says.",QGEN,en,CBS News
2020-09-08 15:41:35-05:00,"Qiagen, Ellume to build portable antigen-testing hubs for COVID-19","Shortly after unveiling a portable, digital testing system for COVID-19 antibodies late last month, Qiagen has now announced plans to leverage the same platform for a rapid antigen test to identify active coronavirus infections.",QGEN,en,FierceBiotech
2020-09-08 15:05:19-05:00,Qiagen to launch rapid coronavirus test it says could be used in airports and stadiums,"In a statement, Qiagen CEO Thierry Bernard added that the antigen tests are meant to supplement, not replace, the molecular, or PCR, tests, which are the most accurate tests on the market.",QGEN,en,CNBC
2020-09-08 11:54:00-05:00,Ministerbesuch in Hilden: Qiagen investiert 110 Millionen Euro in seinen Standort,"Mit 110 Millionen Euro baut das Biotech-Unternehmen Qiagen seine Produktion von Corona-Tests aus. Das Land NRW steuert 18,3 Millionen Euro bei. Dienstag besuchen die Landesminister Andreas Pinkwart und Karl-Josef Laumann den Betrieb im Hildener Osten.",QGEN,de,Rheinische Post
2020-09-08 09:41:07-05:00,Corona: 18 Millionen Euro: NRW fördert Produktion von Corona-Tests,Das Land NRW unterstützt Qiagen mit rund 18 Millionen Euro. Das Unternehmen mit Sitz in Hilden arbeitet derzeit an einem Corona-Schnelltest.,QGEN,de,Westfälische Rundschau
2020-09-08 09:14:00-05:00,Mit 18 Millionen Euro für Qiagen: NRW fördert Produktion von Corona-Tests,Das Biotechunternehmen Qiagen baut mit finanzieller Hilfe des Landes Nordrhein-Westfalen seine Produktionskapazitäten für Corona-Tests an seinem Standort Hilden bei Düsseldorf aus.,QGEN,de,Aachener Zeitung
2020-09-07 03:29:00-05:00,Qiagen: Einfach besser als zuvor,Nach der geplatzten Übernahme von Qiagen durch den US-Laborausrüster Thermo Fisher Scientific steht das deutsche Gendiagnostik-Unternehmen zwar wieder allein da – aber dafür besser als zuvor.,QGEN,de,Finanztreff
2020-09-03 15:15:31-05:00,Börsenindizes: Covestro verteidigt Dax-Platz gegen Qiagen – Wacker Chemie glückt Rückkehr in MDax,Der Chemiekonzern aus Leverkusen verteidigt seinen Platz im Börsenoberhaus. Shop Apotheke und Wacker Chemie gelingt der Sprung in den kleineren MDax.,QGEN,de,Handelsblatt
2020-09-03 04:30:05-05:00,Qiagen-Aktie nahe dem Allzeithoch: Warum Anleger so scharf auf den Titel sind,"Der langfristige Aufwärtstrend bei den Aktien von Qiagen schreitet voran. Die 200-Tagelinie strebt zielgerichtet nach oben. Nun steht mit der Marke bei 45 Euro ein größerer Widerstand bevor - dort liegt das bisherige Allzeithoch. Die Kursstärke überzeugt; ein Break out könnte gelingen. Was den Reiz an Qiagen ausmacht, auf welche Schlüsselmarken…",QGEN,de,BORSE ONLINE
2020-09-02 16:40:36-05:00,Adani Group plans to raise $1 billion via sale of equity to fund takeover of Mumbai airports,"Mumbai: The Adani Group is planning to raise at least $1 billion through the sale of equity to fund the takeover of two Mumbai airports from GVK Group, said people with knowledge of the matter.The conglomerate is currently in talks with about four global wealth funds, including Qatar Investment Authority (QIA) — a partner in Adani Electricity— as well as a Canadian and a Singapore-based fund. Adani Airport Holdings will likely sell a 10-20% holding to raise the funds, said the people cited above. QIA could be a frontrunner, they said. An investment banker had also approached the group on behalf of another large sovereign wealth fund from the Middle East, said one of them.“As part of our company policy, we do not comment on market speculation,” a spokesperson said. QIA didn’t comment. Investment bankers including Morgan Stanley, Citi, JPMorgan are in discussions with the Adani Group on managing the sale, sources said. The banks couldn’t be contacted immediately for comment.Adani has already won bids to develop six other airports. “The addition of the Mumbai International Airport and the Navi Mumbai International Airport to our existing portfolio provides us a transformational platform that will help shape and create strategic adjacencies for our other B2B businesses,” Adani Group chairman Gautam Adani said in a separate press statement on Wednesday.To Acquire Rs 13,500 Crore DebtThe Navi Mumbai facility is awaiting the start of construction.The Adani Group has signed concession agreements for Ahmedabad, Lucknow and Mangaluru but has sought and secured additional time from the state-run Airports Authority of India to take over the airports as the Covid-19 pandemic has impacted business.",QGEN,en,Economic Times India
2020-09-02 05:00:00-05:00,Qiagen vs. Covestro – Wer darf in den Dax-Index,Wer kommt in den Dax,QGEN,de,CMC Markets
2020-09-01 20:55:38-05:00,Indexzusammensetzung: Covestro versus Qiagen – Wer gewinnt das Duell um die Mitgliedschaft im Dax?,"Am Donnerstagabend entscheidet sich, ob die Biotechfirma Qiagen den Leverkusener Chemiekonzern im Dax verdrängt. Experten kennen die Antwort bereits.",QGEN,de,Handelsblatt
2020-09-01 02:00:52-05:00,"Symrise, Qiagen & Co.: Bloß nicht in den Dax!",Symrise und Qiagen sind heiße Anwärter für den Dax. Doch der Aufstieg hat oft unliebsame Folgen. Woran liegt das – und was bedeutet das…,QGEN,de,Frankfurter Allgemeine Zeitung
2020-08-26 01:20:28-05:00,"Avis d'analystes du jour : Adecco, ALD, Dassault Systèmes, Equinor, Genmab, Qiagen, U-Blox, Vifor...","Beaucoup de santé aujourd'hui dans les recommandations d'analystes, à l'image d'Alcon, Qiagen, Genmab ou Vifor. Du pétrole aussi du côté de Barclays et un nouvel avis sur Dassault Systèmes. Le saumon…",QGEN,fr,Zonebourse
2020-08-25 19:00:00-05:00,ANALYSE-FLASH: Jefferies hebt Ziel für Qiagen auf 46 Euro - 'Hold',"NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat das Kursziel für Qiagen von 41,50 auf 46,00 Euro angehoben, aber die Einstufung auf 'Hold' belassen …",QGEN,de,Finanztreff
2020-08-25 14:30:00-05:00,Coronavirus tracker: FDA faces blood plasma backlash; Qiagen plots portable antibody test launch,"FDA Commissioner Stephen Hahn backpedalled claims on blood plasma's efficacy. Meanwhile, health experts blasted Hahn for ""wasting trust"" in the agency. Qiagen plans to roll out a digital antibody test before the end of the month. Medtronic's pandemic revenue slump is subsiding. Plus, doctor-sales rep relationships have grown amid the pandemic, a study found.",QGEN,en,FiercePharma
2020-08-25 11:30:00-05:00,Qiagen-Aktie: Nach dem Gebot ist vor dem Gebot - was Anleger wissen sollten,"Nachdem die Mindestannahmequote nicht erreicht worden war, zog Thermo Fisher das zuvor auf 43 Euro pro Aktie erhöhte Gebot für Qiagen zurück. Der MDAX-Wert muss zudem 95 Millionen Dollar an den US-Medizintechniker zahlen. Von Jörg Lang",QGEN,de,BORSE ONLINE
2020-08-25 10:54:00-05:00,QIAGEN führt COVID-19-Test auf dem US-Markt ein - Aktie knapp im Minus,"Hierbei handelt es sich um einen einfach zu bedienenden, digitalen Test, der auf einem portablen Gerät ausgeführt wird. Er kann in zehn Minuten Antikörper in Personen nachweisen, die dem SARS-CoV-2 Virus, dem Auslöser von COVID-19, ausgesetzt waren. Die Einführung des Antikörpertests folgt auf",QGEN,de,Finanzen CH
2020-08-25 07:38:16-05:00,"The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT ) Cancer Genetics Inc (NASDAQ: CGIX ) (announced a deal to buy organoid start up company StemoniX) Cardiff Oncology Inc (NASDAQ: CRDF ) Catabasis Pharmaceuticals Inc (NASDAQ: CATB ) Cerus Corporation (NASDAQ: CERS ) (moved on FDA's emergency use authorization for plasma therapy as a potential COVID-19 treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Inozyme Pharma Inc (NASDAQ: INZY ) Kamada Ltd. (NASDAQ: KMD) (reacted to the news of EUA for plasma anti-COVID-19 therapy) Keros Therapeutics Inc (NASDAQ: KROS ) Lantern Pharma Inc. (NASDAQ: LTRN ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Principia Biopharma Inc (NASDAQ: PRNB ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Qiagen NV (NYSE: QGEN ) Revance Therapeutics Inc (NASDAQ: RVNC ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) (FDA granted a third fast-track designation to its lead drug candidate, repotrectinib) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 24) Acorda Therapeutics Inc (NASDAQ: ACOR ) Alector Inc (NASDAQ: ALEC ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Hoth Therapeutics Inc (NASDAQ: HOTH ) Iterum Therapeutics PLC (NASDAQ: ITRM ) Kymera Therapeutics Inc (NASDAQ: KYMR ) (IPOed Friday) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Polypid Ltd (NASDAQ: PYPD ) Poseida Therapeutics, Inc. (NASDAQ: PSTX ) Recro Pharma Inc (NASDAQ: REPH ) Teligent Inc (NEW JERSEY) (NASDAQ: TLGT ) Tricida Inc (NASDAQ: TCDA ) (FDA rejected its drug to treat metabolic acidosis and requested additional data) Unity Biotechnology Inc (NASDAQ: UBX ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus Qiagen Launches Rapid …","PYPD,QGEN",en,Benzinga
2020-08-25 02:24:37-05:00,Indexvorschau: Corona belastet die Chemiebranche: Covestro zittert um den Dax-Erhalt,Der Kunststoffhersteller Covestro muss im September möglicherweise im Dax Platz für das Biotechunternehmen Qiagen machen. Auch im MDax und im SDax stehen Wechsel an.,QGEN,de,Handelsblatt
2020-08-25 01:39:00-05:00,Qiagen: Aktie mit Wachstumspotenzial,Am Montag hat eine Kaufempfehlung der Citigroup den Aktien von Qiagen Auftrieb gegeben. Am Dienstag reist der positive Newsflow nicht ab: Denn Qiagen kann in den USA einen digitalen Sars-Cov-2-Test einführen.,QGEN,de,Finanztreff
2020-08-25 01:17:57-05:00,Qiagen To Roll Out Rapid Antibody Covid-19 Test In US As Citigroup Turns Bullish,"Qiagen announced the rollout of its new access anti-SARS-CoV-2 antibody test, an easy-to-use digital test, to be shipped to the US as early … The post Qiagen To Roll Out Rapid Antibody Covid-19 Test In US As Citigroup Turns Bullish appeared first on Smarter Analyst .",QGEN,en,Smarter Analyst
2020-08-24 10:53:00-05:00,QIAGEN-Aktie nach 20-Jahreshoch im Minus: Ex-Post-Finanzvorstand Rosen übernimmt bei QIAGEN,"Der frühere Finanzchef der Deutschen Post , Lawrence Rosen, rückt als Nachfolger von Hakan Björklund an die Spitze des Gremiums auf. Björklund hatte den Deal des Biotechnologie- und Gendiagnostikunternehmens mit Thermo Fisher…",QGEN,de,Finanzen AT
2020-08-24 07:02:38-05:00,QIAGEN-Aktie auf 20-Jahreshoch: Ex-Post-Finanzvorstand Rosen übernimmt bei QIAGEN - Citigroup-Kaufempfehlung,"Der frühere Finanzchef der Deutschen Post, Lawrence Rosen, rückt als Nachfolger von Hakan Björklund an die Spitze des Gremiums auf. Björklund hatte den Deal des Biotechnologie- und Gendiagnostikunternehmens mit Thermo Fisher Scientific mit vorangetrieben, der letztlich an der mangelnden…",QGEN,de,Finanzen AT
2020-08-24 02:42:38-05:00,Neuer Chefkontrolleur für QIAGEN: Ex-Post-Finanzvorstand Rosen übernimmt,"Der frühere Finanzchef der Deutschen Post, Lawrence Rosen, rückt als Nachfolger von Hakan Björklund an die Spitze des Gremiums auf. Björklund hatte den Deal des Biotechnologie- und Gendiagnostikunternehmens mit Thermo Fisher Scientific mit vorangetrieben, der letztlich an der mangelnden…",QGEN,de,Finanzen AT
2020-08-24 01:01:13-05:00,"EN DIRECT DES MARCHES : Axa, Carrefour, Casino, MND, Facebook, Microsoft, Qiagen, Sulzer...","L'actualité des entreprises est très calme en ce début de semaine, signe que la rentrée sera très progressive. Quelques opérations ont été annoncées, en Inde pour Axa et concernant Mercialys pour…",QGEN,fr,Zonebourse
2020-08-22 23:00:00-05:00,Aktien-Expertin Silke Schlünsen im Interview: Covestro vor dem DAX-Abstieg - Qiagen in den Leitindex?,"Wir haben mit Silke Schlünsen, der Aktien-Expertin der Mainfirst Bank, über Delivery Hero als neues Dax-Mitglied gesprochen und sie gefragt, welcher Konzern als nächster aus dem deutschen Leitindex absteigen könnte. Von Ralf Witzler",QGEN,de,BORSE ONLINE
2020-08-22 03:18:48-05:00,"Qiagen: Hakan Björklund verlässt das Unternehmen, Larry Rosen übernimmt",Wenige Tage nach dem Scheitern des Verkaufs von Qiagen an Thermo Fisher zieht sich Aufsichtsratschef Hakan Björklund von seinem Posten mit sofortiger Wirkung zurück. Die geplatzte Übernahme war eine krachende Niederlage für den ehemaligen Nycomed-Chef.,QGEN,de,manager magazin
2020-08-21 11:12:00-05:00,Geplatzte Übernahme: Qiagen: Aufsichtsratschef Hakan Björklund geht - Larry Rosen rückt nach,Nach der gescheiterten Übernahme des Diagnostikkonzerns durch Thermo Fischer verlässt der Chefaufseher das Unternehmen. Gründe werden nicht genannt.,QGEN,de,Handelsblatt
2020-08-19 06:32:33-05:00,"The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) DarioHealth Corp (NASDAQ: DRIO ) iTeos Therapeutics Inc (NASDAQ: ITOS ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Natera Inc (NASDAQ: NTRA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Otonomy Inc (NASDAQ: OTIC ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Pacira Biosciences Inc (NASDAQ: PCRX ) PDL BioPharma Inc (NASDAQ: PDLI ) Principia Biopharma Inc (NASDAQ: PRNB ) Qiagen NV (NYSE: QGEN ) Shockwave Medical Inc (NASDAQ: SWAV ) Silk Road Medical Inc (NASDAQ: SILK ) Syros Pharmaceuticals Inc (NASDAQ: SYRS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 18) Acorda Therapeutics Inc (NASDAQ: ACOR ) Alector Inc (NASDAQ: ALEC ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Interpace Biosciences Inc (NASDAQ: IDXG )(announced receipt of letters from recently departed employees regarding billing and compliance issues) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Poseida Therapeutics, Inc. (NASDAQ: PSTX )( announced clinical hold on its Phase 1 prostate cancer study) Predictive Oncology Inc (NASDAQ: POAI ) Recro Pharma Inc (NASDAQ: REPH ) Unity Biotechnology Inc (NASDAQ: UBX ) Stocks In Focus Venrock Reports Purchase of 451K Unum Shares Unum Therapeutics Inc (NASDAQ: UMRX ) shares advanced after Venrock Healthcare Partners III L.P. said in a filing it has purchased 451,000 shares of Unum's common stock in a series of transactions effected between Aug. 14 and Aug. 18, bringing the total number of shares owned by the fund to 4.355 million The stock climbed 16.24% to $3.15 in after-hours trading.",QGEN,en,Benzinga
2020-08-19 05:50:00-05:00,QIAGEN-Aktie legt zu: QIAGEN bringt neue Produkte für Coronavirus-Forschung auf den Markt,"Die Produkte erweitern als jüngste Neuzugänge das Angebot an Probentechnologien, diagnostischen Tests und Instrumenten sowie Forschungswerkzeugen, die im weltweiten Kampf gegen die COVID-19-Pandemie eingesetzt werden können, so das Unternehmen. ""Diese Lösungen verschaffen tiefer gehende, umfassendere Einblicke in die Biologie…",QGEN,de,Finanzen CH
2020-08-17 05:38:00-05:00,QIAGEN-Aktie legt zu: QIAGEN-Gründer empfiehlt Rücktritt des Aufsichtsratschefs,"""Ich bin froh, dass die Übernahme mit klarer Mehrheit gescheitert ist und QIAGEN unabhängig bleibt. Das ist gut für den Biotech -Standort Hilden, nun droht in der Hildener Zentrale keine Streichung mehr von Stellen in Zentralfunktionen"", sagte…",QGEN,de,Finanzen CH
2020-08-17 01:41:02-05:00,QIAGEN NV : Berenberg raises its recommendation to Buy | MarketScreener,"Berenberg increases his rating from Neutral to Buy. The target price is being increased from EUR 39 to EUR 50. | August 17, 2020",QGEN,en,MarketScreener
2020-08-16 19:00:00-05:00,ANALYSE-FLASH: Berenberg hebt Qiagen auf 'Buy' - Ziel hoch auf 50 Euro,HAMBURG (dpa-AFX Broker) - Die Privatbank Berenberg hat Qiagen von 'Hold' auf 'Buy' hochgestuft und das Kursziel von 39 auf 50 Euro angehoben. Das …,QGEN,de,Finanztreff
2020-08-14 22:00:00-05:00,"Nach geplatzter Übernahme: „Ich bin froh, dass Qiagen unabhängig bleibt“",Mitgründer Detlev Riesner sieht den Biotech-Standort Hilden gestärkt. Nach dem geplatzten Thermo-Fisher-Deal empfiehlt er Chefkontrolleur Hakan Björklund den Rücktritt: „Der Aufsichtsrat hat nicht gut nachverhandelt.“,QGEN,de,Rheinische Post
2020-08-14 16:18:02-05:00,GlobalData : Thermo Fisher's failed Qiagen acquisition will not significantly affect its future growth | MarketScreener,"14 Aug 2020 Thermo Fisher's failed Qiagen acquisition will not significantly affect its future growth Posted in Medical Devices Following… | August 14, 2020",QGEN,en,MarketScreener
2020-08-14 06:58:00-05:00,Qiagen: Gescheiterte Übernahme birgt neues Potenzial,Die Deutsche Bank sieht nach dem Scheitern der Übernahme den Startschuss für einen Kursanstieg gekommen.,QGEN,de,Finanztreff
2020-08-14 06:13:00-05:00,"Impact of COVID-19 on the Cytomegalovirus Tests Industry, 2020-2030 - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact)"" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Cytomegalovirus Test market for the year 2020 and beyond. Companies Mentioned DiaSorin S.p.A. F. Hoffman-La Roche Ltd. Qiagen N.V. Quidel Corp. bioMerieux SA Bio-Rad Labs Inc. Cytomegalovirus (CMV) is a widely distributed pathogen","QGEN,QDEL",en,Business Wire
2020-08-14 05:06:00-05:00,KRAS Tests - Global Market Forecast Model 2020-2030 (with COVID-19 Impact Estimates) - ResearchAndMarkets.com,"DUBLIN--(BUSINESS WIRE)--The ""KRAS Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)"" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on KRAS Tests market for the year 2020 and beyond. Companies Mentioned Qiagen N.V. F. Hoffmann-La Roche Ltd. Thermo Fisher Scientific Inc. Takara Bio Inc. Panagene Inc. Amoy Diagnostics Co. Ltd. Colorectal cancer (CRC) is the third most common",QGEN,en,Business Wire
2020-08-14 01:25:25-05:00,"Avis d'analystes du jour : Arkema, Daimler, Givaudan, HelloFresh, Qiagen, Ryanair, Vinci, Zurich Insurance...","Dernière sélection de la semaine avec des ajustements consécutifs à une actualité chargée sur Qiagen, Freenet, ThyssenKrupp et Straumann. Sur les valeurs françaises, Arkema et Vinci font l'objet…",QGEN,fr,Zonebourse
2020-08-14 01:11:00-05:00,"M&A-Deals: Sunrise, Qiagen, Hermes","Sunrise und UPC Schweiz finden doch zueinander, die Qiagen-Übernahme ist gescheitert, und Hermes kooperiert mit Private Equity: Die spannendsten M&A-Deals der Woche finden Sie in unserem FINANCE-Rückblick.",QGEN,de,FINANCE Magazin
2020-08-13 16:41:00-05:00,Qiagen: Übernahme gescheitert – was nun?,Die geplante milliardenschwere Übernahme des Biotechnologie- und Gendiagnostikunternehmens Qiagen durch den US-Technologiekonzern Thermo Fisher Scientific ist geplatzt. 13.08.2020,QGEN,de,Deraktionaer
2020-08-13 12:59:00-05:00,Hildener Biotech-Konzern: Qiagen-Übernahme gescheitert,Nur 47 Prozent der Aktionäre nahmen das Angebot des US-Laborausrüsters Thermo Fisher an. Nun muss Qiagen 95 Millionen Dollar zahlen - und bleibt unabhängig. Für Hilden ist das eine gute Nachricht.,QGEN,de,Rheinische Post
2020-08-13 12:13:51-05:00,"Wirecard, Qiagen, Knorr-Bremse - das war Donnerstag, der 13.8.2020","Jeden Abend fassen wir die wichtigsten Wirtschaftsnews des Tages zusammen. Heute mit allerlei Schmutzigem im Wirecard-Skandal, dem geplatzten Qiagen-Verkauf und dem Chefwechsel bei Knorr-Bremse.",QGEN,de,manager magazin
2020-08-13 11:15:54-05:00,The American Thermo Fisher Decided Not to Take Over the Biotechnologist Qiagen - FOX News Point,The American Thermo Fisher has decided not to take over the German biotechnologist Qiagen. The parties had agreed that at least two-thirds of Qiagen's shareholders should support the proposal…,QGEN,en,Fox News Point
2020-08-13 11:00:44-05:00,QIAGEN-Übernahme durch Thermo Fisher gescheitert - QIAGEN-Aktie im Minus,"Bis zum Ende der Frist am 10. August wurden Thermo Fisher rund 107,5 Millionen ausstehende QIAGEN -Aktien angedient, das entspricht einer Annahmequote von nur 47,02 Prozent, wie das Unternehmen…",QGEN,de,Finanzen CH
2020-08-13 07:49:21-05:00,Qiagen: Thermo Fischer scheitert mit Übernahme,Die geplante milliardenschwere Übernahme des deutschen Biotechnologie-Unternehmens Qiagen ist geplatzt. Der US-Technologiekonzern Thermo Fisher hat zu wenig Papiere angedient bekommen.,QGEN,de,manager magazin
2020-08-13 07:21:44-05:00,"QIAGEN-Übernahme durch Thermo Fisher scheitert an Annahmeschwelle - QIAGEN-Aktie im Plus, Thermo Fisher-Papiere geben nach","Bis zum Ende der Frist am 10. August wurden Thermo Fisher rund 107,5 Millionen ausstehende QIAGEN -Aktien angedient, das entspricht einer Annahmequote von nur 47,02 Prozent, wie das Unternehmen…",QGEN,de,Finanzen CH
2020-08-13 06:53:21-05:00,Biotech: Qiagen-Übernahme ist gescheitert – Thermo Fisher macht Rückzieher,Der US-Konzern verfehlte mit seiner Offerte die Annahmeschwelle deutlich. Qiagen muss nun einen Millionenbetrag an Thermo Fisher zahlen.,QGEN,de,Handelsblatt
2020-08-13 06:30:00-05:00,"Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement","WALTHAM, Mass., Aug. 13, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has lapsed. Based on information…",QGEN,en,PR Newswire
2020-08-12 10:16:00-05:00,BRAF Tests - Global Market Analysis and Forecast Model 2015-2030 (COVID-19 Impact) - ResearchAndMarkets.com,"DUBLIN--(BUSINESS WIRE)--The ""BRAF Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)"" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on BRAF Tests market for the year 2020 and beyond. Companies Mentioned F. Hoffmann-La Roche Ltd. bioMerieux SA Thermo Fisher Scientific Inc. Qiagen NV Illumina Inc Amoy Diagnostics Co. Ltd. Abbott Laboratories Biocartis SA Melanoma is accounted",QGEN,en,Business Wire
2020-08-11 08:23:00-05:00,Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results,"WALTHAM, Mass. , Aug. 11, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO ), the world leader in serving science, today provided an overview of the process to report the final results from the acceptance period of its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN , Frankfurt Prime Standard: QIA)), which expired at 24:00 hours ( Frankfurt am Main local time) / 18:00 hours ( New York local time) on Monday, August 10, 2020 . Due to German practice regarding the booking by custodian institutions of tenders submitted before the expiration of the offer acceptance period and the calculation and publication of final results, Deutsche Bank Aktiengesellschaft and American Stock Transfer & Trust Company, the settlement agents for the offer, expect to provide Thermo Fisher with a final determination of the number of shares tendered on Thursday, August 13, 2020 . As soon as practicable after the determination is made, Thermo Fisher will publicly announce the final results and publish those results in the German Federal Gazette.",QGEN,en,Benzinga
2020-08-11 05:19:00-05:00,"Global Human Papilloma Virus (HPV) Tests Market 2015-2030 Featuring Hologic, Roche Diagnostics, Qiagen, Biocare Medical, Abbott Laboratories and Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)"" report has been added to ResearchAndMarkets.com's offering. This market model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Human Papilloma Virus Tests market for the year 2020 and beyond. Factors like favourable government policies, hig",QGEN,en,Business Wire
2020-08-07 19:15:00-05:00,"Qiagen, Pandion See Activist Actions","Davidson Kempner Capital Management reported an 8% interest the Netherlands-based molecular testing firm Qiagen. Boxer Capital now owns 2,107,513 shares of newly public clinical-stage biopharmaceutical firm. Pandion Therapeutics.",QGEN,en,Barron's
2020-08-06 10:49:45-05:00,Davidson Kempner says again it will not be tendering Qiagen shares,"Hedge fund Davidson Kempner said again on Thursday it will not be tendering its shares in Qiagen , days after Thermo Fisher Scientific said its offer to buy the German genetic test maker expires…",QGEN,en,MarketScreener
2020-08-06 02:51:10-05:00,Übernahme durch Amerikaner?: Ein wilder Ritt mit Qiagen,Nach einem langen Tauziehen um eine mögliche Übernahme will sich das Hildener Diagnostikunternehmen von Amerikanern kaufen lassen. Große…,QGEN,de,Frankfurter Allgemeine Zeitung
2020-08-05 12:00:00-05:00,Thermo Fisher will nicht nachbessern: Qiagen-Übernahme könnte platzen,Der US-Laborausrüster Thermo Fisher will sein Angebot nicht noch einmal erhöhen – doch genau darauf drängen die Großaktionäre des Hildener Unternehmens. Ein Scheitern der Gespräche würde für Qiagen teuer.,QGEN,de,Rheinische Post
2020-08-05 05:29:00-05:00,Diagnosespezialist: Thermo Fisher will Angebot für Qiagen nicht weiter erhöhen,"Der US-Laborausrüster will, der Hildener Diagnosespezialist will auch. Dennoch droht die Übernahme nun an investierten Hedgefonds zu scheitern.",QGEN,de,Handelsblatt
2020-08-05 02:35:00-05:00,QIAGEN profitiert von Nachfrage nach Corona-Tests - Aktie nachbörslich dennoch leichter - QIAGEN-Aktie unter Druck,"Der Umsatz mit den entsprechenden Produkten sei in der ersten Jahreshälfte weltweit hoch gewesen, teilte das Unternehmen am Dienstagabend bei der Vorlage seiner endgültigen Zahlen zum zweiten Quartal und zum ersten Halbjahr mit. Die Nachfrage nach Quantiferon-TB, einem Test auf Tuberkulose, und anderen Anwendungen sei jedoch zurückgegangen, weil…",QGEN,de,Finanzen CH
2020-08-04 17:03:00-05:00,Biotechunternehmen: Qiagen kann dank Corona-Tests Gewinn verdoppeln,Das Biotechunternehmen profitiert von der Corona-Pandemie. Der Gewinn legt um 101 Prozent auf knapp 90 Millionen Dollar zu. Auch der Umsatz ist deutlich gestiegen.,QGEN,de,Handelsblatt
2020-08-02 22:31:54-05:00,Alibaba and Qatar lead last-minute US$300 million financing of Chinese electric car start-up Xpeng ahead of New York IPO,"Alibaba Group and Qatar’s sovereign wealth fund are among the last-minute investors in Chinese smart electric vehicle start-up, Xpeng Motors, ahead of its initial public offering in New York, according to a person familiar with the matter.Alibaba, which owns the South China Morning Post, is topping up its existing investment in Xpeng while The Qatar Investment Authority (QIA) is a first-time investor in the company.The US$300 million capital injection brings Xpeng’s C+ round of financing to US…",QGEN,en,South China Morning Post
2020-08-02 08:00:21-05:00,Qiagen: Einmal kräftig nachgelegt - Großzügige Offerte,"Im Übernahmepoker um das MDAX-Unternehmen Qiagen hat der US-Konzern Thermo Fisher sein Angebot auf 43 Euro je Aktie erhöht. Aktionäre der Biotechfirma sollten das Angebot annehmen. Von Ralf Witzler, Euro am Sonntag",QGEN,de,BORSE ONLINE
2020-07-31 08:52:03-05:00,Davidson Kempner ups stake in Qiagen to 7.3%,"Hedge fund Davidson Kempner, which is rejecting a sweetened offer from Thermo Fisher for Qiagen , said it had increased its stake in the takeover target to 7.3%.",QGEN,en,Reuters
2020-07-31 01:15:00-05:00,"M&A-Deals: Qiagen, SAP, ThyssenKrupp","Ein weiterer Qiagen-Aktionär stört die Übernahme durch Thermo Fisher, SAP will weiter zukaufen und ThyssenKrupps Stahlsparte könnte doch als Ganzes verkauft werden: Die spannendsten M&A-Deals der Woche finden Sie in unserem FINANCE-Rückblick.",QGEN,de,FINANCE Magazin
2020-07-29 07:01:03-05:00,Qiagen investor PSquared won't tender shares in Thermo Fisher bid,"Switzerland-based PSquared Asset Management on Wednesday unveiled a stake of more than 4% in Qiagen , adding it would not tender its shares into a $12.9 billion offer by U.S. laboratory equipment supplier Thermo Fisher .",QGEN,en,Reuters
2020-07-29 06:32:01-05:00,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Medpace Holdings Inc (NASDAQ: MEDP ) (saw an extension of its earnings-induced momentum) NeoGenomics, Inc. (NASDAQ: NEO )(reacted to its second-quarter results) OncoSec Medical Inc (NASDAQ: ONCS ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Trevena Inc (NASDAQ: TRVN ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 28) Nkarta Inc (NASDAQ: NKTX ) Nurix Therapeutics Inc (NASDAQ: NRIX )(IPOed Friday) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN ) Stocks In Focus Alector Slips After Presenting Dementia Drug Trial Results Alector Inc (NASDAQ: ALEC ) announced at the virtual 2020 Alzheimer's Association International Conference, or AAIC, preliminary results from a Phase 1b and open-label Phase 2 studies of AL001 for the treatment of people with frontotemporal dementia with a progranulin gene mutation, or FTD-GRN, with the Phase 1 study showing AL001 was generally safe and well-tolerated.",QGEN,en,Benzinga
2020-07-29 04:48:52-05:00,Davidson Kempner to reject 'inadequate' Qiagen takeover,Event-driven manager calls for revised bid,QGEN,en,HFM Global
2020-07-28 23:28:15-05:00,Qatar sovereign fund in advanced talks with RIL for $1.5 bn investment in JioFiber: Report,"Qatar Investment Authority (QIA)'s proposal to invest $1.5 billion (about Rs 11,200 crore) in JioFiber is gathering pace, Mint has reported quoting sources.According to the report, the sovereign fund's talks with Reliance on the deal are now at an advanced stage.Mukesh Ambani-led RIL has already raised over $20 billion via stake sales in Jio Platforms. The company is now looking to monetise its fibre assets held under Jio Digital Fiber, it said.RIL has roped in Citigroup Global Markets, Moelis and Co and ICICI Securities Ltd have as investment bankers for the deal, revealed the Mint report.QIA's proposal is the latest among a host of similar deals executed in recent times by RIL which is trying to remodel itself as primarily a consumer tech player, pivoting away from being just an oil & gas behemoth. Jio is also betting big on 5G for propelling the next set of services.Over a dozen companies including Qualcomm ventures, Intel Capital, Facebook, Google, Abu Dhabi’s two largest sovereign investment arms (Abu Dhabi Investment Authority and Mubadala) Silver Lake, Vista Equity Partners, General Atlantic, KKR, TPG, L Catterton and Saudi Arabia’s Public Investment Fund (PIF), have already put their money on Ambani.","QGEN,QCOM",en,Economic Times India
2020-07-27 04:42:50-05:00,"Atlantia : Blackrock, Qatar's QIA interested in Atlantia's tollroad unit - sources | MarketScreener","U.S. asset manager BlackRock and Qatar's sovereign fund QIA are interested in investing in Atlantia's motorway unit along with Italian state lender Cassa Depositi e Prestiti , two sources with… | July 27, 2020",QGEN,en,MarketScreener
2020-07-25 11:05:02-05:00,"QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | MarketScreener","DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide… | July 25, 2020",QGEN,en,MarketScreener
2020-07-23 18:30:00-05:00,Global Helicobacter Pylori Diagnostics Market Analysis Highlights the Impact of COVID-19 2020-2024 | Resistance of H. Pylori to Antibiotics to Boost Market Growth | Technavio,"Technavio has been monitoring the global helicobacter pylori diagnostics market size and it is poised to grow by USD 209.59 million during 2020-2024, progressing at a CAGR of over 8% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200723005618/en/ Technavio has announced its latest market research report titled Global Helicobacter Pylori Diagnostics Market 2020-2024 (Graphic: Business Wire) Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.",QGEN,en,Benzinga Feeds
2020-07-23 07:25:53-05:00,"The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) BioLife Solutions Inc (NASDAQ: BLFS ) CALLIDITAS THER/S ADR (NASDAQ: CALT ) Catalent Inc (NYSE: CTLT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Hologic, Inc. (NASDAQ: HOLX ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunic Inc (NASDAQ: IMUX ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) ( reported forecast-beating second-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Novo Nordisk A/S (NYSE: NVO ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Otonomy Inc (NASDAQ: OTIC ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 22) Akouos Inc (NASDAQ: AKUS ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Forma Therapeutics Holdings Inc (NASDAQ: FMTX ) Fusion Pharmaceuticals Inc (NASDAQ: FUSN ) Gritstone Oncology Inc (NASDAQ: GRTS ) Nkarta Inc (NASDAQ: NKTX ) RENALYTIX AI ADR (NASDAQ: RNLX ) (went public Friday) Tricida Inc (NASDAQ: TCDA ) Stocks In Focus Midatech Terminates Sale Process, Strategic Review to Continue Midatech Pharma PLC-ADR (NASDAQ: MTP ), a drug delivery technology company, said it has terminated the formal sale process initiated in late April after it failed to receive any proposals from third parties.",QGEN,en,Benzinga
2020-07-18 08:38:26-05:00,Investors keep pushing Qiagen to seek better offer (NYSE:QGEN),Union Investments and Davidson Kempner both continue to say Qiagen (NYSE:QGEN) should push Thermo Fisher Scientific (NYSE:TMO) even harder for a higher bid,QGEN,en,Seeking Alpha
2020-07-18 00:25:09.569000-05:00,"China ermuntert Broker und Fonds zu Fusionen, Union Investment hofft auf höheres Angebot für Qiagen – und weitere Wirtschaftsmeldungen | NZZ","NZZ Nachrichten, Hintergründe, Meinungen aus der Schweiz, International, Sport, Digital, Wirtschaft, Auto & mehr. Fundierte Berichterstattung rund um die Uhr.",QGEN,de,Neue Zürcher Zeitung
2020-07-18 00:25:09-05:00,"China ermuntert Broker und Fonds zu Fusionen, Union Investment hofft auf höheres Angebot für Qiagen – und weitere Wirtschaftsmeldungen",No summary available.,QGEN,de,Neue Zürcher Zeitung
2020-07-17 09:56:00-05:00,Folgen für Arbeitnehmer und Aktionäre: Teure Übernahmeschlacht um Qiagen,"Nachdem der US-Konzern Thermo Fisher sein Angebot für die Hildener Biotech-Perle erhöht hat, wächst der Druck auf die Arbeitnehmer. Ein Großaktionär ist noch immer nicht zufrieden und verlangt eine weitere Aufstockung.",QGEN,de,Rheinische Post
2020-07-17 06:41:01-05:00,"The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 16) AC Immune SA (NASDAQ: ACIU ) ( announced clinical trial update for its Alzheimer's vaccine candidate) argenx SE – ADR (NASDAQ: ARGX ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) Dynavax Technologies Corporation (NASDAQ: DVAX )(announced a collaboration with Mt. Sinai to develop a universal influenza vaccine candidate with CpG1018 adjuvant) Heat Biologics Inc (NASDAQ: HTBX ) Novavax, Inc. (NASDAQ: NVAX ) Qiagen NV (NYSE: QGEN )( Thermo Fisher Scientific Inc. (NYSE: TMO ) announced a sweetened offer to buy the company) Quest Diagnostics Inc (NYSE: DGX ) Otonomy Inc (NASDAQ: OTIC ) Principia Biopharma Inc (NASDAQ: PRNB )(reacted to buyout rumors) Relay Therapeutics Inc (NASDAQ: RLAY ) (jumped 75.25% on its debut) Sanofi SA (NASDAQ: SNY ) (Bloomberg reported the French biotech is on a lookout to buy biotech companies, including Principia) TIZIANA LF SCIE/S ADR (NASDAQ: TLSA ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 16) Avidity Biosciences Inc (NASDAQ: RNA ) Legend Biotech Corp (NASDAQ: LEGN ) Nkarta Inc (NASDAQ: NKTX ) (IPOed last Friday) Repare Therapeutics Inc (NASDAQ: RPTX ) Tricida Inc (NASDAQ: TCDA ) ( received a letter from FDA citing deficiencies in its NDA for the approval of metabolic …",QGEN,en,Benzinga Feeds
2020-07-17 02:02:27-05:00,Biotechindustrie: Thermo Fisher erhöht Offerte für Qiagen – Investor fordert mehr,Die erhöhte Offerte von Thermo Fisher für Qiagen ist einigen Investoren noch nicht genug. Sie sehen den Unternehmenswert nicht angemessen dargestellt.,QGEN,de,Handelsblatt
2020-07-16 10:37:19-05:00,American Buyer Increases Offer for Biotechnologist Qiagen - INC News,"The American Thermo Fisher has increased its offer for the German-Dutch biotechnologist Qiagen. This step follows complaints from shareholders, who found the initial amount to be below par…",QGEN,en,INC News
2020-07-16 10:11:28-05:00,Thermo Fisher's sweetened Qiagen bid fails to win over key investor | MarketScreener,"Thermo Fisher Scientific raised its bid for Qiagen by 900 million euros on Thursday but failed to win over a key investor who is seeking a higher price for the German genetic test maker…. | July 16, 2020",QGEN,en,MarketScreener
2020-07-16 09:28:29-05:00,Thermo Fisher raises Qiagen bid by $1 billion,Thermo Fisher Scientific raised its bid for Qiagen by 900 million euros ($1 billion) on Thursday in an effort to rescue a deal that some of the German genetic test maker's shareholders said undervalued the company's prospects.,QGEN,en,Reuters
2020-07-16 09:27:09-05:00,US-Konzern Thermo Fisher erhöht Angebot für deutsche Biotech-Perle Qiagen - manager magazin - Unternehmen,Das deutsche Biotech-Unternehmen Qiagen zählt zu den Gewinnern der Corona-Krise. Folge: Der vor Beginn der Pandemie ausgehandelte Übernahmedeal durch Thermo Fischer bildet den Unternehmenswert inzwischen nicht mehr ab.,QGEN,de,manager magazin
2020-07-16 07:59:00-05:00,Medizintechnik: Thermo Fisher bessert Übernahmeangebot für Qiagen nach,Das US-Unternehmen senkt die Annahmeschwelle für die Aktionäre des Hildener Diagnostikkonzerns. Zudem steigt der gebotene Kaufpreis pro Aktien.,QGEN,de,Handelsblatt
2020-07-16 07:31:22-05:00,"The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) Atossa Therapeutics Inc (NASDAQ: ATOS ) (announced results from lab studies of AT-301, its COVID-19 nasal spray drug candidate) AstraZeneca plc (NYSE: AZN ) (moved on reports that it could issue an update on its coronavirus vaccine program soon) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) (announced publication of a study demonstrating its DecisionDx-UM test results significantly impacted treatment plan recommendations for patients with uveal melanoma) Catalent Inc (NYSE: CTLT ) Cytokinetics, Inc. (NASDAQ: CYTK ) (issued an investor update on its cardiovascular pipeline) ESSA Pharma Inc (NASDAQ: EPIX ) (announced enrollment of first patient in Phase 1 study of its prostate cancer drug) Genetic Technologies Limited (NASDAQ: GENE ) (issued an update on its COVID-19 Severity Risk Test) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Hologic, Inc.",QGEN,en,Benzinga
2020-07-16 04:17:24-05:00,Qiagen-Aktionär Davidson Kempner trommelt gegen Thermo-Fisher-Offerte,Muss Thermo-Fisher sein Übernahmeangebot für Qiagen doch erhöhen? Nach einer starken Geschäftsentwicklung aufgrund der Coronakrise lehnt der Finanzinvestor Davidson Kempner die bisherige Offerte ab – und wirbt um Mitstreiter.,QGEN,de,FINANCE Magazin
2020-07-15 09:30:03-05:00,Davidson Kempner spurns Thermo Fisher's Qiagen offer as 'wholly inadequate',"Hedge fund Davidson Kempner said on Wednesday Thermo Fisher Scientific's offer to buy German genetic test maker Qiagen was ""wholly inadequate"" and that it would not be tendering its shares into the deal at the current price.",QGEN,en,Reuters UK
2020-07-15 06:30:17-05:00,"The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Altimmune Inc (NASDAQ: ALT ) (priced its $115 million worth of common stock and pre-funded warrant offering) Beigene Ltd (NASDAQ: BGNE ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Imv Inc (NASDAQ: IMV ) (provided an update on its coronavirus vaccine program) INmune Bio Inc (NASDAQ: INMB )( announced positive interim Phase 1b data for its Alzheimer's drug) OncoSec Medical Inc (NASDAQ: ONCS ) Qiagen NV (NYSE: QGEN ) Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) (announced initiation of clinical study of its fostamatinib for treating COVID-19 pneumonia) TIZIANA LF SCIE/S ADR (NASDAQ: TLSA ) Vaxart Inc (NASDAQ: VXRT ) VBI Vaccines Inc (NASDAQ: VBIV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) Acorda Therapeutics Inc (NASDAQ: ACOR ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) BELLUS Health Inc (NASDAQ: BLU ) Brickell Biotech Inc (NASDAQ: BBI ) Forma Therapeutics Holdings Inc (NASDAQ: FMTX )(IPO quiet period expired) Genfit SA (NASDAQ: GNFT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) INVENTIVA SA/ADR (NASDAQ: IVA ) (IPOed Friday) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Nkarta Inc (NASDAQ: NKTX ) (IPOed Friday) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Poseida Therapeutics, Inc.",QGEN,en,Benzinga
2020-07-13 14:26:34-05:00,Thermo Fisher under mounting pressure to up Qiagen bid - UFP (NYSE:PKI),United First Partners chief Stephane Mardel says bullish preliminary results from life science toolmaker PerkinElmer (PKI +3.5%) is ratcheting up the press,QGEN,en,Seeking Alpha
2020-07-13 11:51:31-05:00,Biotech: Qiagen rechnet dank Corona mit stark erhöhtem Wachstum,"Das Unternehmen ist zuversichtlich, dass die Nachfrage nach Coronavirus-Testprodukten anhält. Nun gibt es Spekulationen um eine Erhöhung des Übernahmeangebots.",QGEN,de,Handelsblatt
2020-07-13 11:05:00-05:00,QIAGEN-Aktie gefragt: Aktionärsvertreter von QIAGEN hält Offerte von circa 50 Euro für angemessen - anhaltendes Wachstum erwartert,"Ein Preis von 50 Euro je Aktie wäre ein fairer Wert für QIAGEN als Standalone-Unternehmen, heisst es in einem offenen Brief an Management und Aufsichtsrat von QIAGEN. Thermo Fisher bietet derzeit 39 Euro pro…",QGEN,de,Finanzen CH
2020-07-13 09:20:00-05:00,Qiagen: Diese Rallye sollten Anleger nicht verpassen,Am Donnerstag überraschte Qiagen bereits durch starke vorläufige Zahlen. Heute hebt der Diagnostikkonzern aufgrund der hohen Nachfrage nach Testprodukten gegen das Coronavirus die prognose an – die Rallye geht damit weiter.,QGEN,de,Finanztreff
2020-07-13 08:36:28-05:00,When Bad News Is Good News for an M&A Deal,"Now that we’re in a full-blown pandemic, Qiagen shareholders are right to ask for more from U.S. rival Thermo Fisher.",QGEN,en,The Washington Post
2020-07-13 08:11:12-05:00,"Qiagen N : provides update on Q2 2020 results, announces strong outlook for Q3 and FY 2020, and 2021 perspectives in light of coronavirus pandemic | MarketScreener","Venlo, The Netherlands, July 13, 2020 -QIAGEN N.V. today announced additional information on preliminary results for the second quarter and first half of 2020, along with an outlook… | July 13, 2020",QGEN,en,MarketScreener
2020-07-13 06:04:11-05:00,QIAGEN (QGEN) Reports Encouraging Preliminary Q2 Results,Preliminary net revenues for second-quarter 2020 improved 18-19% at CER.,QGEN,en,Yahoo Finance
2020-07-13 03:22:00-05:00,QIAGEN-Aktie gefragt: Aktionärsvertreter von QIAGEN hält Offerte von circa 50 Euro für angemessen,"Ein Preis von 50 Euro je Aktie wäre ein fairer Wert für QIAGEN als Standalone-Unternehmen, heisst es in einem offenen Brief an Management und Aufsichtsrat von QIAGEN. Thermo Fisher bietet derzeit 39 Euro pro…",QGEN,de,Finanzen CH
2020-07-13 01:40:05-05:00,Marktüberblick: Qiagen nach Zahlen fest,"Der deutsche Aktienmarkt zeigte sich zum Wochenausklang fest. Marktbeobachter verwiesen zur Begründung auf die Hoffnung, dass sich die Volkswirtschaften weiter vom Corona-Tief erholen werden. Daneben stützten erste Ergebnisse der startenden Q2-Berichtssaison. Der DAX verabschiedete sich mit einem Plus von 1,15 Prozent…",QGEN,de,GodmodeTrader
2020-07-11 07:41:40-05:00,QIAGEN-Aktionärsvertreter hält Offerte von circa 50 Euro für angemessen,"Ein Preis von 50 Euro je Aktie wäre ein fairer Wert für QIAGEN als Standalone-Unternehmen, heisst es in einem offenen Brief an Management und Aufsichtsrat von QIAGEN. Thermo Fisher bietet derzeit 39 Euro pro…",QGEN,de,Finanzen CH
2020-07-10 14:57:00-05:00,Davidson Kempner Letter to Qiagen NV,"LONDON, July 10, 2020 /PRNewswire/ -- To: Dr. Håkan Björklund (Chairman of the Supervisory Board) Stéphane Bancel (Supervisory Board Director) Dr. Metin Colpan (Supervisory Board Director) Prof. Dr. Ross Levine (Supervisory Board Director) Prof. Dr. Elaine Mardis (Supervisory Board…",QGEN,en,PR Newswire
2020-07-10 11:11:39-05:00,Thermo Fisher bid for Qiagen inadequate - Davidson Kempner (NYSE:QGEN),"QIAGEN N.V. (QGEN +1.3%) is up modestly, albeit on below-average volume, on the heels of a letter to its board from institutional investor Davidson Kempner",QGEN,en,Seeking Alpha
2020-07-10 06:53:00-05:00,Übernahmeschlacht in Hilden: Hoffen auf höhere Offerte für Qiagen,"Gute Quartalszahlen heizen die Spekulation an, dass die Übernahme für Thermo Fisher teurer wird. Falls der US-Konzern scheitert, wäre Qiagen ein Kandidat für den Dax – und Hilden viele Sorgen los.",QGEN,de,Rheinische Post
2020-07-10 06:25:13-05:00,"The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …","QGEN,QDEL,PYPD",en,Benzinga
2020-07-10 04:28:03-05:00,QIAGEN NV : Warburg Research reiterates its Neutral rating | MarketScreener,"Ulrich Huwald from Warburg Research retains his Neutral opinion on the stock. The target price remains set at EUR 39. | July 10, 2020",QGEN,en,MarketScreener
2020-07-10 02:17:00-05:00,QIAGEN-Aktie steigt klar: QIAGEN steigert Gewinn im zweiten Quartal kräftig,"Eine schwächere Kundennachfrage in anderen Produktbereichen sei dadurch überkompensiert worden, teilte das Diagnostikunternehmen am frühen Donnerstagabend überraschend mit. Nach vorläufigen Berechnungen kletterte der Umsatz den Angaben zufolge bei konstanten Wechselkursen um ca. 18 bis 19 Prozent, Anfang Mai hatte der Konzern…",QGEN,de,Finanzen CH
2020-07-10 00:51:00-05:00,Qiagen: Umsatzsprung feuert Spekulationen an,Aufgrund der Nachfrage nach Coronavirus-Testprodukten ist der Umsatz von Qiagen im zweiten Quartal unerwartet stark gestiegen – das dürfte die Spekulation um eine Nachbesserung des Übernahmeangebots erneut anfachen.,QGEN,de,Finanztreff
2020-07-09 13:20:00-05:00,QIAGEN-Aktie legt nachbörslich zu: QIAGEN steigert Gewinn im zweiten Quartal kräftig,"Eine schwächere Kundennachfrage in anderen Produktbereichen sei dadurch überkompensiert worden, teilte das Diagnostikunternehmen am frühen Donnerstagabend überraschend mit. Nach vorläufigen Berechnungen kletterte der Umsatz den Angaben zufolge bei konstanten Wechselkursen um ca. 18 bis 19 Prozent, Anfang Mai hatte der Konzern…",QGEN,de,Finanzen CH
2020-07-09 12:54:44-05:00,"Corona-Gewinner Qiagen wächst kräftiger als erwartet, Übernahmepreis könnte steigen - manager magazin - Unternehmen","Der Boom an Coronavirus-Tests treibt die Geschäfte von Qiagen. Mit den guten Zahlen könnte die deutsche Biotech-Ikone ihren Übernahmepreis noch in die Höhe treiben, sagen Experten.",QGEN,de,manager magazin
2020-07-09 12:54:44-05:00,Qiagen wächst kräftiger als erwartet,"Der Boom an Coronavirus-Tests treibt die Geschäfte von Qiagen. Mit den guten Zahlen könnte die deutsche Biotech-Ikone ihren Übernahmepreis noch in die Höhe treiben, sagen Experten.",QGEN,de,manager magazin
2020-07-09 11:26:06-05:00,Qiagen N : announces preliminary results for Q2 2020 | MarketScreener,"Venlo, The Netherlands, July 9, 2020 -QIAGEN N.V. announces preliminary sales and adjusted earnings per share results for the second quarter of 2020. Net sales… | July 9, 2020",QGEN,en,MarketScreener
2020-07-08 09:39:00-05:00,Hilden: Qiagen will Standort in Hilden offenbar halten,"Mit guten Nachrichten für Hilden sind die Bundestagsabgeordnete Michaela Noll und die Landtagsabgeordnete Claudia Schlottmann von einem Gespräch beim Biotech-Unternehmen Qiagen zurückgekehrt. „Der Standort Hilden bleibt und soll weiter gestärkt werden“, hatte Qiagen-Finanzvorstand Roland Sackers den beiden CDU-Politikerinnen erklärt.",QGEN,de,Rheinische Post
2020-07-03 10:29:51-05:00,Major Qiagen shareholder demands higher bid from Thermo Fisher - source,"The coronavirus pandemic has boosted Qiagen's prospects and a takeover by Thermo Fisher no longer makes sense unless the offer is increased substantially, one of the German genetic test maker's top ten shareholders told Reuters on Friday.",QGEN,en,Reuters UK
2020-07-03 09:38:22-05:00,Major Qiagen shareholder opposes Thermo Fisher takeover - source,"The coronavirus pandemic has boosted Qiagen's prospects as a standalone company and a takeover by Thermo Fisher no longer makes sense unless the offer is increased substantially, one of the German genetic test maker's top ten shareholders told Reuters on Friday.",QGEN,en,Reuters
2020-07-02 06:16:00-05:00,"Outlook into the Cell Culture Protein Surface Coating Global Industry to 2025 - Featuring PerkinElmer, Promega & Qiagen Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Cell Culture Protein Surface Coating Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025"" report has been added to ResearchAndMarkets.com's offering. The global cell culture protein surface coating market is currently experiencing strong growth. Looking forward, the publisher expects the market to grow at a CAGR of around 12% during 2020-2025. A cell culture protein surface coating helps in enhancing the adhesion and proliferatio",QGEN,en,Business Wire
2020-07-01 05:14:00-05:00,"Global COVID-19 Detection Kits Market Analysis 2020-2025 Featuring BGI, Cepheid, Abbott, Roche, RayBiotech, BioFire Diagnostics, Co-Diagnostics, GenMark Diagnostics, Qiagen and Randox Labs - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""COVID-19 Detection Kits Market - Growth, Trends and Forecasts (2020-2025)"" report has been added to ResearchAndMarkets.com's offering. The Global COVID-19 Detection Kits Market is expected to register a CAGR of 8% during the forecast period. This is attributing increasing incidences of COVID-19 and rising geriatric population globally. According to the World Health Organization, COVID- 19 outbreak declared as a pandemic due to the worldwide spread and severity of d",QGEN,en,Business Wire
2020-06-29 18:30:00-05:00,Analysis of COVID-19 Impact: Tumor (Cancer) Profiling Market 2020-2024 | Increasing Cancer Research and Funding to Augment Growth | Technavio,"Technavio has been monitoring the tumor (cancer) profiling market and it is poised to grow by USD 4.85 billion during 2020-2024, progressing at a CAGR of 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200629005559/en/ Technavio has announced its latest market research report titled Global Tumor (Cancer) Profiling Market 2020-2024 (Graphic: Business Wire) Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.",QGEN,en,Benzinga Feeds
2020-06-24 03:55:35-05:00,QIAGEN winkt hoher Sondergewinn durch Verkauf einer Beteiligung in den USA - Aktie wenig bewegt,"Die auf die Genomanalyse spezialisierte amerikanische Firma steht vor der Übernahme durch den Branchenkollegen Invitae, der sich den Kauf bis zu 1,4 Milliarden Dollar kosten lässt. QIAGEN rechnet nun mit einem Veräusserungsgewinn vor Steuern von etwa 120 Millionen US-Dollar (107…",QGEN,de,Finanzen CH
2020-06-19 13:15:00-05:00,Global Market Outlook for the Coronavirus Diagnostics Market to 2027,"DUBLIN , June 19, 2020 /PRNewswire/ -- The ""Coronavirus Diagnostics - Global Market Outlook (2018-2027)"" report has been added to ResearchAndMarkets.com's offering. The Global Coronavirus Diagnostics market accounted for $4.64 billion in 2018 and is expected to reach $8.82 billion by 2027 growing at a CAGR of 7.4% during the forecast period. The exponential rise in cases of COVID-19 and growing healthcare spending and increasing need to protect the population from such outbreaks are the major factors propelling the market growth. However, factors such as lack of skilled nursing staff is hampering the market growth. Based on type, the serology tests segment is going to experience lucrative growth during the forecast period as diagnostic tests are done using blood samples. Furthermore, these tests are helpful in determining patients with mild or no symptoms. By geography, North America is likely to have experience huge demand due to growing investments in R&D activities which is further expected to create huge market opportunities for diagnostic players over the next few years.",QGEN,en,Benzinga Feeds
2020-06-18 22:15:00-05:00,Coronavirus Test Kits Market in APAC 2020-2024 | Increasing Incidence Of Coronavirus to Boost Growth | Technavio,"Technavio has been monitoring the coronavirus test kits market in APAC and it is poised to grow by USD 50.15 million during 2020-2024. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200618005796/en/ Technavio has announced its latest market research report titled Coronavirus Test Kits Market in APAC 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Latest Free Sample Report on COVID-19 Impact The market is fragmented, and the degree of fragmentation will decelerate during the forecast period. 3D Biomedicine Science & Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co.",QGEN,en,Benzinga Feeds
2020-06-11 07:09:59-05:00,Ysios Capital raises EUR155m for Spanish biotech fund,"Ysios Capital raises EUR155m for Spanish biotech fund Submitted By Karin Wasteson | 11/06/2020 - 1:09pm Spanish biotech VC firm Ysios Capital has held a first close of its third fund, Ysios BioFund III, at EUR155 million. The fund has a final target size of EUR200 million. Ysios Capital is the largest venture capital firm in Spain specialised in biotechnology with EUR346 million under management through three funds; Ysios BioFund I, Ysios BioFund II Innvierte and Ysios BioFund III. The firm expects to close four new investments shortly. “For this third fund, we have a pipeline of very promising projects at advanced stage, both in Spain and in the rest of Europe, and we aim to close at least five operations this year,” says Karen Wagner, partner of Ysios Capital. Ysios BioFund III has expanded its investor base with new national institutional investors, international family offices, and the European Investment Fund via The European Fund for Strategic Investments (EFSI), with the support of the European Union under the Investment Plan for Europe. “We have had an excellent support from our existing investor base, but also from new investors who are becoming interested in the biotech sector and have chosen us as their reference firm in the sector,” says Julia Salaverria, partner at Ysios Capital. “In the context of the current Covid-19 pandemic, the biotechnology sector has become even more relevant as one of the key sectors that will prepare society for new health threats,” she added.",QGEN,en,PrivateEquityWire
2020-06-08 07:01:00-05:00,"COVID-19 Test Kit Manufacturers in the US - Evolving Opportunities with Abott, BD, Biomerieux, Qiagen | Gain Complimentary Access to SpendEdge’s Procurement Platform",LONDON--(BUSINESS WIRE)-- #MarketIntelligence--SpendEdge has identified the top Coronavirus (COVID 19) test kit manufacturers in the US.,QGEN,en,Business Wire
2020-06-05 10:31:46-05:00,Qiagen (QGEN) Up 4.3% Since Last Earnings Report: Can It Continue?,Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,QGEN,en,Zacks Investment Research
2020-06-05 06:34:09-05:00,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 4) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) argenx SE – ADR (NASDAQ: ARGX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Imara Inc (NASDAQ: IMRA ) Inari Medical Inc (NASDAQ: NARI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Passage Bio Inc (NASDAQ: PASG ) Qiagen NV (NYSE: QGEN ) Replimune Group Inc (NASDAQ: REPL ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 4) Evofem Biosciences Inc (NASDAQ: EVFM )(priced its 28.5 million common stock offering) Iterum Therapeutics PLC (NASDAQ: ITRM ) Stocks In Focus Adamas' Regulatory Application For Label Expansion For Parkinson's Drug Accepted For Review Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) said the FDA has accepted its sNDA for Gocovri as a treatment for OFF episodes in Parkinson's disease patients receiving levodopa-based therapy.,QGEN,en,Benzinga
2020-06-04 08:03:00-05:00,Earnings Estimates Moving Higher for QIAGEN (QGEN): Time to Buy?,"QIAGEN (QGEN) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.",QGEN,en,Zacks Investment Research
2020-06-04 07:13:59-05:00,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Fortress Biotech (NASDAQ: FBIO ) Imara Inc (NASDAQ: IMRA ) Inari Medical Inc (NASDAQ: NARI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Keros Therapeutics Inc (NASDAQ: KROS ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) Pliant Therapeutics Inc (NASDAQ: PLRX ) (went public Wednesday) Protara Therapeutics Inc (NASDAQ: TARA ) Qiagen NV (NYSE: QGEN ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 3) Cellectar Biosciences Inc (NASDAQ: CLRB ) (priced a $20-million common stock offering) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Genfit SA (NASDAQ: GNFT ) Stocks In Focus Kezar Reports Positive Early Stage Results For KZR-616 In Systemic Lupus Erythematosus Kezar Life Sciences, Inc. (NASDAQ: KZR ) announced updated results from the Phase 1b portion of the Phase 1b/2 MISSION study, which is evaluating the safety and tolerability of KZR-616 in patients with systemic lupus erythematosus with and without nephritis, showing overall improvements across seven measures of disease activity.",QGEN,en,Benzinga
2020-06-01 08:59:00-05:00,Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio,Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.,QGEN,en,Zacks Investment Research
2020-05-29 06:41:27-05:00,Lufthansa steht vor dem Abflug aus dem DAX,"Lufthansa-Aktien seit Jahresbeginn um 40 Prozent eingebrochen - Abstieg des dritten DAX-Gründungsmitglieds seit 2018. Lufthansa-Chef Carsten Spohr ist nicht zu beneiden: Die Coronavirus-Krise setzt der AUA-Muttergesellschaft schwer zu, die Verhandlungen über ein milliardenschweres Rettungspaket des deutschen Bundes ziehen sich hin und nun steht das DAX-Gründungsmitglied auch noch vor dem Abstieg aus der ersten deutschen Börsenliga. Steil bergab Seit Jahresbeginn brach der Aktienkurs um mehr als 40 Prozent ein - noch nie in der Firmengeschichte ging es innerhalb eines knappen halben Jahres so steil bergab. Daher wird die Deutsche Börse bei der außerordentlichen Überprüfung der Index-Zusammensetzung am 4. Juni wohl den Abstieg der Lufthansa in den Nebenwerte-Index MDax verkünden, wie Analysten prognostizieren. Wirksam würde die Veränderung im Rahmen der ""Fast Exit""-Regel mit 22. Juni. Die Fluggesellschaft wäre nach der Commerzbank und ThyssenKrupp das dritte Gründungsmitglied, dass sich seit 2018 aus dem DAX verabschieden muss.",QGEN,de,KURIER Medienhaus
2020-05-29 06:22:24-05:00,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) ADC Therapeutics SA (NYSE: ADCT ) (IPOed May 15) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO )( announced a collaboration study for razuprotafib in COVID-19 treatment) Aileron Therapeutics Inc (NASDAQ: ALRN ) Arca Biopharma Inc (NASDAQ: ABIO ) ( reacted to its planned foray into COVID-19 treatment) argenx SE – ADR (NASDAQ: ARGX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) ChemoCentryx Inc (NASDAQ: CCXI ) GENMAB A/S/S ADR (NASDAQ: GMAB )(announced positive topline Phase 3 data for daratumumab in light-chain amyloidosis) Imara Inc NASDAQ: (IMRA) Liquidia Technologies Inc (NASDAQ: LQDA ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Qiagen NV (NYSE: QGEN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Vermillion, Inc. (NASDAQ: VRML ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 28) Zafgen Inc (NASDAQ: ZFGN ) Stocks In Focus Karyopharm to Present Positive Selinexor Data In Multiple Myeloma Patients At ASCO Karyopharm Therapeutics Inc (NASDAQ: KPTI ) announced detailed results from the pivotal Phase 3 BOSTON study that evaluated once-weekly selinexor in combination with once-weekly Velcade and low-dose dexamethasone, or SVd, compared to the standard twice-weekly Velcade plus low-dose dexamethasone, or Vd, in second-line to fourth-line setting in multiple myeloma patients.",QGEN,en,Benzinga Feeds
2020-05-28 10:40:08-05:00,QGEN vs. RGEN: Which Stock Is the Better Value Option?,QGEN vs. RGEN: Which Stock Is the Better Value Option?,QGEN,en,Zacks Investment Research
2020-05-28 10:34:00-05:00,"Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics","Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics",QGEN,en,Zacks Investment Research
2020-05-27 10:11:21-05:00,Qiagen: Wie Håkan Björklund die Biotech-Perle verschleuderte,Wie Chefkontrolleur Håkan Björklund den Deal seines Lebens fabrizieren wollte und dabei eine Perle der Biotechszene zum Rabattpreis in die USA verramscht.,QGEN,de,manager magazin
2020-05-27 10:07:48-05:00,Hinter den Kulissen einer Milliardenschlacht: Qiagen - wie eine deutsche Biotech-Ikone verschleudert wird,Wie Chefkontrolleur Håkan Björklund den Deal seines Lebens fabrizieren wollte und dabei eine Perle der Biotechszene zum Rabattpreis in die USA verramscht.,QGEN,de,manager magazin
2020-05-27 06:25:23-05:00,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) ADC Therapeutics SA (NYSE: ADCT ) (IPOed May 15) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE )(announced positive one-year Phase 1/2 study and Phase 2 open-label extension study of pegzilarginase in Arginase 1 Deficiency patients) Allogene Therapeutics Inc (NASDAQ: ALLO ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX )( announced positive top-line data from a late-stage study of efgartigimod in patients with generalized Myasthenia Gravis) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN )(gained on sell-side comment on the company being a potential target for Sanofi SA (NASDAQ: SNY ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) Catalent Inc (NYSE: CTLT ) ChemoCentryx Inc (NASDAQ: CCXI ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Cue Biopharma Inc (NASDAQ: CUE ) Evoke Pharma Inc (NASDAQ: EVOK ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Harpoon Therapeutics Inc (NASDAQ: HARP ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc.",QGEN,en,Benzinga
2020-05-21 07:01:32-05:00,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.) ADC Therapeutics SA (NYSE: ADCT ) (went public May 15) Allogene Therapeutics Inc (NASDAQ: ALLO ) Ascendis Pharma A/S (NASDAQ: ASND ) (announced first-quarter results) Altimmune Inc (NASDAQ: ALT ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Cue Biopharma Inc (NASDAQ: CUE ) (reacted to first-quarter results) Evoke Pharma Inc (NASDAQ: EVOK ) (announced FDA's conditional approval for the brand name Gimoti for its nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis) GENMAB A/S/S ADR (NASDAQ: GMAB ) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Novo Nordisk A/S (NYSE: NVO ) PDL BioPharma Inc (NASDAQ: PDLI ) Pulmatrix Inc (NASDAQ: PULM ) Qiagen NV (NYSE: QGEN ) Soleno Therapeutics Inc (NASDAQ: SLNO ) Surface Oncology Inc (NASDAQ: SURF ) - announced an oncology partnership with Merck & Co., Inc. (NYSE: MRK ) VBI Vaccines Inc (NASDAQ: VBIV ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) (announced $20-million Series A financing to establish a Chinese joint venture) Down In The Dumps (Biotech stocks that hit 52-week lows on May 20.) Genfit SA (NASDAQ: GNFT ) RA Medical Systems Inc (NYSE: RMED ) (priced its 22.22-million-share common stock offering at 45 cents per share) Stocks In Focus Gilead-Galapagos Drug Produces Mixed Results In Ulcerative Colitis Study Gilead Sciences, Inc. (NASDAQ: GILD ) and GALAPAGOS NV/S ADR (NASDAQ: GLPG ) announced top-line results from the Phase 2b/3 trial evaluating the efficacy and safety of filgotinib in adult patients with moderately to severely active ulcerative colitis showing mixed results.","QGEN,PULM",en,Benzinga
2020-05-18 03:28:06-05:00,Biotech: Thermo Fisher startet Übernahmeangebot für Qiagen,Der US-Laborausrüster will mehr als zehn Milliarden Euro für die deutsche Biotechfirma zahlen. Die Annahmefrist für Aktionäre läuft nun bis zum 27. Juli.,QGEN,de,Handelsblatt
2020-05-18 02:15:00-05:00,Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.,"WALTHAM, Mass., May 18, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published the offer document (the ""Offer Document"") for its voluntary tender offer (the ""Tender Offer"") for all of the ordinary shares of QIAGEN N.V. (NYSE:…",QGEN,en,PR Newswire
2020-05-12 11:20:05-05:00,Can Qiagen (QGEN) Run Higher on Rising Earnings Estimates?,"Qiagen (QGEN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",QGEN,en,Zacks Investment Research
2020-05-09 05:15:27.205000-05:00,Adani Transmission Q4 profit falls 60 pc to Rs 59 crore on one-time write off,"Ahmedabad (Gujarat): Adani Transmission Ltd (ATL) on Saturday reported 60 per cent plunge in its Q4 (January to March) profit after tax at Rs 59 crore compared to Rs 147 crore in the corresponding period of previous fiscal. The decline was primarily due to one-time write off finance sunk cost of Rs 185 crore (non-cash item), the company said in a statement. Q4 FY20 revenue came lower by 3 per cent year-on-year at Rs 2,220 crore due to lower share of distribution business on account of subdued power demand by industries. The operational earnings before interest, taxes, depreciation and amortisation (EBITDA) of Rs 893 crore were up by 2 per cent. Transmission operational EBITDA of Rs 618 crore was up by 18 per cent. ""ATL continues to focus on freeing up its equity, reducing cost of debt and bringing in marquee partners to set global corporate practices,"" it said. The company completed its maiden US private placement of 400 million dollars in February to March. It also completed the process of investment by Qatar Investment Authority (QIA) investment in subsidiary company Adani Electricity Mumbai Ltd (AEML).",QGEN,en,Sify.com
2020-05-08 02:26:55-05:00,Dax aktuell: Dax steigt weiter – Laborausrüster Qiagen auf 19-Jahres-Hoch,Der deutsche Aktienmarkt bleibt im Aufwind. Börsianer hoffen auf eine doppelte Entspannung: in der Corona-Pandemie und im Zollstreit USA-China. Qiagen-Aktien klettern auf ein Rekordhoch.,QGEN,de,Handelsblatt
2020-05-07 09:40:00-05:00,"QIAGEN (QGEN) Q1 Earnings Lag Estimates, Operating Margin Up",QIAGEN (QGEN) registered robust revenue growth across all geographies and each of its operating segments in Q1 despite the coronavirus-led economic crisis.,QGEN,en,Zacks Investment Research
2020-05-07 00:00:27-05:00,"DAX startet etwas fester -- Asiens Börsen uneinheitlich -- HeidelbergCement spürt Corona-Folgen -- Munich Re mit Gewinneinbruch -- Conti kappt Investitionen -- PUMA, Evonik, QIAGEN, Lyft im Fokus",Hoher Verlust bei Koenig & Bauer - Hoffnungsschimmer Auftragseingang. Mindestannahmeschwelle bis Sixt Leasing deutlich überschritten. Air France-KLM erwartet nach Milliardenverlust noch heftigere Corona-Folgen. Zalando erwartet 2020 zweistelliges Wachstum und schwarze Zahlen im Gesamtjahr. ElringKlinger erwartet schwierige Zeiten. CompuGroup profitiert von Nachfrage nach Videosprechstunde. 07.05.2020,QGEN,de,FinanzenNet
2020-05-06 02:18:49-05:00,QIAGEN sieht in 2Q Umsatzplus und setzt Jahresprognose aus - Aktie unbeeindruckt,Die Prognose für das Gesamtjahr setzt QIAGEN wegen der Unsicherheit rund um die Corona-Pandemie aus. Auf der Grundlage der bisherigen Trends erwarten die Niederländer für das zweite Quartal 2020 ein Nettoumsatzwachstum von mindestens 12 Prozent gegenüber dem Vorjahr bei…,QGEN,de,Finanzen CH
2020-05-05 00:02:06-05:00,Ausblick: QIAGEN stellt Zahlen zum jüngsten Quartal vor,"QIAGEN wird am 06.05.2020 das Zahlenwerk zum am 31.03.2020 abgelaufenen Jahresviertel vorstellen.7 Analysten schätzen im Schnitt, dass QIAGEN im jüngsten Jahresviertel einen Gewinn von 0,282 USD je Aktie erwirtschaftet hat. Im Vorjahresviertel waren es noch 0,270 USD je Aktie…",QGEN,de,Finanzen CH
2020-04-30 09:39:00-05:00,QIAGEN (QGEN) Q1 Earnings to Gain on Growing Test Kit Sales,QIAGEN (QGEN) is expected to have gained from increased adoption of testing solutions to identify the SARS-CoV-2 in Q1 amid the coronavirus pandemic.,QGEN,en,Zacks Investment Research
2020-04-30 08:24:00-05:00,"Global Liquid Biopsy Markets, 2015-2030: Companies Focusing Primarily on New Product Launches to Meet the Ever-Increasing Need for Liquid Biopsy Products and Services - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Liquid Biopsy Market Global Report 2020-2030"" report has been added to ResearchAndMarkets.com's offering. The global liquid biopsy market was worth $2.9 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 20.80% and reach $6.1 billion by 2023. North America was the largest region in 2019 and Asia-Pacific is expected to grow fastest in the forecast period. Major players in the market are QIAGEN N.V., Roche Diagnostics, Bio-Rad Laborato",QGEN,en,Business Wire
2020-04-28 10:00:13-05:00,"Besonders auffällige Insidertransaktionen bei SAP, Drägerwerk & Qiagen","Während der Erholungsrally im April gab es bei einigen deutschen Unternehmen nennenswerte Insidertransaktionen zu vermelden. Nachfolgend erfahren sie mehr über die Geschehnisse bei SAP, Drägerwerk und Qiagen. Von Jörg Bernhard",QGEN,de,BORSE ONLINE
2020-04-27 07:00:00-05:00,Gilson and QIAGEN Announce Collaboration Aiming to Make Manual Nucleic Acid Extraction More Efficient and Reproducible,"MIDDLETON, Wis.--(BUSINESS WIRE)--Gilson and QIAGEN have partnered to limit operator-dependent variation in manual nucleic acid extraction results and improve traceability.",QGEN,en,Business Wire
2020-04-17 02:43:00-05:00,QIAGEN Launches Assay for Cancer Patients Following FDA's Nod,QIAGEN (QGEN) paves the way for metastatic CRC treatment in adults with the launch of an FDA-approved companion diagnostic test kit.,QGEN,en,Zacks Investment Research
2020-04-15 08:33:00-05:00,QIAGEN (QGEN) Reports Preliminary Revenue Results for Q1,"Investors remain optimistic with QIAGEN's (QGEN) first-quarter 2020 preliminary revenue results, which is likely to benefit from increased testing demand for coronavirus infection.",QGEN,en,Zacks Investment Research
2020-04-14 15:16:00-05:00,"Insights into the Worldwide & Chinese Molecular Diagnostics Markets to 2025 - Featuring Roche, QIAGEN, GenProbe & Abbott Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Molecular Diagnostics Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Application, Product Type"" report has been added to ResearchAndMarkets.com's offering. 2020 Global and Chinese Molecular Diagnostics Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Molecular Diagnostics market with a focus on the Chinese market. The report provide",QGEN,en,Business Wire
2020-04-05 18:30:24-05:00,Test producidos en Barcelona y vendidos al extranjero,"En contraste con algunas empresas que producen exclusivamente para España , hay otras cuyos test, en plena emergencia nacional y con todas las administraciones buscando a la desesperada sistemas de detección del Covid-19, venden también fuera. Es el caso de la firma catalana QIAstat -comprada en 2018 por la multinacional holandesa Qiagen por unos 150 millones- y que produce desde Barcelona y para todo el mundo sus pruebas rápidas tipo PCR QIAstat-Dx. Un portavoz de la compañía precisó a ABC que por política de confidencialidad no revelan qué porcentaje de la producción destinan al mercado internacional, pero sí señala que la parte que se queda en España «bloqueada por el Gobierno no es anecdótica» . Tampoco quiere explicar la compañía el número total de test producidos, si bien fuentes empresariales consultadas por este diario señalan que podrían ser unos 9.000 al día desde que la empresa, con el estallido de la crisis del coronavirus , triplicó turnos. 50 máquinas en España La peculiaridad de las pruebas patentadas por QIAstat -y que se producen tanto en su centro en el parque científico de la Universidad de Barcelona como en una planta de Qiagen en Alemania- es que no son análisis para realizar de manera masiva , sino que son pruebas de alta precisión, más pensados para utilizarse en centros hospitalarios.",QGEN,es,ABC
2020-03-26 12:19:00-05:00,QIAGEN Releases Coronavirus Test Kit in US on New FDA Policy,QIAGEN (QGEN) releases test kits in the United States to speed up the diagnosis of coronavirus per the FDA's latest policy.,QGEN,en,Zacks Investment Research
2020-03-25 12:30:00-05:00,Qiagen-Aktie notiert unter Angebotspreis - eventuell kommt bald eine Einstiegschance,Der auf Diagnostikprodukte spezialisierte Medizintechniker Qiagen hat von Thermo Fisher Scientific ein Übernahmeangebot erhalten. Mit dem US-Wettbewerber wurde schon 2019 verhandelt. Von Jörg Lang,QGEN,de,BORSE ONLINE
2020-03-19 08:12:00-05:00,QIAGEN Gets CE Nod for QIAstat-Dx Respiratory SARS-CoV-2 Test,The regulatory clearance of this test has made QIAGEN (QGEN) a key player in coronavirus diagnosis.,QGEN,en,Zacks Investment Research
2020-03-19 00:12:46-05:00,QIAGEN führt in Europa Schnelltest zur Coronavirus-Erkennung ein - Ergebnis innerhalb einer Stunde,"Dabei handelt es sich um das neu entwickelte QIAstat-Dx-Sars-CoV-2-Atemwegs-Panel zum Nachweis von Sars-CoV-2, teilte das im MDAX notierte Chemie- und Pharma-Unternehmen mit. Das QIAstat-Dx-Testkit sei die erste für den Einsatz in der Coronavirus-Epidemie zugelassene syndromische Testlösung und kann das neuartige Coronavirus…",QGEN,de,Finanzen CH
2020-03-18 05:33:22-05:00,Coronavirus - Rennen um die schnellsten SARS-CoV-2-Tests,"Mehr Covid-19-Erkrankungen, mehr Tests auf SARS-CoV-2: Derzeit läuft bei internationalen Labordiagnostik-Konzernen wie Qiagen, Roche, Abbott etc. ein Wettlauf um die schnellsten Geräte und um die meisten durchführbaren Untersuchungen auf das neue Coronavirus in einem Durchlauf.",QGEN,de,NOEN-Online
2020-03-18 05:10:20-05:00,Rennen um die schnellsten SARS-CoV-2-Tests,"Mehr Covid-19-Erkrankungen, mehr Tests auf SARS-CoV-2: Derzeit läuft bei internationalen Labordiagnostik-Konzernen wie Qiagen, Roche, Abbott etc. ein Wettlauf um die schnellsten Geräte und um die meisten durchführbaren Untersuchungen auf das neue Coronavirus in einem Durchlauf. Am Wiener AKH (MedUni Wien) setzt man auf beide Strategien, erklärte Robert Straßl, Leiter des Laborbereichs Virologie.",QGEN,de,Salzburger Nachrichten
2020-03-18 01:30:00-05:00,Wichtige Kursbewegungen: Virus-Test-Anbieter Qiagen gegen den Trend höher,Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:,QGEN,de,BORSE ONLINE
2020-03-17 10:30:11-05:00,Is QIAGEN N.V. (QGEN) Outperforming Other Medical Stocks This Year?,Is (QGEN) Outperforming Other Medical Stocks This Year?,QGEN,en,Zacks Investment Research
2020-03-16 08:59:00-05:00,QIAGEN's Coronavirus Test Kit Development Gets BARDA Funding,QIAGEN (QGEN) receives support from the government to accelerate the development of the QIAstat-Dx test kit to detect the coronavirus causing virus.,QGEN,en,Zacks Investment Research
2020-03-11 16:52:22-05:00,Qiagen boosting production of chemical needed to test for coronavirus,"German molecular testing company Qiagen said on Wednesday it was ramping up production of a chemical used in some coronavirus tests, after a report that shorta",QGEN,en,Devdiscourse
2020-03-06 02:15:00-05:00,"M&A-Deals: Qiagen, Metro, ProSiebenSat.1","Qiagen wird nun doch zum M&A-Target, bei Metro brodelt es in der Gerüchteküche, und ProSiebenSat.1 schlägt in den USA zu: Die spannendsten M&A-Deals der Woche finden Sie in unserem FINANCE-Rückblick.",QGEN,de,FINANCE Magazin
2020-03-05 11:30:58-05:00,Why Is Qiagen (QGEN) Up 19% Since Last Earnings Report?,Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,QGEN,en,Zacks Investment Research
2020-03-04 05:33:00-05:00,Kommentar zur Qiagen-Übernahme: Das hat die Qiagen-Belegschaft nicht verdient,"Die Übernahme durch den US-Konzern Thermo Fisher ist ein Schlag für die den Biotech-Standort NRW. Die Anteilseigner wollen Kasse machen, und Qiagen lässt die Mitarbeiter hängen.",QGEN,de,Rheinische Post
2020-03-03 23:00:00-05:00,Übernahme durch US-Konzern: Wut und Angst bei Qiagen,"Thermo Fisher schluckt Deutschlands größtes Biotech-Unternehmen. Der Betriebsrat ist entsetzt. Mitgründer Riesner sorgt sich um den Standort Hilden, wo 1300 Mitarbeiter tätig sind. Die Aktie hebt ab.",QGEN,de,Rheinische Post
2020-03-03 13:36:17-05:00,Thermo Fisher Scientific Seeks to Acquire Qiagen in $12B Deal,Thermo Fisher launched an $11.59 billion bid for Qiagen NV. This acquisition may be the next big thing in the biomedical field.,QGEN,en,Coinspeaker
2020-03-03 12:04:00-05:00,Qiagen wird übernommen,Das Unternehmen zählt zu den wenigen Profiteuren der Coronavirus-Krise. Die Aktie schoss am Dienstag in die Höhe.,QGEN,de,DiePresse·com
2020-03-03 11:01:46-05:00,Thermo Fisher agrees to buy genetic tester Qiagen in US$11.5 billion deal,Thermo Fisher Scientific Inc has agreed to buy German genetic testing company Qiagen in a US$11.5 billion deal as the U.S.-based group looks to bolster its health diagnostic business.,QGEN,en,Channel NewsAsia
2020-03-03 10:34:34-05:00,US-Börsen schnellen nach Leitzinssenkung in die Gewinnzone,"Übernahme von Qiagen durch Thermo Fisher im Fokus - ""Super Tuesday"" Höhepunkt der Vorwahlen für Rennen um US-Präsidentschaft Die New Yorker Börsen sind nach den starken Gewinnen vom Vortag am Dienstag mit negativer Tendenz in den Handel gegangen, zogen in der ersten halben Stunde des Handels jedoch schnell ins Plus. Die Kehrtwende lag an der US-Notenbank, die wegen der sich abzeichnenden wirtschaftlichen Auswirkungen des Coronavirus ihren Leitzins überraschend um einen halben Prozentpunkt gesenkt hat. Gegen 16.00 Uhr stieg der Dow Jones Industrial Index um 347,64 Einheiten oder 1,30 Prozent auf 27.050,96 Zähler. Der S&P-500 Index gewann 45,48 Punkte oder 1,47 Prozent auf 3.135,71 Zähler. Der Nasdaq Composite Index gewann 109,16 Punkte oder 1,22 Prozent auf 9.061,33 Einheiten. Der Leitzins liegt der Federal Reserve zufolge nun im Korridor von 1 bis 1,25 Prozent. Für Zurückhaltung hatten zuvor nicht ganz überzeugende Aussagen nach einer Telefonkonferenz der Finanzminister und Notenbanker großer Industrieländer (G-7) zu den wirtschaftlichen Folgen des Coronavirus gesorgt.",QGEN,de,Kurier.at
2020-03-03 08:27:14-05:00,Thermo Fisher To Buy Qiagen For $11.5B,"Thermo Fisher Scientific Inc. (NYSE: TMO ) announced it will acquire Qiagen (NYSE: QGEN ) for €39 ($43.34) per share in cash. Qiagen is a provider of life science and molecular diagnostic company and generated 2019 revenue of $1.53 billion. The transaction values Qiagen at approximately $11.5 billion at current exchange rates, which includes the assumption of approximately … Full story available on Benzinga.com",QGEN,en,Benzinga
2020-03-03 07:27:18-05:00,Übernahme von Qiagen: Und ein weiterer deutscher Biotech-Pionier wird amerikanisch,"Die Gespräche galten bereits als gescheitert, nun geht Qiagen doch an ein US-Unternehmen. Qiagen punktete jüngst mit einem Coronavirus-Test – für die Übernahme könnte das eine wichtige Rolle gespielt haben.",QGEN,de,WirtschaftsWoche
2020-03-03 07:10:39-05:00,Frentic Rally Reverses On Speculation G-7 Stimulus Will Disappoint,"Frentic Rally Reverses On Speculation G-7 Stimulus Will Disappoint Monday's ferocious rally halted and reversed on several occasions overnight, following a report that the G7 meeting that started moments ago, at 7am ET this morning, and which sparked a record point gain in the Dow Jones Index, may disappoint. Specifically Reuters reported that while G7 finance officials and central bankers will discuss ways to bolster their economies against the impact of the spreading coronavirus outbreak, the meeting will not be another Shanghai Accord (contrary to widespread speculation) as they are not expected to specifically call for new spending or coordinated interest rate cuts, but merely will pledge to work together to mitigate damage on economies from coronavirus spread . As reported yesterday, finance ministers and central bank governors from the G-7, led by Fed Chair Jerome Powell and Treasury Secretary Steven Mnuchin will hold a conference call at 700AM ET/1200 GMT to discuss the outbreak.",QGEN,en,Zero Hedge
2020-03-03 06:39:26-05:00,Mega-Deal in der Biotechbranche - Thermo Fisher schluckt Qiagen,"Das größte deutsche Biotechunternehmen wandert nach monatelangem Ringen im amerikanische Hände: Qiagen soll für 10,4 Milliarden Euro an den US-Laborausrüster Thermo Fisher verkauft werden. Eine entsprechende Vereinbarung hätten die Vorstände und Kontrollgremien beider Firmen geschlossen, teilte Qiagen am Dienstag mit.",QGEN,de,BORSE ONLINE
2020-03-03 05:18:38-05:00,Thermo Fisher to buy Qiagen in $11.5bn deal,US laboratory equipment maker Thermo Fisher Scientific has agreed to buy Qiagen in an $11.5bn deal.,QGEN,en,Share Cast
2020-03-03 04:30:18-05:00,Thermo Fisher Scientific : to Buy Qiagen in $10.1 Billion Deal | MarketScreener,"By Adria Calatayud Thermo Fisher Scientific Inc. said Tuesday that it has agreed to acquire Frankfurt-listed provider of molecular diagnostics Qiagen NV in a deal that values the target at… | March 3, 2020",QGEN,en,MarketScreener
2020-03-03 04:19:00-05:00,Qiagen shares surge after agreeing to be bought by Thermo Fisher for $11.5 billion,"Qiagen shares surged 19% to 37.84 euros after Thermo Fisher Scientific said it would buy the diagnostics firm for 39 euros per share in cash, which is a 23%…",QGEN,en,MarketWatch
2020-03-03 03:45:00-05:00,Biotech-Urgestein: Thermo Fisher übernimmt Qiagen wohl doch,Ende 2019 war eine Übernahme noch am Veto der Qiagen-Geschäftsführung gescheitert – nun wird das deutsche Biotech-Unternehmen wohl doch vom US-Konzern Thermo Fisher Scientific aufgekauft.,QGEN,de,WirtschaftsWoche
2020-03-03 03:42:00-05:00,DAX eröffnet stärker: Qiagen geht nach Übernahme durch die Decke,"Die Aussicht auf Notenbanken-Hilfen zur Bewältigung von Konjunkturdämpfern durch den Coronavirus hellt die Stimmung der Dax-Anleger wieder auf. Der deutsche Leitindex stieg zur Eröffnung am Dienstag um 1,4 Prozent auf 12.018 Punkte.",QGEN,de,BORSE ONLINE
2020-03-03 03:35:00-05:00,QIAGEN-Aktie schnellt hoch: Thermo Fisher legt Übernahmeofferte vor,"Der Laborausrüster Thermo Fisher hat ein Übernahmeangebot für das im TecDAX notierte Unternehmen vorgelegt. Wie QIAGEN mitteilte, bietet",QGEN,de,Finanzen CH
2020-03-03 03:19:33-05:00,Dax Aktuell: Dax startet Erleichterungsrally - Biotech-Aktie Qiagen steigt um 20 Prozent,"Viele Indizien sprechen dafür, dass in dieser Handelswoche die Kurse am deutschen Aktienmarkt wieder steigen. Anleger sollten aber vorsichtig bleiben.",QGEN,de,Handelsblatt
2020-03-03 02:48:05-05:00,Thermo Fisher to buy Qiagen for €10.4B,"While talks broke off late last year, Thermo Fisher Scientific (NYSE:TMO) is acquiring Dutch molecular-testing firm Qiagen (NYSE:QGEN) for €10.4B, includin",QGEN,en,Seeking Alpha
2020-03-03 02:45:00-05:00,QIAGEN-Aktie schnellt vorbörslich hoch: Thermo Fisher legt Übernahmeofferte vor,"Der Laborausrüster Thermo Fisher hat ein Übernahmeangebot für das im TecDAX notierte Unternehmen vorgelegt. Wie QIAGEN mitteilte, bietet",QGEN,de,Finanzen CH
2020-03-03 02:31:00-05:00,Milliarden-Übernahme in Hilden: US-Konzern schluckt Qiagen,"Thermo Fischer übernimmt das Vorzeigeunternehmen, das einst von der Uni Düsseldorf aus gegründet worden ist. Der Deal hat ein Volumen von elf Milliarden Dollar.",QGEN,de,Rheinische Post
2020-03-03 02:20:00-05:00,Thermo Fisher legt Übernahmeofferte für QIAGEN vor,"Der Laborausrüster Thermo Fisher hat ein Übernahmeangebot für das im TecDAX notierte Unternehmen vorgelegt. Wie QIAGEN mitteilte, bietet",QGEN,de,Finanzen CH
2020-03-03 02:15:06-05:00,Qiagen N.V. : Thermo Fisher lance une OPA amicale à 39 EUR par action | Zone bourse,"Qiagen avait renoncé, fin 2019, à se vendre après avoir passé en revue ses options. La donne a changé début 2020 puisque l'un des prétendants de l'époque, Thermo Fisher, va finalement racheter… | 3 mars 2020",QGEN,fr,Zonebourse
2020-03-03 02:05:05-05:00,QIAGEN N.V.: Conclusion of a Business Combination Agreement between QIAGEN N.V. and Thermo Fisher Scientific Inc.; Announcement of a public tender offer by Thermo Fisher Scientific Inc. | MarketScreener,"DGAP-Ad-hoc: QIAGEN N.V. / Key word: Offer QIAGEN N.V.: Conclusion of a Business Combination Agreement between QIAGEN N.V. and Thermo Fisher Scientific Inc.; Announcement of a public tender offer… | March 3, 2020",QGEN,en,MarketScreener
2020-03-03 01:38:26-05:00,"EN DIRECT DES MARCHES : Air Liquide, Sanofi, SES, Albioma, Qiagen, Swiss Re, Xerox, Apple...",La perspective d'une action coordonnée des grandes économies mondiales et de leurs banques centrales pour préserver l'économie des effets de l'épidémie de COVID-19 a dopé hier les indices américains….,QGEN,fr,Zonebourse
2020-03-02 10:23:00-05:00,"Dropbox, Groupon, QIAGEN, Zoom Video Communications and Novavax highlighted as Zacks Bull and Bear of the Day","Dropbox, Groupon, QIAGEN, Zoom Video Communications and Novavax highlighted as Zacks Bull and Bear of the Day",QGEN,en,Zacks Investment Research
2020-02-28 06:58:00-05:00,"The Zacks Analyst Blog Highlights: Abbott Laboratories, Myriad Genetics, LabCorp, QIAGEN and Thermo Fisher","The Zacks Analyst Blog Highlights: Abbott Laboratories, Myriad Genetics, LabCorp, QIAGEN and Thermo Fisher",QGEN,en,Zacks Investment Research
2020-02-27 09:05:00-05:00,QIAGEN Ships Test Kits to China for Detecting Coronavirus,QIAGEN (QGEN) expands the molecular testing portfolio by shipping QIAstat-Dx Respiratory 2019-nCoV Panel to China for faster detection of coronavirus SARS-CoV-2.,QGEN,en,Zacks Investment Research
2020-02-13 18:15:00-05:00,"2020-2025 Human Papillomavirus (HPV) Testing Industry Report - Roche, Qiagen, Hologic and Abbott are Dominating the Competition","DUBLIN , Feb. 13, 2020 /PRNewswire/ -- The ""Human Papillomavirus (HPV) Testing Market - Global Outlook and Forecast 2020 - 2025"" report has been added to ResearchAndMarkets.com's offering. The global HPV testing market is expected to grow at a CAGR of over 12% during the period 2019-2025. Key Market Insights The analysis of the global HPV testing market provides sizing and growth opportunities for the forecast period 2020-2025. Offers sizing and growth prospects of the market for the forecast period 2020-2025. Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market. Includes a detailed analysis of growth drivers, challenges, and investment opportunities. Delivers a complete overview of segments and the regional outlook of the market. Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage. The increased procurement of the latest-generation HPV testing analyzers and test kits, coupled with the high prevalence of HPV-related infections and cancers, especially cervical and vaginal, influences the growth of the global HPV testing market.",QGEN,en,Benzinga Feeds
2020-02-12 10:34:00-05:00,"Global Molecular Weight Marker Market (2020 to 2024) - Featuring Merck KGaA, New England Biolabs, Promega & QIAGEN NV Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Global Molecular Weight Marker Market 2020-2024"" report has been added to ResearchAndMarkets.com's offering. The analyst has been monitoring the global molecular weight marker market and it is poised to grow by USD 307.59 mn during 2020-2024, progressing at a CAGR of 12% during the forecast period. The reports on global molecular weight marker market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor an",QGEN,en,Business Wire
2020-02-11 05:52:00-05:00,"Qiagen: Coronavirus, Übernahmespekulationen - da tut sich was…",Die Aktie des Diagnostik-Spezialisten Qiagen hat in den vergangenen Tagen wieder deutlich zulegen können. 11.02.2020,QGEN,de,Deraktionaer
2020-02-07 19:17:10-05:00,Byju’s raises fresh $200 million from General Atlantic,"Byju's had raised $150 million in funding, led by Qatar Investment Authority (QIA), in July last year at an expected valuation of around $5.5 billion.",QGEN,en,The Financial Express
2020-02-05 07:00:00-05:00,Wichtige Kursbewegungen: Quartalszahlen sorgen für Rückenwind bei Qiagen,Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:,QGEN,de,BORSE ONLINE
2020-02-03 01:22:49-05:00,Ausblick: QIAGEN öffnet die Bücher zum abgelaufenen Quartal,"QIAGEN wird am 04.02.2020 Zahlen zum jüngsten Quartal vorlegen, das am 31.12.2019 abgelaufen ist.Die Schätzungen von 12 Analysten belaufen sich beim EPS auf durchschnittlich 0,433 USD je Aktie. Im Vorjahresquartal hatten noch 0,400 USD je Aktie in den Büchern gestanden.Auf der Umsatzseite prognostizieren 11…",QGEN,de,Finanzen CH
2020-01-30 00:34:31-05:00,RMZ-Mitsui Fudosan JV to develop $1 billion assets,"BENGALURU: Business park developer RMZ Corp has entered into a strategic, equal partnership with Mitsui Fudosan (Asia), a subsidiary of Tokyo-based realty company Mitsui Fudosan Co, to develop assets worth around $1 billion in major Indian cities.The first development undertaken with this joint venture is a 3.5 million sq ft project, RMZ Ecoworld 30, located on the Outer Ring Road in Bengaluru. The companies also plan to expand into cities such as Hyderabad, Mumbai and Delhi-NCR.“This venture is in line with our ‘Hyper Growth-Vision 2025’, where RMZ Corp is rapidly scaling towards achieving its aggressive expansion plan to develop 85 million sq ft of assets under management by 2025,” managing director Arshdeep Sethi said.RMZ Ecoworld today is a 75-acre development. Of this, 54 acres consisting of Phase 1 development of 7.5 million sq ft has been completed and is home to companies such as Morgan Stanley, Honeywell, State Street Bank, Standard Chartered, Shell, Royal Bank of Scotland, Danske Bank, SAP and KPMG.","RBS,QGEN",en,The Economic Times India
2020-01-29 12:00:00-05:00,"$22.5Bn+ Molecular Diagnostics Market Insights, 2025 - Featuring Company Analysis of Roche Diagnostics, Abbott Laboratories, Myriad Genetics, Qiagen, and bioMerieux","/PRNewswire/ -- The ""Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies"" report has been added to…",QGEN,en,PR Newswire
2020-01-28 12:31:25-05:00,Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth,Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,QGEN,en,Zacks Investment Research
2020-01-17 07:15:36-05:00,SMALL CAP MOVERS: Lekoil value plunges by two-thirds as it falls victim to investment scam,Junior oiler Lekoil was the major story on AIM this week with its value dropping by around two-thirds after falling victim to con artists posing as the Qatar Investment Authority (QIA).,QGEN,en,Daily Mail Online
2020-01-14 02:30:00-05:00,LEKOIL Provides Update On Qatari Investment Authority Facility | Independent Newspapers Nigeria,"LEKOIL Limited (LEKOIL), the oil and gas exploration and production company with focus on Nigeria and West Africa, has provided further update on the facility it purportedly entered into with the Qatar Investment Authority (QIA).",QGEN,en,Independent Newspapers Nigeria
2020-01-13 16:20:00-05:00,Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer,"THOUSAND OAKS, Calif., Jan. 13, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced strategic collaborations with leading diagnostic companies Guardant Health, Inc. and QIAGEN N.V. to develop blood- and tissue-based companion diagnostics (CDx), respectively, for investigational…",QGEN,en,PR Newswire
2020-01-10 12:30:00-05:00,Qiagen: Warum die Aktie um mehr als 20 Prozent eingebrochen ist,"Großer Schreck kurz vor dem Jahreswechsel: Um rund 20 Prozent stürzte die Aktie der deutsch-niederländischen Biotechfirma ab. Von Sven Parplies, Euro am Sonntag",QGEN,de,BORSE ONLINE
2020-01-09 15:51:41-05:00,"Byju’s raises $200 million from Tiger Global, valuation rises $2.5 billion to $8 billion","Byju's last raised $150 million in funding, led by Qatar Investment Authority (QIA), in July 2019 at an expected valuation of around $5.5 billion.",QGEN,en,The Financial Express
2020-01-08 10:30:00-05:00,"Outlook on Sample Preparation Markets in Genomics, Proteomics and Epigenomics, 2024 - Featuring Bio-Rad Labs, Danaher, Merck Millipore, PerkinElmer, Qiagen, Thermo Fisher Scientific, and More","DUBLIN, Jan. 8, 2020 /PRNewswire/ -- The ""Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets"" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the global market for sample preparation in genomics, proteomics and…",QGEN,en,PR Newswire
2019-12-31 09:11:00-05:00,Qiagen stock collapses after take-over talks fall apart,The sale of the biotechnology group Qiagen from Hilden is off the table for the time being and it caused a drop in the price of Qiagen shares.,QGEN,en,Born2Invest
2019-12-29 08:16:45-05:00,Kommentar: Qiagen hat trotz des Kurseinbruchs großes Potenzial,"Nach der Absage der Übernahmegespräche muss Qiagen nun beweisen, dass es aus eigener Kraft stärker wachsen kann. Die Aktionäre brauchen Geduld.",QGEN,de,Handelsblatt
2019-12-27 14:32:55-05:00,QGEN Calls Pick Up as Stock Recovers,QGEN shares have been making big moves this week,QGEN,en,Schaeffers Investment Research
2019-12-27 13:11:00-05:00,Qiagen bleibt allein,"Die Anleger reagierten auf die Absage des geplanten Verkaufs frustriert, die Aktie verlor massiv.",QGEN,de,DiePresse·com
2019-12-27 09:32:00-05:00,Doch keine Übernahme: Qiagen-Aktie bricht ein,"Der Wert eines Anteilsscheins sackte um etwa ein Fünftel ab, nachdem der Biotechnologie-Konzern Qiagen einer Übernahme von Investoren einen Riegel vorgeschoben hat. Die Firma wolle eigenständig bleiben.",QGEN,de,WirtschaftsWoche
2019-12-27 05:19:00-05:00,Verkaufspläne verworfen - Qiagen-Aktie geht die Luft aus,"Nach der Absage der Qiagen-Führung an einen Verkauf ist die Kursfantasie rund um das Biotech-Unternehmen zerstoben. Die Aktien der deutsch-niederländischen Firma büßten am Freitag an der Frankfurter Börse fast ein Fünftel ihres Wertes ein und lagen mit 30 Euro kaum über dem Niveau von Mitte November, als Qiagen Überlegungen zu einem möglichen…",QGEN,de,BORSE ONLINE
2019-12-27 03:31:32-05:00,"Qiagen bleibt nun doch eigenständig - ""Alternativen nicht überzeugend""","Das Biotech-Unternehmen Qiagen will nun doch eigenständig bleiben. Gespräche mit möglichen Übernahme-Interessenten würden beendet, da die verschiedenen Alternativen nicht überzeugend gewesen seien, teilte das im MDax notierte Unternehmen am Dienstagabend mit.",QGEN,de,BORSE ONLINE
2019-12-27 03:15:21-05:00,Dax Aktuell: Dax profitiert von US-Rally – Qiagen-Aktie verliert gut 20 Prozent,Die Rekordhochs an der Wall Street sowie das anscheinend gut gelaufene US-Weihnachtsgeschäft helfen dem deutschen Leitindex. Anleger strafen Qiagen ab.,QGEN,de,Handelsblatt
2019-12-26 19:42:32-05:00,"Amazon and Immunomedics rise; Qiagen, Hovnanian move lower","Stocks that moved substantially or traded heavily on Thursday: Amazon and Immunomedics rise, while Qiagen, Hovnanian Enterprises move lower",QGEN,en,ABC News
2019-12-26 18:02:00-05:00,Qiagen tumbles after biotech rejects takeover bids,Qiagen NV lost about one-fifth of its market value on Thursday after the Dutch biotechnology company said earlier this week that it would focus on its…,QGEN,en,MarketWatch
2019-12-26 15:57:34-05:00,"PreMarket Prep Recap: Qiagen Pulls The Rug Out From Investors Banking On A Deal, Bad Data Equals Bad Price Action For Spectrum Pharmaceuticals","Benzinga's PreMarket Prep show resumed Thursday after a pause for the Christmas holiday. As always, there were a few market movers to cover and two informative interviews. Qiagen Decides Not To Sell When you have ownership in a company that decides to put itself up for sale, it can be good news and bad news. Of course, the good news is that speculators will rally the issue to the theoretical price at which the company will sell. The bad news comes if the stock rallies significantly, but in the end the company decides not to pursue a sale. In that scneario, the shares will often return to the area where they traded before a strategic review was initiated. On Nov. 14, Qiagen NV (NYSE: QGEN ) added to its 5% gain from the previous day, when it was reported by Bloomberg that Thermo Fisher Scientific Inc. (NYSE: TMO ) was considering buying the company. The news instigated a rally that did not end until the issue peaked Dec. 2 at $43.16,. The buyers up to that level were expecting a takeout at that price or higher.",QGEN,en,Benzinga Feeds
2019-12-26 11:44:00-05:00,Kurseinbruch an Wall Street: Qiagen sagt eigene Übernahme ab,Der abgesagte Verkauf des Biotechnologie-Konzerns Qiagen hat am Donnerstag an der Wall Street ein Erdbeben ausgelöst. Die auch in New York notierte Aktie brach zeitweise um ein Viertel ein.,QGEN,de,Rheinische Post
2019-12-26 06:50:00-05:00,Qiagen Plunges After Saying It Won't Pursue a Sale,The genetic testing company will remain a stand-alone business following a review of strategic alternatives.,QGEN,en,The Street
2019-12-26 05:35:36-05:00,QIAGEN will nunmehr doch eigenständig weiterarbeiten - US-Aktie nachbörslich tiefer,"Gespräche mit möglichen Übernahme-Interessenten würden beendet, da die verschiedenen Alternativen nicht überzeugend gewesen seien, teilte das im deutschen MDAX notierte Unternehmen am Dienstagabend mit. Das Management sei zu dem Schluss gekommen, dass dies die beste…",QGEN,de,Finanzen CH
2019-12-25 05:08:00-05:00,Doch kein Verkauf: Diagnosespezialist Qiagen bleibt eigenständig,"Der Verkauf des Biotechnologie-Konzerns Qiagen aus Hilden ist vorerst vom Tisch. Nach ergebnislosen Gesprächen mit Interessenten beschlossen Vorstand und Aufsichtsrat, dass der Konzern mit seinen 5200 Mitarbeitern doch eigenständig bleiben soll.",QGEN,de,Rheinische Post
2019-12-25 03:23:00-05:00,Biotech: Qiagen beendet Gespräche mit Übernahme-Interessenten,"Das Unternehmen teilt mit, dass die Angebote für eine Übernahme nicht überzeugend gewesen seien. Das Management will sich auf seine eigene Strategie konzentrieren.",QGEN,de,Handelsblatt
2019-12-24 20:35:09-05:00,Qiagen bleibt nun doch eigenständig - Blick,"Das Biotech-Unternehmen Qiagen will nun eigenständig bleiben. Gespräche mit möglichen Übernahme-Interessenten würden beendet, da die verschiedenen Alternativen nicht überzeugend gewesen seien, teilte das im deutschen MDax notierte Unternehmen am Dienstagabend mit.",QGEN,de,Blick
2019-12-24 20:34:00-05:00,Qiagen will nunmehr doch eigenständig weiterarbeiten,"BERLIN - Das Biotech-Unternehmen Qiagen will nun eigenständig bleiben. Gespräche mit möglichen Übernahme-Interessenten würden beendet, da die verschiedenen Alternativen nicht überzeugend gewesen seien, teilte das im deutschen MDax notierte Unternehmen am Dienstagabend mit.",QGEN,de,Volksblatt
2019-12-24 14:30:00-05:00,Qiagen stock plunges more than 25% after opting against sale,Qiagen NV shares plummeted more than 25% in late trading on Tuesday after the company announced that a strategic review had ended with a decision to not…,QGEN,en,MarketWatch
2019-12-24 13:43:00-05:00,QIAGEN beendet Gespräche zur Sondierung möglicher strategischer Alternativen und beschließt Fokussierung auf eigenständige Strategie zur zukünftigen Wertschöpfung,"QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) („QIAGEN“ oder die „Gesellschaft“) teilte heute mit, dass die Gesellschaft die zuvor veröffent",QGEN,de,Business Wire
2019-12-17 02:30:00-05:00,Global Food Safety Testing Market 2020-2024 | Evolving Opportunities With QIAGEN NV and Thermo Fisher Scientific Inc. | Technavio,"LONDON--(BUSINESS WIRE)-- #AsureQuality--The food safety testing market is expected to grow by USD 6.62 billion during 2020-2024, according to the latest market research report by Technavio",QGEN,en,Business Wire
2019-12-14 13:22:00-05:00,"2019 Metagenomics Kits Market Growth Analysis 2019-2024 | By Thermo Fisher Scientific, Illumina, Perkin Elmer, Merck, Qiagen, Promega","Dec 14, 2019 (Reporthive Research via COMTEX) -- Chicago, United States, Global Metagenomics Kits Market report covers extensive analysis of the market…",QGEN,en,MarketWatch
2019-12-11 21:36:37-05:00,QIA deal may renew foreign interest in power distribution,"A shareholder subordinated debt investment is also part of the deal in which QIA’s total investment is pegged at Rs 3,200 crore.",QGEN,en,The Economic Times India
2019-12-11 06:04:20-05:00,"Qatar sovereign wealth fund QIA buys 25.1 per cent stake in Adani Electricity Mumbai for Rs 3,200 cr","Adani Electricity Mumbai Ltd is a part of Adani Transmission Ltd, while Qatar Investment Authority (QIA) is the sovereign wealth fund of the Qatar.",QGEN,en,The Financial Express
2019-12-02 04:30:00-05:00,Qiagen-Aktie: Laborspezialist vor der Übernahme - das sollten Anleger jetzt wissen,"Der Labor- und Diagnostikspezialist Qiagen steht wohl vor der Übernahme. Was dahintersteckt und worauf Anleger sich jetzt einstellen müssen. Von Julia Groß, Euro am Sonntag",QGEN,de,BORSE ONLINE
2019-11-28 02:15:00-05:00,QIAGEN and DiaSorin Get FDA Approval for LIAISON QFT-Plus,"QIAGEN (QGEN) and DiaSorin begin the commercial launch of the QFT-Plus test in the United States, following the FDA clearance.",QGEN,en,Zacks Investment Research
2019-11-27 05:33:24-05:00,Bieterkampf um Qiagen: Was das deutsche Biotech-Unternehmen so spannend macht,"Vaterschaftstest, Mord, Krebsforschung. Hier helfen DNA-Analysen des deutschen Biotechexperten Qiagen. Die Technologien locken Aufkäufer; der Übernahmekampf läuft. Worum es dabei geht und wer die besten Chancen hat.",QGEN,de,WirtschaftsWoche
2019-11-27 02:00:00-05:00,QIAGEN and DiaSorin Receive FDA Approval for The LIAISON QuantiFERON-TB Gold Plus Test on LIAISON Platforms and Begin Commercial Launch,QIAGEN and DiaSorin receive FDA approval for the LIAISON QuantiFERON-TB Gold Plus Test on LIAISON platforms and begin commercial launch,QGEN,en,Business Wire
2019-11-26 08:06:41-05:00,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) (Guggenheim initiated coverage of stock with Buy rating and $50 price target) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) (announced achievement of enrollment target in a Phase 3 trial of drug to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioNTech SE – ADR (NASDAQ: BNTX ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Epizyme Inc (NASDAQ: EPZM ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Globus Medical Inc (NYSE: GMED ) Halozyme Therapeutics, Inc.",QGEN,en,Benzinga
2019-11-22 02:15:00-05:00,"M&A-Deals: Qiagen, Thomas Cook, Roche","Qiagen wird zum regelrechten M&A-Target, Thomas Cook kehrt zu seinen Wurzeln zurück, und Roche kauft in den USA zu: Die spannendsten M&A-Deals der Woche finden Sie in unserem FINANCE-Rückblick.",QGEN,de,FINANCE Magazin
2019-11-21 23:00:00-05:00,"Interview mit Qiagen-Gründer Detlev Riesner: „In wünsche mir, dass Qiagen unabhängig bleibt“",Der Gründer des Biotech-Konzerns warnt Investoren vor einer Schließung der Zentrale in Hilden. Er spricht über den plötzlichen Chefwechsel und die Rechte der Mitarbeiter.,QGEN,de,Rheinische Post
2019-11-21 02:42:00-05:00,QIAGEN Expands Existing Deal With LabCorp for Better Treatment,QIAGEN (QGEN) announces the expansion of partnership with LabCorp (LH) to make genetic information available for clinical and research purposes.,QGEN,en,Zacks Investment Research
2019-11-19 23:00:00-05:00,Biotech-Riese aus Hilden: Übernahmekampf um Qiagen droht,"Die Aktie des Biotech-Unternehmens steigt weiter. Qiagen hat mehrere Angebote erhalten. Eins soll vom US-Konzern Thermo Fisher kommen, den früher Marijn Dekkers führte. In Hilden wächst die Sorge vor Jobabbau.",QGEN,de,Rheinische Post
2019-11-19 07:56:14-05:00,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 18) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Antares Pharma Inc (NASDAQ: ATRS ) Arvinas Inc (NASDAQ: ARVN ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Cabaletta Bio Inc (NASDAQ: CABA ) Crispr Therapeutics AG (NASDAQ: CRSP ) DexCom, Inc. (NASDAQ: DXCM Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) )(announced a partnership with Novo Nordisk A/S (NYSE: NVO ) for developing RNAi therapies) Frequency Therapeutics Inc (NASDAQ: FREQ )(reacted to its third-quarter results) GENMAB A/S/S ADR (NASDAQ: GMAB ) IGM Biosciences Inc (NASDAQ: IGMS ) Insulet Corporation (NASDAQ: PODD ) Karuna Therapeutics Inc (NASDAQ: KRTX )( announced positive results for its mid-stage schizophrenia drug) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) Krystal Biotech Inc (NASDAQ: KRYS ) The Medicines Company (NASDAQ: MDCO )(announced full results of its ORION-9 Phase 3 study of inclisiran at the American Heart Association 2019 annual meeting) Medtronic PLC (NYSE: MDT ) Neurocrine Biosciences, Inc.",QGEN,en,Benzinga
2019-11-19 04:39:18-05:00,Biotechunternehmen: Zahl der Interessenten wächst: Bieterkampf um Qiagen zeichnet sich ab,Mehrere Interessenten loten eine Übernahme der Biotechfirma aus. Der Kaufpreis könnte mehr als zehn Milliarden Euro betragen. Was das Unternehmen so interessant macht.,QGEN,de,Handelsblatt
2019-11-19 03:58:19-05:00,Biotechunternehmen: Warum viele Bieter um Qiagen kämpfen,Mehrere Interessenten loten eine Übernahme von Qiagen aus. Der Kaufpreis für das Biotechunternehmen könnte mehr als zehn Milliarden Euro betragen.,QGEN,de,Handelsblatt
2019-11-18 05:23:26-05:00,Übernahmepoker um Qiagen erwartet: Aktien auf Höhenflug,Spekulationen auf ein Übernahmepoker um Qiagen beflügeln die Aktien des Biotechunternehmens. Qiagen hat nach eigenen Angaben verschiedene Offerten für eine Übernahme der Gesellschaft erhalten.,QGEN,de,BORSE ONLINE
2019-11-18 03:29:57-05:00,European shares extend winning streak; Qiagen jumps as company explores sale,"European shares edged closer to a record level on Monday, as optimism around U.S.-China trade talks and a surprise move by Chinas central bank in cutting a key",QGEN,en,Devdiscourse
2019-11-18 01:48:28-05:00,"EN DIRECT DES MARCHES : Airbus, Renault, ADP, La Française des Jeux, Marie Brizard, Qiagen, HP / Xerox...","Bruno Le Maire, qui veut un pro pour Renault, a fait savoir que les souscriptions des particuliers pour la privatisation de la FDJ sont plus élevées que prévu. Dans le volet M&A, Qiagen va examiner…",QGEN,fr,Zonebourse
2019-11-18 01:30:00-05:00,"Der Morgen kompakt: Sechs Themen, die Anleger heute Morgen wissen sollten","Welche Themen sind am Montagmorgen wichtig für die Finanzmärkte? Heute unter anderem im Blick: Der Chef der Telekom-Tochter T-Mobile US, JohnLegere, will einem Medienbericht zufolge nicht zum angeschlagenen US-Büroplatzvermieter WeWork wechseln, Qiagen hat mehrere nicht verbindlicheÜbernahme-Offerten erhalten und China hat den Verlauf der…",QGEN,de,BORSE ONLINE
2019-11-16 03:00:37-05:00,QIAGEN-Aktie zeitweise vom Handel ausgesetzt: Mehrere Interessenbekundungen,"Das Unternehmen hat gleich mehrere Interessenbekundungen erhalten, wie QIAGEN am Freitag in Venlo mitteilte. Diese seien unverbindlich und stünden unter Bedingungen. Dem Unternehmen zufolge gehe es dabei um den Erwerb sämtlicher Aktien. Vorstand und Aufsichtsrat…",QGEN,de,Finanzen CH
2019-11-16 01:58:32-05:00,Qiagen (NYSE:QGEN) Receives New Coverage from Analysts at Stifel Nicolaus,"Stifel Nicolaus initiated coverage on shares of Qiagen (NYSE:QGEN) in a report published on Thursday, The Fly reports. The firm issued a hold rating and a $33.00 price target on the stock. Several other brokerages also recently weighed in on QGEN. UBS Group restated a neutral rating on shares of Qiagen in a research report […]",QGEN,en,Modern Readers
2019-11-16 00:41:00-05:00,QIAGEN Recebe Várias Indicações de Interesses Condicionais e Não Vinculativas e Decide Entrar em Discussões para Explorar Possíveis Alternativas Estratégicas,A QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) (,QGEN,de,Business Wire
2019-11-15 17:25:00-05:00,Biotechunternehmen: Qiagen prüft mehrere Übernahme-Angebote,Der deutsche Biotechkonzern hat mehrere nicht verbindliche Interessensbekundungen bekommen. Namen nannte Qiagen allerdings nicht.,QGEN,de,Handelsblatt
2019-11-15 03:21:31-05:00,Dax Aktuell: Dax nimmt wieder Jahreshoch ins Visier – Analyst erwartet Bieterkampf um Qiagen,US-Wirtschaftsberater Kudlow hat zum Handelsstreit wenig erhellendes gesagt und dennoch die Märkte beflügelt. Diese Entwicklung könnte weitergehen.,QGEN,de,Handelsblatt
2019-11-15 03:20:37-05:00,Dax Aktuell: Dax greift wieder Jahreshoch an – Analyst erwartet Bieterkampf um Qiagen,US-Wirtschaftsberater Kudlow hat zum Handelsstreit mit China wenig erhellendes gesagt und dennoch die Märkte beflügelt. Diese Entwicklung könnte weitergehen.,QGEN,de,Handelsblatt
2019-11-15 02:10:17-05:00,"Avis d'analystes du jour : Vallourec, Lagardère, Qiagen, ABB, Naturgy, Zurich, Norma...","Les trimestriels de Vallourec sont plutôt bien accueillis par Jefferies. Barclays reprend ou entame le suivi de plusieurs dossiers du secteur de l'énergie dans le Sud de l'Europe, avec une préférence…",QGEN,fr,Zonebourse
2019-11-14 14:14:24-05:00,"JPMorgan Upgrades Qiagen After Product Surveys, Valuation Analysis","New management at Qiagen NV (NYSE: QGEN ) would likely pursue several opportunities for portfolio rationalization and cost reduction, according to JPMorgan. The Analyst JPMorgan’s Tycho Peterson upgraded the rating on Qiagen from Underweight to Overweight, while raising the price target from $25 to $40. The Thesis The swing to a bullish rating for Qiagen follows “our recent buy-side survey, two new product surveys, and valuation analysis,” Peterson said in the upgrade note. There have been news reports of a possible Qiagen takeout in the near term. Barring this, … Full story available on Benzinga.com",QGEN,en,Benzinga Feeds
2019-11-14 09:15:00-05:00,Qiagen's stock extends surge after J.P. Morgan swings to bullish from bearish,"Shares of Qiagen N.V. surged 3.3% in premarket trading Thursday, after J.P. Morgan analyst Tycho Peterson swung to bullish from bearish on the…",QGEN,en,MarketWatch
2019-11-14 06:30:59-05:00,Qiagen Jumps on Report Thermo Fisher Is Considering a Bid,Qiagen rises following a report that says Thermo Fisher Scientific is considering a purchase of the Dutch molecular-testing company….QGEN,QGEN,en,The Street
2019-11-14 05:23:50-05:00,Mögliche Übernahme: Thermo Fisher tritt wohl an Qiagen mit Milliarden-Gebot heran,Der US-Laborausrüster zeigt Interesse an dem deutschen Biotech-Unternehmen gezeigt. Qiagen wäre eine weitere interessante Ergänzung für Thermo Fisher.,QGEN,de,Handelsblatt
2019-11-14 02:38:00-05:00,"EN DIRECT DES MARCHES : ArcelorMittal, AXA, Renault, Altice Europe, Néovacs, Qiagen, Disney, HP...","En marge d'une actualité macroéconomique chargée aujourd'hui, les publications de résultats d'entreprises continuent, avec quelques poids lourds en Europe, dont Bouygues, Merck KGaA, Henkel ou EDF. Le…",QGEN,fr,Zonebourse
2019-11-13 21:15:00-05:00,Mögliche Übernahme: Thermo Fisher tritt an Qiagen mit Milliarden-Gebot heran,Der US-Laborausrüster hat laut einem Medienbericht sein Interesse an dem deutschen Biotech-Unternehmen gezeigt. Eine offizielle Bestätigung gibt es noch nicht.,QGEN,de,Handelsblatt
2019-11-06 15:17:00-05:00,"Global HPV Testing & PAP Test Market Analysis Report, 2019-2024 - Key Players are Abbott Laboratories, Qiagen, Becton, Dickinson & Company, and Roche - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""HPV Testing & PAP Test Market - Growth, Trends, and Forecast (2019 - 2024)"" report has been added to ResearchAndMarkets.com's offering. The HPV testing & PAP test market is expected to witness rapid growth due to the increasing number of cervical cancer cases across the globe, an increasing number of cervical cancer screening programs and the introduction of advanced technological innovations. The increasing incidence rate of cervical and vaginal cancer is",QGEN,en,Business Wire
2019-11-01 03:01:33-05:00,Qiagen N.V. (QGEN) Q3 2019 Earnings Call Transcript | The Motley Fool,"QGEN earnings call for the period ending September 30, 2019.",QGEN,en,The Motley Fool
2019-11-01 02:04:58-05:00,"Avis d'analystes du jour : Airbus, Air France, Amundi, Euronext, Peugeot, Suez, Qiagen, Zalando...","Les dernières publications trimestrielles de résultats ont inspiré les analystes, notamment sur Air France KLM, Amundi et Tenaris. MainFirst croit en Peugeot après l'annonce du mariage avec Fiat…",QGEN,fr,Zonebourse
2019-10-31 02:09:00-05:00,"QIAGEN (QGEN) Beats Q3 Earnings Estimates, Cuts Revenue View",We are impressed with QIAGEN's (QGEN) year-over-year growth across majority of operating segments in Q3.,QGEN,en,Zacks Investment Research
2019-10-23 09:34:05-05:00,Qiagen (QGEN) Q3 Earnings Preview: What's in the Cards?,Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,QGEN,en,Zacks Investment Research
2019-10-15 07:31:00-05:00,QIAGEN (QGEN) Launches QIAseq FastSelect Technology Kits,The launch of the kits is expected to bolster QIAGEN's (QGEN) Life Sciences Business Area,QGEN,en,Zacks Investment Research
2019-10-10 06:19:00-05:00,"QIAGEN Down on Dim Q3 Prelim Sales, Startling CEO Departure","If the dismal preliminary sales performance was not enough, then the news pertaining to QIAGEN's (QGEN) current CEO Peer M. Schatz's stepping down came as another huge blow.",QGEN,en,Zacks Investment Research
2019-10-10 02:42:00-05:00,QIAGEN Inks Deal With Illumina to Deliver NGS-Based IVD Kits,QIAGEN (QGEN) aims to fast-track the adoption of NGS-based IVD test and improve patient outcomes through the new partnership deal.,QGEN,en,Zacks Investment Research
2019-10-08 14:16:00-05:00,Qiagen’s Results Are Hitting Health-Care Stocks. Here’s What to Do Next.,"By midafternoon on Tuesday, health-care stocks in the S&P 500 had surrendered $50 billion in market capitalization.",QGEN,en,Barron's
2019-10-08 11:11:41-05:00,"European stocks drop on trade, Brexit anxiety; Qiagen tumbles 21%",European shares fell on Tuesday as an escalation in U.S.-China trade tensions and Brexit worries along with disappointing corporate news dented sentiment.,QGEN,en,Reuters UK
2019-10-08 08:45:50-05:00,"Qiagen Shares Tumbles Following Q3 Sales Warning, Sudden CEO Departure","Qiagen NV (NYSE: QGEN ) shares were coming under intense selling pressure Tuesday following a trio of announcements from the company. The stock was sliding 19.06% to $25.95 at the time of publication, the lowest in three years. China Weakness Hurts The German molecular and genetic testing company announced preliminary third-quarter results and said it expects net sales growth of 3% at constant exchange rates, lower than its previous outlook for 4-5% CER growth. Qiagen attributed the weakness to significantly weaker-than-expected developments in China. Excluding China sales, total sales growth at CER was 6%. The company said it expects adjusted EPS to fall within its previous outlook of about 35-36 cents at CER. Collaboration Deal With Illumina In a bid to free up resources, Qiagen announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN ), giving up on development of its next-gen genome sequencing machines. The companies struck a 15-year partnership under which Qiagen receives non-exclusive rights to commercialize IVD kits to be used with Illumina's MiSeq Dx and NextSeq 550Dx …",QGEN,en,Benzinga
2019-10-08 07:56:00-05:00,"Qiagen Stock Plunges as CEO Departs, Sales Fall Short",The departure of the CEO comes amid a flurry of other unsettling news about the molecular-diagnostics firm.,QGEN,en,Barron's
2019-10-08 02:31:00-05:00,"Qiagen shares stumble on sales warning, CEO departure",Qiagen shares stumbled 17% as the diagnostics firm said third-quarter sales at constant exchange rates will grow 3% instead of the previous estimate of 4% to…,QGEN,en,MarketWatch
2019-09-20 10:56:00-05:00,QIAGEN (QGEN) Hurt by Low QuantiFERON-TB Sales & FX Headwind,Poor QuantiFERON-TB sales in Americas and an unfavourable currency translation affect QIAGEN's (QGEN) overall performance.,QGEN,en,Zacks Investment Research
2019-09-19 20:38:11-05:00,Qatar Fund in talks with Adani Group for discom stake,"MUMBAI: Qatar Investment Authority is in negotiations with the Adani Group to buy a minority stake in the latter’s flagship power transmission and distribution asset — Adani Electricity Mumbai Limited (AEML). The 14-year-old sovereign wealth fund of the oil-rich Gulf nation could invest as much as Rs 3,000-4,000 crore for a minority stake of 20-25% in the business, said people in the know.Adani Electricity Mumbai Limited, the country’s largest private sector integrated power utility, is a wholly owned subsidiary of Adani Transmission. In August 2018, Anil Ambani sold his Mumbai power distribution business to Adani Transmission Ltd (ATL) for Rs 12,700 crore, allowing the latter to enter the discom business. Subsequently, the Mumbai business got housed under a dropdown subsidiary.The acquisition was financed by a Rs 8,500 crore of term debt from a consortium of banks led by State Bank of India, Yes Bank and ICICI Bank.Deal’s Final Contours in WorksThe funds are likely to help provide growth equity to the business and also deleverage the balance sheet.",QGEN,en,The Economic Times India
2019-08-23 08:31:20-05:00,Qiagen (QGEN) Down 8.7% Since Last Earnings Report: Can It Rebound?,Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,QGEN,en,Zacks Investment Research
2019-08-16 08:51:00-05:00,QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results,The study outcome has been a major step for QIAGEN (QGEN) toward offering accurate diagnosis and treatment of gastroenteritis.,QGEN,en,Zacks Investment Research
2019-07-31 02:51:00-05:00,"QIAGEN (QGEN) Misses Q2 Earnings Estimates, Lowers View",QIAGEN (QGEN) registers revenue growth across majority of its geographies in Q2.,QGEN,en,Zacks Investment Research
2019-07-24 19:55:02-05:00,Qiagen (QGEN) Q2 Earnings and Revenues Miss Estimates,"Qiagen (QGEN) delivered earnings and revenue surprises of -2.94% and -1.24%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",QGEN,en,Zacks Investment Research
2019-07-23 09:32:38-05:00,Qiagen (QGEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,QGEN,en,Zacks Investment Research
2019-07-01 16:00:52-05:00,"Qatar Investment Authority, Douglass Emmett acquire $365 million...","Qatar Investment Authority (QIA) and real estate investor Douglas Emmett Inc have acquired a $365 real estate development in California, the Qatari sovereign wealth fund said on Monday.",QGEN,en,Reuters
2019-07-01 15:00:00-05:00,QIA & Douglas Emmett Acquires The Glendon - Los Angeles,"LOS ANGELES , July 1, 2019 /CNW/ -- The Qatar Investment Authority (QIA) and Douglas Emmett , Inc. (NYSE: DEI ) today announced a further $365 million acquisition by their multibillion dollar real estate partnership. This latest investment made an acquisition of The Glendon , a residential community in Westwood with 350 apartments and approximately 50,000 square feet of retail. The Glendon is located within walking distance of UCLA Campus, and the Ronald Reagan UCLA Medical Center in Westwood . Westwood has more than 300 local shops and restaurants, and 1.7 million square feet of Class A high rise office properties previously purchased in a partnership between QIA and Douglas Emmett. Westwood will also be the home of the 2028 Olympic Village. The location provides excellent connectivity to the area's growing population from primary transportation corridors including the I-405 and I-10 Freeways, as well as the LA Metro Purple Line extension planned for 2026. QIA and Douglas Emmett to date have acquired nine office buildings in West Los Angeles along Wilshire Boulevard and in Downtown Santa Monica .",QGEN,en,Benzinga
2019-06-20 01:57:00-05:00,QIAGEN Inks Distribution Deal With Mckesson Medical-Surgical,The distribution agreement will enable QIAGEN (QGEN) to expand reach in the healthcare market.,QGEN,en,Zacks Investment Research
2019-06-17 00:10:41-05:00,RMZ Corp aims to double commercial portfolio over the next 5 years,"BENGALURU: Bengaluru-based RMZ Corp is looking to double its commercial portfolio to 75 million square feet over the next five years, said a senior executive, who did not wished to be named.The company, which recently entered into an agreement with DB Realty to transform the sixdecade-old Kamalistan Studio in Mumbai, has acquired 30 acres in Gurugram to add to its growing office portfolio.“The company hasn’t raised any foreign capital to develop projects. We bought back all foreign partners in 2018,” the executive said.In one of the largest buybacks by a private company, RMZ Corp recently purchased 45% shares held by QIA and Baring Private Equity Partners for around $1billion.In 2013, QIA had invested ?600 crore in RMZ Corp for a 23% stake, while Baring Private Equity Partners had invested ?450 crore in 2012 for a 21% stake in the holding company, RMZ Infotech. The homegrown firm currently has over 35 million sq ft of project operational assets across major cities in the country. RMZ Corp also plans to acquire assets in key markets such as Bengaluru, Mumbai, Chennai and Hyderabad.",QGEN,en,The Economic Times India
2019-06-11 08:22:00-05:00,Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now,"QIAGEN (QGEN) is enjoying investors' high confidence, courtesy of the QIAstat-Dx system.",QGEN,en,Zacks Investment Research
2019-06-06 08:58:00-05:00,QIAGEN-DiaSorin Union to Enhance QuantFERON for Lyme Disease,QIAGEN (QGEN) expects multi-site clinical validations for this new system during 2020 Lyme disease season.,QGEN,en,Zacks Investment Research
2019-06-05 08:30:40-05:00,Qiagen (QGEN) Up 4% Since Last Earnings Report: Can It Continue?,Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,QGEN,en,Zacks Investment Research
2019-05-20 09:53:27-05:00,"Qiagen Snags FDA Nod For Molecular Diagnostic System, Announces US Launch","Qiagen NV (NYSE: QGEN ) shares were spiking higher Monday following the announcement of FDA approval for its molecular diagnostic testing system. What Happened Germany-based Qiagen, a provider of sample and assay technologies for molecular diagnostics and applied testing, said the FDA has given 510(k) clearance for its QIAstat-Dx syndromic testing system. Following the clearance, the company announced the U.S. launch of the testing system along with the multiplex QIAstat-Dx Respiratory Panel for simultaneous qualitative detection and identification of multiple respiratory viral and bacterial pathogens. QIAstat-Dx is a … Full story available on Benzinga.com",QGEN,en,Benzinga
2019-05-17 10:53:03-05:00,QIAGEN Partners Inovio to Develop Companion Diagnostics,QIAGEN's (QGEN) Sample to Insight workflows and expertise in developing diagnostic solutions will aptly compliment Inovio regarding Precision Medicine in immuno-oncology.,QGEN,en,Yahoo Finance
2019-05-16 15:16:13-05:00,Qiagen teams up with Inovio to develop liquid biopsy companion diagnostic,No summary available.,QGEN,en,Seeking Alpha
2019-05-13 13:32:00-05:00,Qiagen Looks to Growth in the Second Half of the Year,The QIAstat should accelerate growth for the diagnostic testing company.,QGEN,en,The Motley Fool
2019-05-10 07:20:04-05:00,Qiagen to buy back fourth tranche of shares,QIAGEN N.V. (QGEN) has initiated the repurchase of the fourth tranche of 2M common shares announced on January 31. The transactions will be executed exclus,QGEN,en,Seeking Alpha
2019-05-07 19:23:30-05:00,Qiagen NV (QGEN) Q1 2019 Earnings Call Transcript,"QGEN earnings call for the period ending March 31, 2019.",QGEN,en,The Motley Fool
2019-05-07 14:37:04-05:00,Qiagen NV (QGEN) CEO Peer Schatz on Q1 2019 Results - Earnings Call Transcript,"Qiagen NV (NYSE:QGEN) Q1 2019 Earnings Conference Call May 07, 2019, 09:00 ET Company Participants John Gilardi - VP, Corporate Communications & IR Peer Sch",QGEN,en,Seeking Alpha
2019-05-06 17:45:06-05:00,Qiagen (QGEN) Tops Q1 Earnings Estimates,"Qiagen (QGEN) delivered earnings and revenue surprises of 3.85% and -0.76%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",QGEN,en,Zacks Investment Research
2019-05-06 15:55:53-05:00,"Qiagen Q1 top line up 2%, earnings down 9%",QIAGEN N.V. (QGEN) Q1 results ($M): Sales: 348.7 (+1.5%); consumables & related: 313 (+2%). Net income: 29.5 (-8.7%); non-GAAP net income: 62.0 (+4.0%); EP,QGEN,en,Seeking Alpha
2019-05-06 15:25:07-05:00,"Qiagen beats by $0.01, misses on revenue",Qiagen (QGEN): Q1 Non-GAAP EPS of $0.27 beats by $0.01; GAAP EPS of $0.13. Revenue of $348.7M (+1.5% Y/Y) misses by $2.98M. Press Release,QGEN,en,Seeking Alpha
2019-05-05 16:35:29-05:00,Qiagen Q1 2019 Earnings Preview,No summary available.,QGEN,en,Seeking Alpha
2019-05-03 07:36:00-05:00,Why Earnings Season Could Be Great for QIAGEN (QGEN),QIAGEN (QGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,QGEN,en,Zacks Investment Research
2019-04-29 09:31:41-05:00,Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,QGEN,en,Zacks Investment Research
2019-04-19 14:40:03-05:00,"Qatar's sovereign fund, Crown Acquisitions named as investors in...",Qatar Investment Authority (QIA) and private realty firm Crown Acquisitions said on Friday they were the unnamed investors in a deal with Vornado Realty Trust valued at $5.56 billion that involves a portfolio of prime New York retail properties.,QGEN,en,Reuters UK
2019-04-19 14:35:45-05:00,"UPDATE 2-Qatar's sovereign fund, Crown Acquisitions named as investors in $5.6 bln New York deal",Qatar Investment Authority (QIA) and private realty firm Crown Acquisitions said on Friday they were the unnamed investors in a deal with Vornado Realty Trust valued at $5.56 billion that involves a portfolio of prime New York retail properties.,QGEN,en,Reuters
2019-04-19 11:41:46-05:00,UPDATE 1-Qatar's sovereign fund joins Crown Acquisitions to buy NY properties,Qatar Investment Authority (QIA) and private realty firm Crown Acquisitions have jointly bought a significant stake in a portfolio of prime New York retail properties owned by Vornado Realty Trust.,QGEN,en,Reuters
2019-04-19 11:28:20-05:00,Qatar's sovereign fund joins Crown Acquisitions to buy NY properties,Qatar Investment Authority (QIA) and private realty firm Crown Acquisitions have jointly bought a significant stake in a portfolio of prime New York retail properties owned by Vornado Realty Trust.,QGEN,en,Reuters
2019-04-16 04:54:00-05:00,QIAGEN Drives Molecular Diagnostics Suite With New Test Kit,QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification.,QGEN,en,Zacks Investment Research
2019-04-03 15:18:57-05:00,LabCorp on board with Qiagen companion diagnostic access program,No summary available.,QGEN,en,Seeking Alpha
2019-03-29 03:11:00-05:00,"QIAGEN Unveils Liquid Biopsy Workflows & Panels, Widens Suite",QIAGEN (QGEN) is progressing well with its testing menu expansion strategy.,QGEN,en,Zacks Investment Research
2019-03-22 07:16:07-05:00,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 21) Abbott Laboratories (NYSE: ABT ) Baxter International Inc (NYSE: BAX ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) CareDx Inc (NASDAQ: CDNA ) Catalyst Pharmaceuticals Inc (NASDAQ: CPRX ) CYCLERION THERA/SH (NASDAQ: CYCNV ) Glaukos Corp (NYSE: GKOS ) Masimo Corporation (NASDAQ: MASI ) Merck & Co., Inc. (NYSE: MRK ) Qiagen NV (NYSE: QGEN ) Uniqure NV (NASDAQ: QURE ) Veracyte Inc (NASDAQ: VCYT ) XBiotech Inc (NASDAQ: XBIT ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on March 21) Biogen Inc (NASDAQ: BIIB )( discontinued development of one of its Alzheimer's candidate aducanumab) Unity Biotechnology Inc (NASDAQ: UBX ) Stock In Focus Immutep Granted U.S. Patent For its Cancer Treatment Method Australian biotech IMMUTEP LTD/S ADR (NASDAQ: IMMP ) has been granted a new patent entitled … Full story available on Benzinga.",QGEN,en,Benzinga
2019-03-21 06:51:16-05:00,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 20) AstraZeneca plc (NYSE: AZN ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) Cytokinetics, Inc. (NASDAQ: CYTK )(Following planned interim analysis, the company along with partner Amgen, Inc. (NASDAQ: AMGN ) (announced a large-scale Phase 3 study evaluating their cardiac myosin activator omecamtiv mecarbil in 8000 heart failure patients will continue unchanged.) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND ) Orthopediatrics Corp (NASDAQ: KIDS ) Qiagen NV (NYSE: QGEN ) Veracyte Inc (NASDAQ: VCYT ) XBiotech Inc (NASDAQ: XBIT ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 20) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Evogene Ltd (NASDAQ: EVGN ) G1 Therapeutics Inc (NASDAQ: GTHX ) resTORbio, Inc. (NASDAQ: TORC ) (priced its common stock offering …",QGEN,en,Benzinga
2019-03-15 16:07:59-05:00,"Notable Friday Option Activity: QGEN, PSMT, UBNT",Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Qiagen NV Symbol QGEN where a total of 9 286 contracts have traded so far representing approximately 928 600 underlying shares That amounts to about 65 of QGEN s average,QGEN,en,Nasdaq
2019-03-15 07:36:17-05:00,Qiagen started at neutral with $42 stock price target at UBS,"This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.",QGEN,en,MarketWatch
2019-03-08 07:25:10-05:00,Qiagen teams up with Tecan to improve tuberculosis test,No summary available.,QGEN,en,Seeking Alpha
2019-02-21 13:59:02-05:00,HTG Molecular up 15% on amended deal with Qiagen,No summary available.,QGEN,en,Seeking Alpha
2019-02-05 17:45:08-05:00,QIAGEN NV (QGEN) CEO Peer Schatz on Q4 2018 Results - Earnings Call Transcript,No summary available.,QGEN,en,Seeking Alpha
2019-02-05 09:15:05-05:00,Qiagen N.V. 2018 Q4 - Results - Earnings Call Slides,No summary available.,QGEN,en,Seeking Alpha
2019-02-04 16:07:42-05:00,"Qiagen EPS in-line, misses on revenue",No summary available.,QGEN,en,Seeking Alpha
2019-01-14 16:05:29-05:00,New Qiagen TB test OK'd in Canada,"Health Canada approves QIAGEN's (QGEN) QuantiFERON-TB Gold Plus, an in vitro diagnostic test that detects latent tuberculosis infection. The company says i",QGEN,en,Seeking Alpha
2019-01-14 16:05:29-05:00,New Qiagen TB test OK'd in Canada,"Health Canada approves QIAGEN's (QGEN) QuantiFERON-TB Gold Plus, an in vitro diagnostic test that detects latent tuberculosis infection. The company says i",QGEN,en,Seeking Alpha
